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ABSTRACT
A review of the literature concerning cobalt, vitamin E, and selenium and their 
effects on immunity in ruminants is included, concentrating particularly on the 
definition and diagnosis of cobalt deficiency.
Five experiments are reported, the first three of which explore the requirement of 
goats for cobalt to prevent subclinical deficiency. Included in this is the effect of 
cobalt supplem entation on immunity, and also a prelim inary investigation of 
different forms of vitamin E supplementation and their suitability for treating vitamin 
E deficiency. In each experiment 24 feral cross goats were depleted of cobalt and 
then assigned to various levels of cobalt supplementation. In experiments 1 and 2 
half the goats were supplemented with vitamin E in the last month of the experiment.
The symptoms of vitamin deficiency observed included loss of weight, loss of 
appetite, pale mucous membranes and 'weepy eyes'. Concentrations less than 0.07 
mgCo/kgDM in the diet are likely to lead to deficiency and this is between the 
comparable requirements for cattle (0.04-0.07) and sheep (0.07-0.08). Deficiency is 
best confirmed by measuring both MMA and vitamin B^  ^ concentrations. Serum 
MMA concentrations between 15-20 //mol/1 and serum vitamin B^  ^concentrations 
between 50-100 ng/1 were associated with subclinical deficiency, and these differ 
from the levels associated with subclinical deficiency in sheep (MMA 10-15 //mol/1, 
Bj2  200-400 ng/1) and cattle (MMA 2-4 //mol/1, Bj^ 150-200 ng/1). Serum succinate 
was not found to be reliable as an indicator of cobalt status. No effects on immune 
function were observed. Both oral and injectable vitamin E treatments raised plasma 
vitamin E concentrations, although the injectable treatment produced a rapid but 
short lived response, whereas daily oral supplementation produced a more gradual 
but long term response. Erythrocyte stability appeared to show some promise as a
15
method of detecting vitamin E deficiency, but results were not conclusive. Results of 
these experiments are discussed and compared with the relevant literature.
The fourth experiment investigated different methods of supplementing calves with 
vitamin E. Twelve calves were depleted of vitamin E and then randomly assigned to 
three groups, receiving either oral, injectable or no vitamin E supplement. Half the 
calves on each treatment also received injections of vitamin Again injection of 
vitamin E was found to produce a rapid, massive but short lived response in plasma 
vitamin E concentrations; however repeated injections produced an adverse reaction 
if insufficient time (<  3 weeks) was left between treatments. Oral supplementation 
produced a more gradual, but sustained response with no adverse reactions. Thus 
injection is highly suitable for rapid treatm ent of deficient anim als, but oral 
supplementation is a more long term solution where instant effects are not required. 
In calves erythrocyte stability was unsuitable as an indicator of vitamin E status. A 
small increase in % kill of E.coli and C. albicans but not of S, aureus was observed 
in the vitamin Bj^ supplemented calves, but no effect of vitamin E status was 
observed. Results are discussed and compared to other results in this field.
The final experim ent investigated the effect of cobalt deficiency on appetite 
preference in sheep, and by means of different treatments, oral cobalt, vitamin B^  ^
injection, and methionine injection, attempted to gain some insight into the metabolic 
reason behind this phenomenon. Thirteen mature Suffolk cross castrates were 
maintained on a cobalt deficient diet, until they showed loss of appetite; they were 
then given one of the three treatments to see if this would restore their appetite. 
Vitamin B^  ^ injections produced a rapid response, while cobalt treatment was also 
effective but took longer to work. Methionine treatment failed to improve appetite, 
suggesting that it is the failure of the propionate to succinate pathway which is 
responsible for the loss of appetite, and that it is absorbed vitam in B^  ^which 
reverses the symptoms and not free cobalt in the rumen. Results are discussed in the
16
light of other work.
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CHAPTER 1
LITERATURE REVIEW
19
1.1. COBALT.
1.1.1. History and discovery of cobalt and cobalt deficiency.
The first recorded descriptions of cobalt deficiency date back to Robert Frazer of 
Devon and James Hogg of Scotland, around 1800. It was found that in certain areas 
ruminants suffered from a wasting disease but on movement to 'healthy pasture' they 
recovered and from this they deduced that a deficiency was involved. Towards the 
end of the 19*^  century 'Tauranga disease' in sheep and 'Bush sickness' in cattle in 
New Zealand were discovered to be similar. Due to the anaemic symptoms iron was 
first suspected, and some iron ores were indeed found to alleviate the disease, 
'Limonite' being found to be both cheap and effective, (cited by Andrews 1970a).
However various other diseases, 'wasting disease' of western Australia, 'pining' in 
Britain, 'coast disease' also of Australia, 'N akuruitis' in Kenya, 'salt lick ' in 
Florida, 'Lechsucht' in Netherlands and Germany, 'G rand Traverse Disease' in 
Michigan and 'Mairoa dopiness' and a general unthriftiness observed in other areas 
of New Zealand, had similar symptoms, yet not all of these were associated with 
areas low in iron. In 1935 two separate groups in Australia, (cited by Andrews 
1970a), identified cobalt as the missing link. The affected areas were either deficient 
in cobalt or it was unavailable to the animal for some reason.
Research (reviewed by Smith and Loosli 1956) indicated that the majority of the 
dietary cobalt requirement of ruminants was used for the synthesis of vitamin B^  ^by 
the rumen micro-organisms, and that it was a deficiency of vitamin B^  ^ in the animal 
which caused the symptoms. Injection of vitamin Bj^ proved effective in preventing 
or curing the disease.
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1.1,2. Role of cobalt/vitamin B12
The major function of cobalt is as an essential component of vitamin (cobalamin) 
and little is known of any functions carried out by cobalt itself but Ibbotson et al 
(1970) suggest that it is involved in stimulating erythropoietin and hence in both red 
and white cell formation in the bone marrow. However, as neither injected vitamin 
Bj2  nor cobalt alleviated the condition they suggest that cobalt might be the precursor 
in the rumen for a second essential factor.
Vitamin B^  ^ is a coenzyme for several reactions of which two are well documented. 
During cobalt deficiency the activities of both these enzymes are impaired (Kennedy 
et al 1991a).
A. Methylmalonyl Co A Mutase.
M ethylm alonyl CoA mutase is required for the conversion of propionate via 
methylmalonyl CoA to succinate in the liver (Marston et al 1961):-
PROPIONATE
ATP 
\p CoA
PROPIONYL CoA
ATP 
Biotin 
\ |/  CO.
Propionyl CoA Synthetase
Propionyl CoA Carboxylase
D-METHYLMALONYL CoA
J/ Methylmalonyl CoA Racemase
L-METHYLMALONYL CoA 
B,12\y  coenzyme 
SUCCINYL CoA
Methylmalonyl CoA mutase
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The activity of methylmalonyl CoA mutase is limited by the availability of the 
coenzyme, vitamin rather than the enzyme itself (Peters and Elliot 1984). 
D uring vitam in deficiency propionate and m ethylm alonic acid (MMA) 
concentrations in the blood are elevated, and many o f the symptoms of cobalt 
deficiency have been attributed to impaired propionate metabolism. Recently 
succinate concentrations have been found to be elevated in the rumen, and in plasma 
during vitamin B^  ^deficiency (Kennedy et al 1991c & d, and Young et al 1991) and 
it has also been observed that succinate can be absorbed from the rumen. This would 
suggest a possible by-pass of propionate metabolism, due to lack of vitamin Bj^ in 
the rumen for conversion of succinate to propionate.
RUMEN LIVER
Succinate ........ > Succinate
Bj2  required Bj2  required
Propionate ------------------------>  Propionate
There is no evidence however that succinate from this source is as freely available to 
the host as succinate produced from propionate in the liver, Kennedy et al (1991c & 
d) and Young et al (1991) suggest that due to this by-pass, the block in the 
propionate to succinate pathway should not be critical, and no deficiency of glucose 
should result in the animal. However MacPherson et al (1973) found that glucose 
deficiency does occur in cobalt deficient ruminants, and Price (1991b) found that the 
breakdown in the propionate pathway occurs before the breakdown of 1-carbon 
metabolism. Thus although the by-pass may compensate to some extent, it is not 
sufficient to prevent cobalt deficiency from adversely affecting systemic metabolism 
of propionate.
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Many experiments have been done to determine whether vitamin deficiency is 
associated with the low milk fat syndrome in dairy cows. The accumulation of 
propionate due to decreased m etabolism  to glucose m ight upset the acetate : 
propionate ratio leading to decreased milk fat synthesis from acetate. However the 
results (cited by M acPherson 1982) failed to determ ine, conclusively, any 
relationship with vitamin B^  ^deficiency.
Lambs grazing pastures where many of the grasses were high in water soluble 
carbohydrates eg. fructan, had a greater requirement for cobalt if ovine white liver 
disease was to be prevented (Ulvund 1990/91).
In in vitro studies using rat liver supernatant fractions, methylmalonyl CoA was 
found to partially inhibit fatty acid synthesis and also to be incorporated into fatty 
acids in place of malonyl CoA (Cardinale et al 1970); the majority of fatty acids 
derived from m ethylm alonyl-CoA were branched, due to the presence of the 
additional methyl group. Further research (Frenkel et al 1973) revealed that 
propionyl CoA competed with acetyl CoA as a substrate for incorporation into fatty 
acids, p rov id ing  a m echanism  for odd chain fatty  acid p ro d u c tio n . Again 
methylmalonyl CoA was found to partially inhibit fatty acid synthesis (Frenkel et al 
1973). The presence of abnormal amounts of branched chain fatty acids, or odd 
chain fatty acids may be physiologically undesirable. Lambs born to vitamin B^  ^
deficient ewes were found to have increased amounts of branched chain fatty acids. 
(Duncan et al 1981).
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B. 5-Methyltetrahydrofolate-Homocysteine Methyltransferase.
The second enzyme, 5-methyltetrahydrofolate-homocysteine methyltransferase is 
involved in the recycling of methionine, catalysing the reaction
5-methyltetrahydrofolate B.. coenzyme methionine
4- --------------------Z> +
homocysteine tetrahydrofolate
Methylcobalamin, the vitamin Bj^ coenzyme, is required for the transfer of a methyl
group from 5-methyltetrahydrofolate to homocysteine.
Methionine recycling has been linked (Kennedy et. al. 1991e) to phosphatidylcholine 
metabolism
,S-adenosyl methionine (SAM)
Methionine S-adenosyl homocysteine
+  ^  (SAH)
tetrahydrofolate
homocysteine 
+
methyltetrahydrofolate
When methionine recycling is blocked this affects the ratio of SAM: SAH and SAM 
is involved in many transmethylation reactions (Stryer 1981) including conversion of 
phosphstidylethanolamine to phosphatidyl choline, conversion of noradrenaline to 
adrenalin, inactivation of catecholamines (noradrenaline and adrenalin) via catechol- 
0-methyltransferase, and méthylation of RNA and DNA, for identification of self 
and non-self nucleic acids.
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Methionine recycling is also linked to folic acid metabolism
HISTIDINE 
UROCANIC ACID
4-IMIDAZOLANE-5-PROPIONIC ACID
FORMIMINO-L-GLUTAMIC ACID (F 
^  TETRAHYDROFOLIC ACID
[GLU)
METHIONINE.
h o m o c y s t e iR e\
5-METHYLTETRAHYDROFOLATE
5-FORMIMINOTETRAHYDROFOLATE
GLUTAMIC ACID
Thus vitamin deficiency leads to elevated concentrations of homocysteine and 
FIGLU. During vitamin Bj^ deficiency a secondary folic acid deficiency is also 
observed. The 'm ethyl trap ' concept is based on the decreased activity of 5- 
methyltetrahydrofolate-homocysteine methyltransferase during cobalt/vitamin B^  ^
deficiency. Metabolically active folates become 'trapped ', and unavailable as 
methyItetrahydrofolates, because the formation of 5-m ethyltetrahydrofolate is 
essentially irreversible in vivo, thus a functioning methionine synthase is essential to 
reconvert methyltetrahydrofolate to tetrahydrofolate (Scott 1992, McDowell 1989). 
Increased proportions of methyltetrahydrofolate, and a decrease in tetrahydrofolate 
c o n ce n tra tio n s  led to the  m ethy l trap  h y p o th esis . In p a r tic u la r  10- 
formyltetrahydrofolate is used as a cofactor for two of the enzymes involved in 
purine biosynthesis and 5,10-methyIenetetrahydrofolate is involved in pyrimidine 
biosynthesis (Scott 1992) thus failure of m ethionine synthase to reconvert 5- 
methyltetrahydrofolate to tetrahydrofolate leads to decreased DNA and RNA 
biosynthesis.
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Sm ith and O sb o u rn e-W h ite  (1973) su g g est th a t the d ep le tio n  o f 
methyltetrahydrofolates in the liver is caused by the failure of the liver to retain 
folates due to a failure to synthesise pteroylpolyglutamates from monoglutamates, a 
failure to completely reduce folates leading to their non retention and a failure to 
transport folates into the deficient cells. Supplementary methionine has been found to 
improve folate retention and Smith and Osbourne-White suggest that vitamin 
may promote folate retention via methionine. As they point out, this would imply 
that a metabolic product was responsible for promoting its own synthesis, however 
in support of this hypothesis M cGing & Scott (1980) found that m ethionine 
supplementation partially reversed the decrease in folate uptake by the liver, of 
vitamin Bj^ deficient rats. Methionine is thought to influence folate metabolism in 
vitamin B^  ^ deficient ewes, by affecting the rate of transport of folates into the liver 
cells (Gawthorne and Smith 1974).
ATP, NADH and NADPH were found in lower concentrations in the livers of 
vitamin B^  ^ deficient ewes, while the ratio of K'‘/Na'^ was abnormally high (Smith 
et al 1974), which suggests that both respiratory derangement and failure of a 
transport process were occurring in the livers. Particularly high concentrations of 
methionine are required for the initiation of protein synthesis, and for maintainance 
of polyribosome integrity (McGown et al 1973, Park et al 1973), and the higher 
methionine requirement for folate retention than for lipid metabolism found by Smith 
et al (1974) may reflect a specific need of folate retention for methionine-initiated 
protein syntheisis.
In man an uninterrupted folate cycle appears to be a p rerequisite  for norm al 
synthesis of methylcobalamin (Quadros et al 1976), which is the cofactor required 
for the homocysteine to methionine reaction, whereas 5-deoxyadenosylcobalamin is 
required for the isomérisation of methylmalonate to succinate. The high tissue
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requirement of sheep for methylcobalamin, for methionine synthesis during wool 
production, exacerbates the shortage of 5-deoxyadenosylcobalamin available for 
propionate metabolism (Suttle 1988).
Folic acid deficiency in animals leads to anaemia and decreased growth, and the 
interference in tetrahydrofolate cycling affects purine synthesis, leading to decreased 
DNA synthesis. The methionine deficiency which results, leads to impaired nitrogen 
retention (decreased wool and body growth of sheep, Underwood 1981) and also to a 
decrease in available S-adenosyl methionine. Smith et al (1974) found that during 
cobalt deficiency the increase in lipids found in the livers of vitamin deficient 
sheep were associated with a decrease in choline concentrations. Injections of 
m eth ion ine, in to  v itam in B^^ d efic ien t sheep, co rrec t the decreased  SAM 
concentrations and lead to normal liver fat content by increasing the activity of liver 
methyltransferase (Ramos Anton et al 1991). An alternative methionine salvage 
pathway via SAM, and 5-S-methyl-thioadenosine, has been postulated by Abeles 
(1992), in both mammals and plants. It is possible that in ruminants this pathway is 
not activated before SAM becomes limiting.
Apart from its function in these two enzyme reactions it has been suggested that 
vitamin B^  ^ is also required for the synthesis of the thyroid hormones. In goats 
(Mgongo et al 1981) cobalt deficiency has been found to increase plasma thyroxine 
concentration, and the free thyroxine index, possibly by affecting the function of the 
hypothalamus.
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1,1,3. Factors affecting the requirement of ruminant animals for cobalt.
Cobalt availability to the ruminant depends on the amount in the soil, the amount 
taken up by the plants, which depends on the type of plant, and may be affected by 
other compounds in the soil (Burridge et al 1983). Different parts of the plant may 
contain differing concentrations of cobalt, and soil contamination greatly affects the 
amount of cobalt ingested (Burridge et al 1983). Pasture improvements may lead to 
cobalt deficiency in grazing livestock, as the species planted tend to take up less 
cobalt, increased growth of the sward decreases incidental soil cobalt ingestion and 
liming decreases the availability of cobalt to plants by increasing the pH of soils. 
The faster growth of animals on more productive pasture also increases the demand 
for cobalt (Paterson 1988). Given the fact that 'limonite' was initially used to treat 
deficiencies, it would appear that even highly insoluble compounds provide a source 
of available cobalt when fed, and certainly appreciable quantities of cobalt oxide and 
carbonate appear to be available (Smith and Loosli 1956).
The ruminant uses cobalt very inefficiently as the rumen microbes synthesise 
physiologically inactive «-analogues of vitamin Bj^, as well as 'true' vitamin B^ -^ 
The «-analogues of vitamin B^  ^are not thought to be absorbed in sheep, however 
there is some evidence that they may be in cattle (Paterson 1988). Some «-analogues 
of vitamin Bj^ are microbiologically active, and may be measured together with 
vitamin B^ ,^ leading to confusion and overestimation when trying to quantify vitamin 
Bj2  using some of the microbiological assays.
The composition of the diet may affect the efficiency of vitamin Bj^ synthesis and 
also the ratio of vitamin B^^^^^'^^^^ogue production. Alfalfa and high energy diets 
stimulate synthesis of all forms of vitamin B^ ,^ but favour «-analogues. High feed 
intakes and high forage diets encourage vitamin B^  ^ synthesis whereas cereals 
stimulate other derivatives (Sutton & Elliot 1972). Cobalt intake of the animal also
28
affects the ratio of vitamin to other derivatives; in animals with a low cobalt 
intake up to 15% of vitamin Bj^ produced may be 'true ', but when cobalt intake is 
high in sheep this can drop as low as 3% (cited by Underwood 1981). Parasitic 
infection may also affect vitamin B^  ^ synthesis, relative to the synthesis of a- 
analogues (Ramos Anton et al 1991), and high concentrations of molybdenum may 
also decrease vitam in Bj^ synthesis in cows. At low feed intakes vitam in B^  ^
production may be lim ited by feed intake before cobalt availab ility  (Smith & 
Marston 1970b) because of the lack of precursors for vitamin B^  ^ synthesis, or due 
to a decreased metabolic activity of the microbes involved. Supplementation of 
ruminants with the base 5,6-dimethylbenzimidazoIe (the precursor of 'true' vitamin 
Bj^) leads to increased synthesis of 'true ' vitamin B^  ^ rather than «-analogues 
(Gawthorne 1970), and has a sparing effect on cobalt (Rickard et al 1975).
Vitamin B^  ^ administered orally was found to be utilised very inefficiently, in fact 
parenterally administered vitamin Bj^ is 35 times more effective (Smith and Loosli 
1956). A group of closely related vitamin Bj^ compounds, the B-analogues of 
cobalam in , have been found to be u tilised  equally  e ffic ien tly  as they are 
interconvertible. Absorption of 'true' vitamin B,^ is poor and can be as low as 3-5% 
in cobalt deficient sheep, while absorption of supplemental cyanocobalamin given 
orally is even worse (Smith & Marston 1970b). Parasitic infection decreases the 
efficiency of absorption of vitamin B^  ^ (Ramos Anton et al 1991).
Ruminants have been found to have a far larger requirement for cobalt than non­
ruminants. Not only because of the inefficiency of incorporation of cobalt into 
vitamin Bj^, or because they absorb vitamin Bj^ much less efficiently than non­
ruminants, but in addition to this they actually have a greater requirem ent for 
vitamin B^  ^ due to its important role in the metabolism of propionate, the synthesis 
of which is a feature of ruminant digestion. In ruminants carbohydrates are broken
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down in the rumen into acetic, propionic and butyric acids, and a combination of 
these three volatile fatty acids is absorbed directly from the rumen. Propionate is the 
sole gluconeogenic volatile fatty acid produced during normal rumen fermentation.
A regular supply of vitamin is required because large excesses in production 
rarely occur in the rumen, and because it is very poorly absorbed. It is stored in the 
liver, kidneys and muscle but not to any great extent, as supply rarely exceeds 
requirement, thus low intakes of cobalt are tolerated only in the short term since 
tissue stores are soon depleted when metabolic demand for the vitamin exceeds the 
amount absorbed from the gut. In the tissues vitamin Bj^ is always found bound to 
another molecule, cobalophilin, and in the gut vitamin Bj^ must be bound to intrinsic 
factor before absorption can take place in the lower intestine.
Sheep are more susceptible to vitamin B^  ^deficiency than cattle (Andrews 1970a), 
and thus have a greater requirement for cobalt; young ruminants are also particularly 
susceptible, possibly because they have no opportunity to build up any stores of 
vitamin B^  ^ (Underwood 1981).
Pasture concentrations below 0.08 mgCo/kgDM (for sheep) or 0.04 mgCo/kgDM 
(fo r  c a ttle )  a re  lik e ly  to re su lt  in d e fic ien cy  (A ndrew s 1970a) a lth o u g h  
concentrations slightly above 0.04 mgCo/kgDM were found to be inadequate for 
calves under certa in  cond itions (M acPherson et al 1973). A lte rn a tiv e ly  
0.07mgCo/kgDM  is the minimum requirement according to Underwood (1981) 
though he recommends an allowance of O.llmgCo/kgDM. It is usually assumed that 
the 0.11 mgCo/kgDM recommended for cattle and sheep will be sufficient for goats 
also, although little research has been done specifically on goats.
Platten (1951) suggests that lactating goats require up to four times the daily cobalt 
intake recommended for sheep. However as the amount is not expressed per kgDM
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intake the difference in feed intake may account for some of this. Goats maintained 
on 0.01 mg/kgDM became deficient (Mgongo et al 1984), while those receiving
0.035 mg/kgDM showed no symptoms during a four month period (Clark et al
1987). Serum vitamin concentrations for the untreated goats decreased below 
100 pmol/1 which would be taken as indicative of marginal deficiency in sheep.
The requirement for cobalt is increased when livestock graze pastures containing the 
grass 'Phalaris tuberosa'. This contains the alkaloid tryptomena, a neurotoxin which 
can be neutralised by the rumen microbes. If the alkaloid is not neutralized the 
condition known as 'phalaris staggers' develops (Lee and Kuchel 1953). Cobalt leads 
to proliferation of the rumen micro-organisms and it is therefore the element itself 
that is required as opposed to vitamin B^  ^ and the action is specific to cobalt, as 
copper, iron, zinc etc. do not produce the same effect (Lee et al 1957).
1.1.4. Deficiency symptoms
The designation 'enzootic marasmus' describes the deficiency which begins, as body 
stores of vitamin B^  ^ become depleted, with a loss of appetite and decreased live 
weight gain. These accelerate and rapid muscle wasting (marasmus) begins and pica 
or depraved appetite may be observed before the onset of severe anaemia which 
eventually results in death, (Underwood 1981). Symptoms of cobalt deficiency may 
sometimes not become apparent (MacPherson 1982) in housed animals, suggesting 
that some form of stress is required to precipitate the clinical signs.
In animals with severe vitamin Bj^ deficiency, visual symptoms include pale mucous 
membranes, skin fragility and lachrymation in sheep and rough coats and increased 
nervousness in cattle. The animals become extremely emaciated and have virtually 
no body fat except for an accumulation in the liver. Smith and M arston (1970a)
31
attribute the loss of weight to metabolic inefficiency due to lack of vitamin in 
addition to the resulting loss of appetite.
C linical deficiency is easily recognised by the symptoms given earlier, but 
subclinical or marginal deficiency, which may well cause major economic loss, is 
difficult to detect. The decreased weight gain, general unthriftiness and increased 
susceptibility to disease are uneconomic but not specific to vitamin B^  ^ deficiency. 
Delayed involution of the uterus, reduction in oestrus, and low sperm counts in 
mature animals (Hidiroglou 1979), and decreased viability of the young, particularly 
lambs between 11 and 17 weeks of age (Duncan et al 1981) also decrease profits, 
but again could be due to any number of causes. Only by measuring the response of 
the animal to cobalt or vitamin Bj^ can vitamin Bj^ deficiency be verified.
The pathological consequences of vitamin B^  ^deficiency include decreased appetite, 
po lioencephalom alac ia  (ce llu la r oedem atous changes in the grey  m atter), 
neurological lesions, white liver disease (fatty degeneration of the liver), cellular 
in filtra tion , bile duct p ro liferation , and release of liver enzym es (aspartate 
aminotransferase, GOT). Some of these symptoms are similar to those produced by 
other deficiencies and this is thought (Suttle 1988) to be because they are the end 
result of a defect in the same biochemical pathway, eg. impaired gluconeogenesis 
produces lesions in the brain in both thiamine and vitamin B^  ^deficiencies, while 
impaired gluconeogenesis in the liver induces similar symptoms in both biotin and 
vitamin B^  ^deficiencies.
Ovine white liver disease, which is also thought to occur in goats, (Black et al
1988) is associated with cobalt/vitamin B^  ^deficiency and diets high in soluble 
carbohydrate (Sutherland et al 1979, Mitchell et al 1982, McLoughlin et al 1986 
and Ulvund 1990/91). On such diets, sheep and goats (but not cattle and red deer) 
synthesise increased amounts of branched chain fatty acids from MMA in their
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livers. A pale swollen liver with diffuse fatty hepatocytes results.
1.1.5. Diagnosis
Determination of levels of ex tractable cobalt in soil or total cobalt in the diet may 
give some indication of whether cobalt supply to livestock is likely to be adequate, 
but analysis of vitamin concentrations in the animal takes absorption and inactive 
analogues into consideration.
Plasm a cobalt concentrations could be m isleading as they do not necessarily 
represent vitamin B^ .^ Liver vitamin Bj^ concentration is a useful indicator of 
vitam in B^  ^ status, but liver samples are not readily obtained. Blood is more 
accesible for sampling and serum vitamin B^  ^ concentrations are widely used for 
assessing vitamin B^  ^ status in man and in the sheep.
Commonly accepted critical diagnostic concentrations (ng vitamin Bj^/l) are (VIC 
Auchincruive):-
Deficient Marginal Adequate
Sheep <200 200-400 400-2500
Cattle < 150 150-200 200-2500
In sheep inactive «-analogs are not thought to occur to any great extent in serum 
making up only 8-14% of total corrinoids; in cattle however they are thought to 
constitute up to 50% of total corrinoids (Halpin et al 1984). In addition variation in 
serum vitamin Bj^ concentrations between individual animals can be large so it is 
best to sample more than a few animals.
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Quantification of serum or plasma vitamin concentrations is also complicated by 
the presence of binders. Vitamin B^  ^ is never found free in the body, intrinsic factor 
is required for absorption and from there on it is passed from one binder to another. 
In sheep vitamin Bj^ is found bound to transcobalamin 2, in cattle however as well 
as this binder there are two others, transcobalamin 1, and transcobalamin 0 which is 
thought to be either a polym eric form of transcobalam in 1 or a com plex of 
transcobalamin 1 with other plasma proteins. Price (1991) found that boiling in 
cyanide was sufficient to release vitamin B^  ^ from transcobalamin 2, but not from 
the transcobalamins 1 or 0 found in cattle. This means that analysis of vitamin B^  ^ in 
cattle plasma may be an underestimate of the total amount present, and could 
therefore lead to an overestimate of the prevalence of vitamin B^  ^ deficiency in this 
species.
Liver diseases may affect vitamin B^  ^ concentrations (Andrews 1970b), and also 
prolonged yarding can lead to increased serum vitamin B^  ^ concentrations. In 
addition to these problems vitamin B^  ^ itself is not a sensitive index of deficiency as 
it shows a storage type response to cobalt supply (Suttle 1986), therefore other 
parameters have been considered.
Serum or urinary MMA concentrations can be measured. However urine samples 
require special techniques for collection, and serum MMA concentration is a 
sensitive indicator of an existing vitamin B^  ^deficiency in sheep (Rice et al 1987).
Commonly accepted critical diagnostic serum MMA concentrations (/xmol/l) are:-
Deficient Marginal Adequate
Sheep >15 10-15 <5(10*)
Cattle > 4  2-4 < 2
*(10) when fed concentrate rations.
34
Andrews (1970b) found MMA concentrations in urine increased rapidly in young 
lambs grazing cobalt deficient pastures, before serum vitamin concentrations 
decreased to levels associated with deficiency. This suggests that low blood vitamin 
B ^ 2  concentrations are not always the first indicator of deficiency.
Rumen MMA concentrations in sheep are also elevated by a cobalt deficient diet 
(Rice et al 1989) but the MMA is not absorbed and does not affect plasm a 
concentrations. According to Lough and Calder (1976) sheep fed a diet of rolled 
barley had elevated MMA concentrations between 10 and 20 mg/1 in their urine and 
they also found evidence of high concentrations of ethylmalonic acid (EMA) in the 
urine. However O 'Harte et al (1989a) found that the low concentrations found in 
plasm a did not in terfere  with test results for vitam in B^  ^deficiency, although 
O'Harte et al (1989b) recommended that 10 /xmoVl be regarded as the upper limit 
of norm ality for concentrate fed sheep. Inappetance due either to the cobalt 
deficiency itself or to parasite infestations may lead to decreased concentrations of 
propionate in the rumen and hence to decreased concentrations of MMA in serum, 
thus some false negatives make it advisable to sample several animals in any group 
(Paterson 1988, Paterson and MacPherson 1990).
O ccasionally m ethylcobalam in deficiency might be of greater in terest than 
adenosylcobalamin deficiency (which is what MMA concentration indicates) and so a 
separate marker for this has been considered. Formiminoglutamate (FIGLU), an 
intermediate in the degradation of histidine has been suggested as an indicator for 
impaired vitamin B^^-dependent methyltransferase activity. Gawthorne (1968) has 
reported that the urinary concentration of this metabolite was a sensitive indicator for 
cobalt/vitamin B^  ^deficiency in lambs and was elevated prior to plasma MMA 
concentrations. However other workers (Stebbings & Lewis 1983 and 1986, Skinner 
1983) found that FIGLU concentrations were only elevated in severe vitamin Bj^
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deficiency after clinical signs of deficiency were apparent, and they concluded that 
FIGLU was unreliable as an indicator for the deficiency. Price (1990) compared 
MMA concentrations with various other parameters and found that plasma urocanate 
response to histidine infusions could be used to detect deficiency. However 
propionate metabolism was found to be affected earlier in vitamin deficiency 
than 1-C metabolism hence it was concluded that MMA concentrations were a better 
indicator of deficiency than plasma urocanate response to histidine infusion.
Other parameters which decrease during vitamin Bj^ deficiency include plasma 
glucose (due to impaired propionate metabolism), alkaline phosphatase, ascorbic acid 
(due to liver damage) and thiamine concentrations (MacPherson et al 1973). 
Param eters which increase during vitam in Bj^ deficiency include aspartate 
am inotransferase (due to liver dam age), and pyruvate concentrations (due to 
thiamine deficiency). These parameters are all non-specific and could also be due to 
many other factors.
Recently during experiments concerned with whether succinate concentrations, in 
both rumen and plasma are affected by cobalt deficiency Kennedy et al (199Id) 
postulated the following critical plasma concentrations (jixmol/1).
Deficient Marginal Adequate
Sheep 24-33 14-24 10-14
The consensus of opinion to date appears to suggest that the use of both vitamin B^  ^
concentrations and MMA concentrations in conjunction leads to the most reliable 
diagnosis especially where sub-clinical vitamin Bj^ deficiency is concerned. (Fisher 
and MacPherson 1990, Paterson and MacPherson 1990).
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1.1.6. Effects of cobalt on feed intake
Failure to metabolise propionate normally (Marston et al 1961), and hence its 
presence in increased concentrations, and proportions relative to the other volatile 
fatty acids in tissues, is thought to be the main cause of the lack of appetite seen in 
vitamin Bj^ deficient animals (Marston et al 1972). Increased concentrations of both 
acetate and propionate were found in the blood of vitamin Bj^ deficient sheep 
(Marston et al 1972), and acetate was metabolised at a slower rate than in control 
sheep. The vitam in Bj^ deficient anim al also tends to have a preference for 
roughage, as opposed to concentrates which lead to a propionate type fermentation 
(MacPherson 1982). Ketelaars and Tolkamp (1992) in their recent review of feed 
intake regulation hypothesise that voluntary food intake is regulated to maintain 
maximum efficiency of oxygen utilization. This would be achieved by an optimum 
intracellular acid load (pH), which in turn would depend on an optimum volatile 
fatty acid concentration in all body compartments. Hence increases in propionate 
concentrations would be unfavourable.
Metabolites known to affect appetite include oestrogens, gastrin, secretin, bombesin, 
CCK and acetyl choline. However a link between these parameters and vitamin B^  ^
deficiency has yet to be established.
Infusion of sodium propionate or sodium acetate into the rumen of lactating cows 
caused a depression in hay or silage intake in a dose related manner, however at 
physiological concentrations effects were not significant (Anil et al 1993). 
Propionate infusion into the hepatic portal vein of sheep has been found to decrease 
intake (Forbes 1983, Farningham 1990), and it is also known that propionate 
clearance from plasma during vitamin Bj^ deficiency is depressed (Marston et al 
1972). Low doses of propionate (200kcal) have been found to produce an apparent 
increase in chaff intake, whereas higher doses (300 kcal) lead to decreases in intake
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(U lyatt 1965, cited by Church 1971). The in itial increase m ight be due to a 
preference for roughage. Acetate is thought to exert its effects on feed intake via 
receptors in the rumen wall, while propionate receptors are thought to be located in 
the liver, alternatively both acetate and propionate may exert their effects via 
osmotic mechanisms (Anil et al 1993). Intraruminal propionate infusion has been 
found to increase plasma insulin (de Jong 1981), even when plasma propionate 
concentrations remained unchanged (Bhattacharyla & Alulu 1975, cited by Forbes 
1986). This suggests that the effect of propionate on appetite may be complex, 
involving changes in insulin metabolism.
Non-ruminants suffering from a protein imbalance due to lack of methionine show 
loss of appetite. In ruminants this is unusual because microbial protein synthesis 
from non-protein nitrogen and sulphur corrects for any deficiencies in the diet. 
H ow ever if  m ethionine recycling was upset this would resu lt in an increased 
requirement for methionine, and might lead to an imbalance and loss of appetite. If 
this were the case then supplying the deficient animal directly with methionine would 
be expected to alter the preference of vitamin Bj^ deficient animals for forage rather 
than concentrates. The mode of action here is not known but might involve knock on 
effects to other amino acids such as tyrosine which are known to be precursors of 
neurotransmitters and so could exert an effect via the central nervous system.
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1.1.7. Evidence Suggesting Cobalt/Vitamin Status Affects the Immune 
System.
Cobalt deficiency is generally accompanied by decreased plasma concentrations of 
ascorbic acid. In 1976 M acPherson et al suggested this decrease m ight be 
responsible for the deficiency in the immune response, which resulted in far more 
cobalt deficient animals succumbing to infection than did cobalt adequate ones. 
However in 1982 MacPherson cited work that suggested ascorbic acid was not 
involved and that the observed effects of cobalt deficiency were due to changes in 
propionate and glucose metabolism.
The earliest work relating cobalt intake to resistance to infection investigated the 
resistance of lambs to worm (mainly Haemonchus contortus) infestations. These 
studies (Weir et al 1948, Shumard et al 1956, Threkeld et al 1956 and Downey 
1965 and 1966b) suggested that the parasite  had a cobalt requirem ent since 
supplementation apparently benefited the parasite, leading to increased fecundity of 
the worm and causing increased anaemia and mortality rate in the host. Certainly 
Diphyllobothrium latum has been found to cause pernicious anaemia in man (Nyberg 
1963) as in this case the worm is capable of utilizing vitamin bound to Intrinsic 
Factor in digesta.
However, other studies (Weir et al 1948, Richard et al 1954 and Downey 1966a) 
have indicated increased host resistance to infection, which appears to be a direct 
contradiction. Differences in worm burden used may however be responsible. The 
first group of experiments used in excess of 20,000, and in most cases 50,000 worm 
larvae, whereas the other experiments used fewer (15,000) worm larvae, or larger 
numbers administered in more than one dose. When large worm burdens were 
involved it would appear that the worms utilise the cobalt or vitamin B^ ,^ and the 
host in effect receives little of the supplement. However when smaller worm burdens
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were involved the host immune response may have been stimulated by increased 
vitamin synthesis and absorption following cobalt supplementation.
Recent work by MacPherson et al (1987a) in cattle showed that in cobalt deficient 
animals, Ostertagia ostertagi had a shorter prepatent period and produced more 
eggs, also the increase in plasma pepsinogen concentrations o f the host during 
infection was smaller in cobalt deficient cattle than in cobalt supplemented animals. 
Ferguson (1990) found similar effects on Ostertagia circumcincta infection in sheep, 
and also significantly higher mortality in the deficient sheep. In 1969 Michel and 
Sinclair showed that Ostertagia ostertagi infection is controlled immunologically, 
which suggests that the immune response of cobalt deficient animals is impaired. 
However Klesius (1988) reported that immunity to Ostertagia ostertagi is very 
slowly acquired and is weak even then. The response is mediated by antibodies 
(hum oral) and also by IgE and m ast cells  (ce llu la r im m unity ), and th is is 
accompanied by an increase in eosinophils. The immune response can however be 
suppressed by the infestation itself, particularly in young animals.
In 1976 Kaplan and Basford looked at the effect of vitamin B^  ^ deficiency on 
polymorphonucleocyte (PMN) activity in humans. They concluded that deficiency 
did no t a ffe c t p h a g o c y to s is , bu t did d ec rease  the  % k ill  o f  the  in g ested  
Staphylococcus aureus, by the PMN, which was not so during folic acid deficiency. 
Vitamin Bj^ deficiency also decreased metabolic activation (Hexose monophosphate 
shunt activation) as determined from the evolution of carbon dioxide, after thirty 
minutes incubation in the presence of glucose.
Ludovici and Axelrod (1951) found no effect of vitamin B^  ^ deficiency on the 
hemagglutination antibody response of rats to human erythrocytes. It is worth noting 
that pteroylglutamic acid deficiency severely impaired this response. Das and
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Hoffbrand (1970) found enlarged lymphocytes and a different chromatin pattern, 
more finely reticulated and open, in pernicious anaemia patients, who cannot absorb 
vitamin because they lack intrinsic factor. These lymphocytes had a greater 
incorporation of radiolabelled thymidine, which was less susceptible to inhibition by 
deoxyuridine. The lymphocytes were described as being more megaloblastoid. They 
concluded that the deficiency resulted in decreased méthylation of deoxyuridylate to 
thymidylate, for which 5,10-m ethylene tetrahydrofolic acid is required. This is 
absent in both folic acid and vitamin Bj^ deficiency. Thymine, for incorporation into 
DNA, is generated by a second pathway, involving thymidine kinase, which has 
increased activity during vitamin B^  ^deficiency.
MacCuish et al (1974) found normal concentrations of B and T lymphocytes in 
pernicious anaemia patients, but radiolabelled thymidine uptake by lymphocytes was 
decreased, suggesting decreased lymphocyte transformation, when they were 
exposed to the PHA m itogen. Further work suggested that blastogenesis was 
unaffected but that labelled thymidine incorporation was decreased, which could be 
due to a defect in thymidine synthetase activity. Thus vitamin B^  ^ seems to mediate 
its effects via the decrease in the availability of folate coenzymes required for 
thymine synthesis.
W right, M acPherson and Taylor (review ed by M acPherson 1982) found that 
neutrophils from cobalt supplemented calves were generally 50% more effective at 
killing C. albicans once ingested, than were neutrophils from cobalt deficient calves. 
MacPherson et al (1987a), Paterson and MacPherson (1987) and Fisher and 
MacPherson (1986) also found that cobalt deficiency led to decreased % kill of C. 
albicans in calves and lambs, and that this was only gradually restored on repletion 
(Paterson & MacPherson 1987). Fisher (1988) suggested that this was a direct effect 
of vitamin Bj^ deficiency as sub-clinical deficiency also affected % kill. Indeed the 
decreased neutrophil function was observed in these experim ents p rio r to the
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elevation in MMA concentrations, suggesting that it is a direct result of deficiency, 
not simply a result of the decreased appetite. Kaplan and Basford (1976) suggested 
that vitam in B^  ^deficiency in humans led to decreased activity  of the hexose 
monophosphate shunt and this could also be the mode of action of vitamin Bj^ 
deficiency in ruminants.
Vitamin Bj^ deficiency in humans leads to decreased cell division, particularly of 
those cells which undergo rapid cell division, such as those of the bone marrow. 
Ibbotson et al (1970) reported decreased white cell counts in cobalt deficient ewes.
Cobalt deficient ewes were found to produce fewer lambs (Fisher & MacPherson 
1991) and the lambs were found to have decreased vigour, there was also an 
increase in the numbers of stillborn lambs and in neo-natal mortality (Fisher and 
MacPherson 1986). Serum IgG concentrations and zinc sulphate turbidity as a 
measure of -globulin concentrations, were decreased in the cobalt-deficient lambs 
(Fisher & MacPherson 1991). Deficient lambs also had a decreased response to 
clostridial vaccination (MacPherson et al 1989).
O verall cobalt deficiency appears to decrease lamb resistance to parasites, to 
decrease % kill by PMN, but not to affect phagocytosis. The decreased killing 
ability seems to be due to decreased activity of the hexose monophosphate shunt, 
though how vitamin Bj^ affects this is not clear. Thymidine uptake by lymphocytes is 
affected, probably due to a defect in thymidine synthetase activity, but this does not 
seem to affect numbers of lym phocytes (blastogenesis), but does affect their 
appearance. Finally cobalt deficiency affects disease resistance, from which it can be 
concluded that supplementation may well be worthwhile financially.
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Several suggestions as to the mode of action of vitamin in these effects have 
been put forward. Folic acid has been found to impair cell mediated immunity and to 
decrease antibody response (Chandra 1991), and so folic acid has been suggested as 
the mediator; however it has already been noted that some of the effects of vitamin 
Bj2  on immunity appear prior to symptoms of functional deficiency, also (Kaplan & 
Basford 1976) that folic acid deficiency did not produce the same effects. Others 
suggest that the effects may be mediated via the action of the key anabolic enzymes, 
on p ro te in  and cell m em brane b iosyn thesis  in rap id ly  d iffe ren tia tin g , and 
proliferating cells such as those in lymphoid tissue. Thus further investigation is 
required into other areas of the immune system, where cobalt might have other 
effects, and to clarify  exactly how those effects that have been observed, are 
mediated.
1.1.8. Supplementation.
Supplementation can be used to prevent or cure cobalt deficiency. Many different 
methods have been used
a. cobalt top dressing of pastures.
b. oral dosing of the animal with cobalt.
c. injection of cobalt.
d. injection of vitamin B^ .^
e. oral dosing with vitamin B^.
f. cobalt bullets.
g. cobalt salt licks.
h. cobalt containing anthelmintics.
i. incorporation of cobalt in the ration.
j. incorporation of cobalt in piped water supplies.
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The most efficient methods have been cobalt top dressing of pastures or the use of 
cobalt bullets (Whitelaw and Russel 1979). Both are long term treatments although 
some problems have occurred with rejection of the slow release cobalt bullet in 
young pre-ruminants and in dairy cows which are fed highly concentrated feeds.
Oral dosing with cobalt requires frequent handling, preferably once a week, although 
very large doses given monthly do provide some benefit (Stewart et al 1955). 
Incorporation in the anthelmintic is more practical but frequently the concentration 
used has not been large enough to act as the sole source of cobalt, although as Suttle 
et al (1990) point out, even a small amount of cobalt will provide some benefit and 
the efficacy of the anthelmintic for its primary purpose must remain the major 
concern. Salt licks provide adequate cobalt if  they are consumed regularly, while 
inclusion of cobalt in the concentrate ration or water supply is only suitable if it can 
be incorporated into the existing routine.
Oral dosing with vitamin Bj^ is wasteful, because of the poor absorption of the 
vitamin, however injections work well, but are fairly expensive. Cobalt injections 
by-pass the rumen, hence incorporation into vitamin Bj^ does not occur, and the 
cobalt per se cannot be utilised by the animal.
Cobalt toxicity is unlikely to cause problems as sheep can withstand concentrations 
up to 3.5 mg/kg and cattle can withstand concentrations up to Img per kg body 
weight per day (McDonald et al 1988). Levels in excess of these are very rare but 
do cause anaemia and death.
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1.2.V1TAM1N E
1.2.1. Introduction.
The original discovery of vitamin E began when certain milk-based diets were found 
to induce sterility in rats, and supplementation with wheat germ oil was found to 
restore reproductive ability. The unknown factor required was termed 'vitamin E '. A 
family of tocopherols and tocotrienols have since been identified of which the most 
biologically active form is a-tocopherol, but the term 'vitamin E' is still commonly 
used to designate the whole family of tocopherols and tocotrienols, or in place of a- 
tocopherol.
Since the discovery and purification of the ditTerent forms of vitamin E, many other 
symptoms of deficiency have been observed, involving changes in the nervous 
system , the m uscles, the liver, the alim entary  trac t, and the fatty  deposits , in 
addition to the reproductive system, suggesting a great diversity of functions for the 
vitamin. In conjunction with the selenium containing enzyme glutathione peroxidase, 
vitamin E is known to prevent the oxidative breakdown of tissue membranes which 
results from hydroperoxidation of polyunsaturated fatty acids.
1.2.2, Functions of Vitamin E.
The function of vitamin E is closely related to its structure
x ' '  o ?'■ I
a -Toco ph cro l
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The OL structure (given here) is thought to be the main biologically active form, 
because it can sit in cell membranes. Some evidence (Chatterton et ol 1961 & Chow 
1985) suggests that the gamma form is also absorbed in calves and that it is absorbed 
and taken up by the tissues as effectively as the a. form; however others (Putnam and 
Comben 1987) suggest that only the a, form is absorbed, transported and utilised, 
and (Rice & McMurray 1982) that only a  tocopherol has been found in the tissues. 
Vitamin E acts as a free radical scavenger as it donates a phenolic hydrogen to the 
in itia l free radical (or lipid peroxide) thus preventing a chain reaction (lipid 
peroxidation). Vitamin E is possibly reconverted by the action of ascorbic acid, or 
glutathione (Chow 1985), which cannot themselves act directly on the lipid because 
they are not lipid soluble and so cannot enter the membrane. Thus vitamin E exerts 
its free radical scavenging role inside the membrane, stabilizing it.
Vitamin E deficiency exacerbates exercise-induced damage to skeletal muscle, and 
this is accompanied by an increase in the formation of oxygen-centered free radicals 
(Jackson 1987), however it is unclear whether the radicals are responsible for the 
tissue damage, or whether damage to tissues results in free radical formation. 
Phoenix et al (1990) reported that vitamin E-deficient muscles had an increased 
susceptibility to intracellular calcium overload, but that addition of a calcium 
ionophore did not seem to have a direct effect on non-enzymic lipid peroxidation. 
They hypothesise that vitamin E may have a structural-membrane-stabilizing role in 
preventing skeletal muscle damage. These effects are thought to be mediated via the 
hydrocarbon phytyl chain, and to be unrelated to antioxidant ability. In particular 
vitamin E is thought to protect the mitochondria from damage by increased calcium 
ion concentrations (Phoenix and Guidoux 1991).
Vitam in E is also involved in arachidonic acid m etabolism  to throm boxane, 
leukotrienes, prostaglandins and prostacyclin. Many people have speculated that 
vitam in E may affect im m unity by decreasing prostaglandin concentrations.
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Increased PUFA concentrations might stimulate prostaglandin synthesis or they may 
directly affect adenyl cyclase. Vitamin E antagonises arachidonic acid peroxidation 
and hence limits formation of the precursors of prostaglandins. Anderson and 
Menzel (1975) found that intraperitoneal injection of vitamin E not only inhibited 
conversion of arachidonic acid to prostaglandins, but also directly inhibited the 
action of prostaglandin E^.
In weanling rabbits fed a vitamin E deficient diet for 4 to 5 weeks, decreased 
concentrations of prostaglandin cyclooxygenase, which generates prostaglandins E^ 
and F^^ in equal quantities, were found in semitendinosus muscle when compared to 
semitendinosus muscle from rabbits supplemented with 50 mg DL-a-tocopherol 
tw ice w eekly (Chan et al 1980a). V itam in E defic iency  also increased  
prostaglandin dehydrogenase activity in skeletal muscle of rabbits, but not in heart 
and kidney (Chan et al 1980b). Overall this would give a low concentration of 
prostaglandins in muscles. This may, however, be a local effect as other workers 
have found decreased concentrations of prostaglandins in serum during vitamin E 
supplementation. Vitamin E reversed the adverse effects of adding heated fat to diets 
(Giani et al 1986), these included altering the balance of platelet thromboxane and 
arterial prostacyclin production.
Prostaglandins have been measured by radioimmunoassay, gas chromatography and 
high performance liquid chromatography. Granstrom and Kumlin (1987), however, 
state that due to the short half lives of prostaglandins in blood and tissues, 
particu larly  if  they are handled, then m easurem ent of certain m etabolites of 
prostaglandins, which can be found in the urine, may be more reliable.
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Other roles for vitamin E (Putnam and Comben 1987) are in DNA synthesis, 
because of observed increases in the concentrations of xanthine oxidase and creatine 
kinase during deficiency, and in protein synthesis (Chow 1985).
1.2.3. The Relationship between Vitamin E and Selenium.
A. Selenium
Selenium was first noted for its toxic effects on animals. This led to analysis of 
selenium concentrations in soils, feedstuffs and animal tissues. Later it was found to 
be an essential part of the diet and several diseases in selenium-deficient animals 
which respond to selenium supplementation were identified including liver necrosis, 
exudative diathesis and muscular dystrophy. The relationship between vitamin E and 
selenium was discovered due to their sparing action on each other in some diseases, 
eg. mulberry heart disease, white muscle disease and exudative diathesis. This led to 
the discovery of the role of selenium in free radical metabolism, and also to the 
discovery of the selenoprotein glutathione peroxidase (GSH-Px). More recently 
came the theory that supplementation with selenium slightly above the normal 
recomended concentration may stimulate the immune system (Spallholz et al 1973a, 
1973b, 1974, 1975, Swecker er g/ 1987/88).
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B. Functions of Selenium.
Selenium is chemically similar to sulphur, and is sometimes incorporated into 
proteins in its place. One particular protein, which contains selenium, is GSH-Px, 
this contains stoichiometric amounts (4g atoms /mole) of selenium, and catalyses the 
reaction
ROOH 2GSH
+ ------
peroxide reduced
glutathione
GSH-Px ROH GSSG
>  H"
alcohol oxidised
glutathione
To regenerate reduced glutathione, NADPH, from the pentose phosphate pathway, 
(or possibly ascorbic acid) is required. The importance of this reaction is twofold, by 
reducing hydrogen peroxide to water GSH-Px prevents the possible formation of 
hydroxyl radicals (.OH), which can attack lipids, proteins and DNA. Secondly GSH- 
Px can act directly on lipid peroxides, preventing a chain reaction. The chain 
reaction that occurs in lipid peroxidation involves rearrangement of the double bonds 
which can seriously affect the properties of membranes, and may lead to cell lysis. 
In addition to 'classical' cytosolic GSH-Px two other forms of the enzyme have been 
discovered, phospholipid hydroperoxide glutathione peroxidase (PGSHPx) which is 
associated with cell membranes, and plasma glutathione peroxidase (Arthur 1992).
A second compound selenoprotein P has been found and its concentration correlates 
very well with some of the effects of selenium which are not due to GSH-Px (Burk
1989). Selenium is not thought to be involved in oxidative phosphorylation directly, 
but it may be involved in oxidation-reduction reactions. According to evidence cited 
by Underwood (1981) selenium may also be involved in fatty acid, glucose, and 
sulphydryl compound metabolism, and the oxidative reactions of the citric acid
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cycle. Because of its tendency to complex with heavy metals selenium also protects 
against the toxic effects of cadmium and mercury.
A third selenoenzyme is iodothyronine 5'-deiodinase type I (IDI), which is involved 
in the conversion of thyroxine (T^) to triiodothyronine (T^) in the liver, kidney and 
thyroid (Arthur 1992). is required for growth hormone synthesis in the pituitary 
gland, and control of thyrotrophin production (Arthur et al 1988). This could lead 
to impaired growth in selenium-deficient animals. Selenium deficiency also affects 
the thyroid gland, possibly because the lack of GSH-Px allows a build up of 
hydrogen peroxide, which is rate limiting for the oxidative step during thyroid 
hormone synthesis and hence causes excess thyroid hormone synthesis and release 
leading to thyroidal depletion of both iodine and hormone. Alternatively it may be 
because of its effects on IDI, or because of the changes in T  ^ : T^ ratio's that result 
from this affecting circulating concentrations of thyrotropin; whichever mechanism 
is involved selenium deficiency exacerbates hypothyroidism. Additionally selenium 
plays an im portant role in non-shivering therm ogenesis as T^ is required for 
production of the uncoupling protein in brown adipose tissue (Arthur 1991).
C. Interrelationship.
The relationship between vitamin E and selenium was established because certain 
deficiency diseases could be cured by administration of either nutrient; they appear 
to have a sparing effect on each other. Further investigation into their functions 
revealed their roles in neutralising free radicals and preventing lipid peroxidation. 
They are not mutually replacable however, mainly because they act in different parts 
of the cell. Vitamin E being situated in the membranes while the selenium containing 
enzymes GSH-Px and PGSHPx are found in the cytosol, and membranes of cells, 
respectively.
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Polyunsaturated fatty acids (PUFA) concentrations dictate the fluidity and hence the 
permeability of membranes, and this function requires the prescence of double 
bonds. The synthesis of prostanoids from arachidonic acid requires a certain 
controlled amount of lipid peroxidation, which is catalysed by enzymes eg. 
lipoxygenase. These enzymes must be prevented from peroxidising other lipids. 
Stray prostanoid synthesis would affect the balance of prostaglandins, prostacyclins 
and thromboxane, upsetting one of the control mechanisms of the body. Thus lipid 
peroxidation is an essential part of normal cell function, but unwanted side reactions 
must be prevented to stop cell damage (Rice and Kennedy 1988).
F ree radicals such as superoxide and hydroxyl radicals can also cause lipid 
peroxidation, these are formed intentionally in phagocytes during the respiratory 
burst to kill pathogens; however they must be prevented from damaging the host 
cells.
1.2.4. Factors Affecting Vitamin E Requirement.
Mixtures of tocols are found in plants, and the concentrations tend to vary in 
different parts of the plant i.e. seeds (particularly in the germ) have more than the 
root. Sun curing decreases available tocols considerably, and preservatives such as 
propionic acid destroy a tocopherol. Addition of high concentrations of minerals 
such as copper and iron to feedstuffs leads to increased breakdown of vitamin E 
(Dove & Ewan 1990).
Different forms of vitamin E are not interconverted and neither is there any synthesis 
in the rumen or gut. Thus all animals require an adequate supply in the diet. If lipid 
absorption is upset i.e. by lack of bile salts, this will affect vitamin E, as this is 
absorbed along with fat, transported in high density lipoproteins (Chow 1985) and
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stored in the fat reserves.
Vitamin E and fats diffuse through the intestinal mucosa and are combined with 
proteins (giving lipoproteins) which are transported by the lymphatic system (as 
chylomicrons), into the general circulation (McDonald et al 1988). Vitamin E is 
found in all lipoprotein fractions, but mainly in apo-B containing lipoproteins 
(Bjorneboe et al 1990). It is frequently secreted from the liver in very low density 
lipoproteins (VLDL).
In chicks, feeds contaminated with Fusarium, which produces the T-2 toxin, caused 
decreased plasma vitamin E concentrations. If micelle promoting substances are 
added to the diet, the problem is alleviated. Coffin and Combs (1981) considered the 
possibility of general lipid malabsorption, but found that duodenal lipase was not 
affected and no excess lipid appeared in the faeces, suggesting that general lipid 
digestion was not impaired. They suggested that the T-2 toxin may act on the liver 
reducing the output of plasma lipoproteins.
Because of their sparing action on each other, requirements for vitamin E and 
selenium are related. The requirement for vitamin E is further complicated by being 
associated with PUFA concentrations. If the peroxidisable index of PUFA in the diet 
is increased from low (linoleic acid free diet) to high (5 % corn oil diet) the amount 
of vitamin E required to prevent 10% haemolysis of erythrocytes increases from 
122ug/100m l packed cells to 196ug/100m l (B ieri & Poukka 1970). H igh 
concentrations of vitamin A or mycotoxins in the diet also decrease available 
concentrations of vitamin E, thus increasing the requirement.
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For ruminants Putnam and Comben (1987) recommend Img/day/kg liveweight, plus 
5mg/kg milk produced, plus 3mg/g PUFA in the ration, of vitamin E. In calves 2.4- 
3.4 mg/day/kg liveweight produced optimum live weight gain (Reddy et al 1987a), 
but the amount of PUFA in the diet was not specified.
If vitamin E deficiency is suspected, confirmation may be obtained by analysis of 
diagnostic parameters.
Normal concentrations of vitamin E are as follows :-
Serum (/onol/1) Liver (/limol/kg)
Sheep 1-6 5-45
Cattle 3-18 20-100
Goats > 10
To measure the vitamin E status, hydrogen peroxide used to be added to a blood 
sample, and the time taken for haemolysis to occur was related to the amount of the 
vitamin present (Chow 1985); more recently vitamin E has been measured directly 
by HPLC.
A. Factors Affecting Selenium Requirement.
The concentration of selenium in the soil affects the amount which can be taken up 
by plants, and the amount taken up by plants in turn affects the selenium intake of 
grazing animals. Some plants are better at extracting and concentrating it than 
others, which can be a problem in selenium rich areas, particularly if they convert it 
to an easily available form. This can lead to selenium toxicity (selenosis, blind 
staggers or alkali disease). This results in emaciation, lack of vitality, hair loss, 
soreness and sloughing off of hooves, stiff joints, cirrhosis of the liver, anaemia and
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atrophy of the heart.This causes the animal to be unwilling to move, and so it may 
die of thirst or starvation. Growth rate and reproductive function are the first things 
to be impaired and deformed young may be born. The selenium is incorporated into 
the tissues in place of sulphur. High concentrations of dietary protein tend to 
decrease toxicity, possibly because of the sulphur containing amino acids. Thus 
when considering supplementing the diet with selenium great care must be taken that 
excess is not given.
Fishmeal tends to be a good source of selenium but most other protein supplements 
vary a great deal. Some forms of selenium are more easily utilized than others, 
there is also evidence that other compounds may in terfere with absorption or 
metabolism of selenium. On comparison of fauna-free with faunated sheep, protozoa 
were found to decrease the bioavailability of selenium (Dayrell et al 1991).
Selenite is thought to be absorbed by diffusion, but it may be reduced in the lumen 
o f the gut p r io r  to ab so rp tio n . T h io ls  (e .g . c y s te in e , cy s team in e  and 
mercaptopyruvate) have been found to increase the mucosal uptake of selenite 
(Scarrer et al 1989). L-leucine and L-glutamic acid inhibit the stimulatory effects 
of L-cysteine on selenite absorption, suggesting the formation of selenoamino acids 
(L-selenodicysteine and L-cystine selenopersulfide) which could be transported via 
the amino acid carriers of the brush border.
Selenate is absorbed faster than selenite, it is actively transported across the brush- 
border membrane against the concentration gradient by two mechanisms, sodium^- 
selenate co-transport, and selenate transport by anion exchange. This is inhibited by 
other anions with two charges. Selenocysteine and selenomethionine are absorbed by 
the sam e c a rr ie rs  as cy s te in e  and m eth io n in e  (W olffram  et al 1989). 
Selenomethionine and methionine have the same affinity for neutral amino acid
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carriers, whereas selenocysteine is a competitive inhibitor of cysteine transport.
Superphosphate fertilisers appear to cause an increased incidence of nutritional 
muscular dystrophy in lambs. Hudman et al (1988) infused soluble phosphate 
(6g/day) as sodium phosphate or sodium chloride intraruminaly into weaner sheep, 
and found that exess phosphate led to lower concentrations of selenium in the liver. 
Selenium concentrations in the blood, kidneys, heart and muscle were unaffected. 
Absorption of selenium from the gut was slower, suggesting a phosphate/selenate 
interaction in the gut. This is supported by the increased concentrations of selenium 
in the faeces and decreased concentrations in the urine of sheep fed the sodium 
phosphate. Selenium also had a faster turnover in phosphate fed sheep suggesting the 
possibility of a second interaction after absorption.
Lupins contain a mycotoxin, Phomopsin leptostremiformis, which causes myopathy, 
indistinguishable from nutritional m uscular dystrophy, in sheep in A ustralia. 
However this myopathy does not respond to selenium supplementation, with or 
without vitamin E supplementation. Costa et al (1986) found that phomopsin 
disrupts microtubule assembly in the liver and hence affects hepatic processing of 
seleno compounds. Seleno compounds absorbed from the gut become more available 
to extrahepatic tissues, and in particular to the kidney, and so excretion of selenium 
in the urine increases. The mycotoxin appears to alter the type or concentration of 
seleno compounds in the plasma and hence the necessary metabolites for normal 
physiological functions are not available. A recent study however (Beetson et al 
1993) has shown that an intramuscular injection of selenomethionine combined with 
an oral dose of a-tocopherol afforded significant protection for young sheep against 
the developement of myopathy.
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High grain diets may decrease the availability of selenium, by lowering rumen pH 
and creating reducing conditions (Van Saun 1989), this increases the dietary 
requirem ent of dairy cows for selenium. Tissue selenium is linearly related to 
dietary selenium (Ku et al 1972), and for diets supplying 400-3 lOOug Se/day to 
non-lactating dairy cows, 51% of Se was absorbed and 41% retained (Harrison and 
Conrad 1984a).
If the calcium concentration of the diet varies much from 0.8%DM intake, apparent 
selenium absorption from natural feedstuffs is decreased in non-lactating cows 
(Harrison & Conrad 1984b). In calves dietary calcium leads to a small decrease in 
apparent selenium absorption at very low and very high concentration, but this was 
of little practical importance in selenium metabolism (Alfaro et al 1987).
Various values for selenium requirement are quoted (Underwood 1981), ranging 
between 0.03 and 0.12 mgSe/kgDM for sheep. The variation is thought to be due to 
different concentrations of vitamin E, sulphur, iron and copper (Van Saun 1989) in 
the diet, and also to different criteria being used to assess changes in function with 
selenium status, such as myopathy, or growth. Additionally different safety margins 
may be applied before quoting a recommendation. A general recommendation of 
0.1-0.12 mgSe/kgDM for sheep and cattle is quoted (Underwood 1981). Van Saun
(1989) s tre sse s  th a t due to the p o te n tia l to x ic ity  and ex p en se  se len ium  
supplem entation should not be general; diagnostic concentrations for various 
parameters are quoted and supplementation is only economic if  deficiency or 
marginal deficiency states are present. Goats are thought to require more selenium 
than lambs or calves (Ramell et al 1989).
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Diagnostic parameters used to define selenium deficiency are:-
Liver selenium concentration (nmoles/kg dry weight of tissue)
Deficiency Marginal Adequate
Sheep <200 200-450 >450
Cattle <200 200-450 >450
Goats <500 500-1100 >1100
M ore commonly because blood samples are easy to take whole blood GSH-Px 
activity (u/ml at 30°C) are used, (using the enzyme colourimetric method described 
in Chapter 2, based on Paglia and Valentine 1967 and Anderson et al 1978, in use at 
VIC, SAC Auchnicruive.)
Deficient 
Sheep < 27
Cattle <15
Marginal
27-42
15-25
Adequate
>42
>25
Atroshi cr a/ (1981) found that within a flock of Finn sheep some animals had a 
genetically lower whole blood GSH-Px, which they claim is an adaptation to low 
available selenium concentrations, suggesting that these sheep have a low er 
requirement for selenium than is normal. These sheep exhibited larger weight gain 
and wool production and a decreased lamb mortality rate, when compared to the 
other sheep in the flock, under the same production conditions. However Samson et 
al (1989) reported no such apparent adaptation in Rocky Mountain Bighorn sheep.
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1.2.5. Deficiency diseases.
Many of the deficiency diseases associated with selenium and vitamin E are the 
same, but not all respond to either substance on its own. Symptoms vary between 
species, but most are caused by peroxidation, which attacks highly oxygenated 
tissues eg. m uscles, liver, lungs, cerebellum , kidney, thyroid , adrenals and 
pancreas.
Deficiency diseases associated with ruminants are
A. Nutritional myopathy or white muscle disease.
Sometimes animals are found to be deficient in vitamin E and/or selenium, and yet 
show no symptoms of disease particularly if housed (Arthur 1988). On turnout 
symptoms frequently appear which may indicate that 'stress' is required to initiate 
the clinical syndrome. Alternatively it may be due to increased concentrations of 
PUFA in the spring grass leading to an increased requirement for antioxidants such 
as vitamin E and glutathione peroxidase, or as Rice and Kennedy (1988) suggest it 
may be a 'conditioned deficiency' due to a diarrhoea inducing agent in young spring 
grass which leads to decreased vitamin E absorption. They speculate that this agent 
is protein in origin. Further evidence for some other factor being involved is that 
housed animals fed grass also demonstrated increased PUFA concentrations, but did 
not have elevated CK concentrations (Arthur 1988).
Nutritional myopathy is characterised by degeneration of muscles, whole groups are 
usually affected e.g.locomotor, thoracic, muscles of the upper digestive tract, or the 
myocardium (Bostedt 1980). If the heart is affected sudden death may occur, 
alternatively respiration and circulation may be impaired. Damage to skeletal 
muscles results in stiff unnatural postures (McDonald et al 1988). Muscle damage
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leads to in c reased  serum  c o n c e n tra tio n s  o f a sp a rta te  am in o tra n s fe ra se  
(SGOT)(Blincoe & Dye 1958), creatine kinase (CK), and lactic dehydrogenase 
(LDH). Treatm ent with either vitam in E or selenium appears to be effective 
(McMurray & McEldowney 1977). The incidence of nutritional myopathy increases 
markedly when only farm produced feeds are fed (Bradley et al 1986), as these are 
frequently stored for long periods and so contain little vitamin E, and in certain 
areas of the country they will also be deficient in selenium. If  concentrates are 
bought in separately they are frequently supplemented with vitamin E and selenium 
by the manufacturers.
Experimental myopathy due to vitamin E deficiency has the same symptoms as 
nutritional myopathy (Safford et al 1954) but the symptoms do not always develop. 
Protected linseed added to the diet (Kennedy et al 1987) exacerbates the condition 
emphasising the symptoms. It might be thought that any unsaturated fat would be 
hydrogenated in the rumen, however evidence (Rice & McMurray 1982) shows that 
this is not 100% efective, and even in fully ruminant calves on turnout to pasture 
there may be a 20 fold increase in plasma linolenic acid. For the same reason cod 
liver oil neutralised the beneficial effect of vitamin E on experimental myopathy 
(Blaxter et al 1952).
Paulson et al (1966) found increases in all 5 forms of serum LD H ,w ith the 
percentage increase being highest in V then IV then III then II and least in I, 
although in absolute terms the increase in III was greatest. Vitamin E alone or with 
selenium restored concentrations but selenium alone only decreased concentrations 
temporarily. There is a suggestion that decreased ubiquinone concentrations are 
found in the tissues during nutritional myopathy, however Poukka (1968) failed to 
detect any significant differences in ubiquinone concentration between healthy and 
diseased calves.
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Peroxide haemolysis of red cells increased in lambs fed maize oil, but not those fed 
cod liver oil, although signs of nutritional myopathy were apparent in cod liver oil 
but not maize oil fed lambs, a-tocopherol prevented nutritional myopathy but not 
peroxide haemolysis, therefore red cell fragility was not due to vitamin E deficiency 
but to the fatty acid composition of the un saturated lipids in the diet (Boyd 1968). 
Addition of vitam in E to the erythrocytes in vitro  was sufficient to prevent 
haemolysis. Supplemental vitamin E decreased red cell haemolysis in dairy cows fed 
a low vitamin E diet (Schingothe et al 1979). Calves fed maize oil developed 
nutritional myopathy if not supplemented with vitamin E (Poukka & Oksanen 1972), 
vitamin E inhibited desaturation but not chain elongation enzymes in the microsomes 
of liver and kidney, but had no apparent effect on the erythrocyte haemolysis test. 
The maize oil fed lambs (Boyd 1968) received 33.5 lU of vitamin E/kg, while the 
calves (Poukka and Oksanen 1972) were fed stripped maize oil. While this may have 
contained large amounts of residual vitamin E, (residual concentrations of vitamin E 
were not quoted) the chemical methods used for the removal of vitamin E frequently 
result in the formation of peroxides, which may explain why the calves developed 
nutritional myopathy but the lambs did not.
B. Unthriftiness.
This condition, found in Australia and New Zealand, leads to weight loss and 
m ortality, but no muscle lesions are found and there is no increase in SGOT 
concentrations. Supplementation with selenium may lead to striking weight gains and 
decreased mortality (Underwood 1981). Subclinical cases probably result in large 
financial losses.
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c . Reproductive disorders.
Selenium and vitamin E deficiencies lead to impaired reproductive performance. In 
ewes selenium deficiency causes high embryonic mortality, which is responsive only 
to selenium. The deficiency is associated with decreased fertility, and increased 
death rate of young lambs (Zachara et al 1989). In cows a mixture of vitamin E and 
selenium proved more effective than selenium alone in preventing premature births, 
weak and dead calves and retained placentae (cited by Underw ood 1981). 
MacPherson et al (1987b) found that selenium supplementation significantly 
decreased the num ber of days between first insem ination and calving, due to 
improved first and second service conception rates. Vitamin E and selenium interact 
in their effects on the number of retained placentae (Harrison et al 1984), however 
selenium alone decreased the incidence of metritis and cystic ovaries.
D. Weak Calf Syndrome.
Rice et al (1986) reported that a single dose of selenium prior to calving was found 
to have no effect on the incidence of weak calf syndrome. Sluijter et al (1990) 
hypothesise that one cause of weak calf syndrome might be selenium deficiency 
altering prostaglandin metabolism leading to premature placental separation.
During selenium deficiency various other parameters alter (Arthur et al 1988) eg. 
plasma urea and creatinine concentrations increase, plasma alkaline phosphatase 
activity decreases and the balance of the thyroid hormones is upset, thyroxine 
concentrations increase and concentrations of the more m etabolically active 
triiodothyronine decrease. This leads to a decreased overall activity of the thyroid 
hormones, promoting anabolism and stimulating growth hormone synthesis in the 
pituitary, thus the imbalance may be responsible for some of the symptoms of 
deficiency.
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1.2,6. Evidence that Vitamin E and Selenium Enhance Immunity.
Megadoses of vitamin E are thought to affect immunity, these may be 3-6 times the 
accepted requirem ent for the animal (Beisel 1982). Vitamin E exibits a general 
antioxidant effect, preventing peroxidation and free radical damage to sensitive 
lym phoreticular cells. It also specifically decreases prostaglandin synthesis and 
inhibits oxidation of arachidonic acid by its effects on key enzymes of oxidative 
phosphorylation, coenzyme Q and cytochrome synthesis, it alters receptor function 
o f cell membranes of lym phocytes (Tengerdy 1986). Low er prostaglandin  
concentrations would in turn lead to a decrease in cAMP concentrations. High 
cAMP concentrations are known to suppress mast cell degranulation and mitogenic 
transform ation. Prostaglandins are one of the possible mediators of vitamin E 's  
action on the immune system as they have been found to increase during vitamin E 
deficiency and are known to modulate the immune system. Prostaglandins inhibit 
lymphocyte blastogenesis and via cyclic AMP they inhibit E-rosette formation, 
macrophage-migration inhibition and lymphocyte-mediated cytotoxicity (cited in 
Langweiler cf o/ 1981).
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A, Humoral Immune Response (HIR).
Increased antibody production in response to stimulation by both mitogens (primary 
immune response) and antigens (secondary immune response) has been recorded 
during vitamin E supplementation. Supplementation with vitamin E has frequently 
been found to increase antibody concentrations compared to those in vitamin E 
deficient animals. Addition of 47 or 200 mg/kg vitamin E to the diet of two different 
s tra in s o f rats enhanced T -cell m itogen responses to concanavalin  A and 
phytohemagglutinin-P, and B-cell responses to lipopolysaccharide, compared to rats 
fed a vitamin E deficient semi-purified diet which resulted in undetectable plasma 
concentrations of vitamin E, (Bendich et al 1983). Marsh et al (1981) found that 
diets deficient in vitamin E or selenium (< 0 .02  mgSe/kg) caused impaired antibody 
response to ovine erythrocytes in two week old chicks, com pared to chicks 
supplemented with selenium (0.1 mgSe/kg) and vitamin E (lOOIU/kg), while three 
week old chicks receiving either vitamin E or selenium supplementation maintained 
antibody responses.
In pigs Ellis and Vorheis (1976) found supplementary vitamin E (100,000 lU/ton of 
feed) increased  anti-E . colt serum  antibody titres  th reefo ld  com pared to 
unsupplemented pigs. Horses supplemented with vitamin E (600mg/day), or vitamin 
E (600 mg/day) and selenium  (5 mg/day) had increased antibody titres after 
vaccination with novel antigens such as tetanus toxoid and equine influenza virus, 
but not to E. coli, compared to unsupplemented horses or horses given selenium 
alone (Baalsrud and Overnes 1986).
In sheep (Tengerdy et al 1983) supplementation with 300 mg [dl]-a-tocopheryl 
acetate increased antibody production in response to Clostridium perfringens type C 
or D toxoids. Cipriano et al (1982) found large but nonsignificant increases in serum 
immunoglobulin (IgGj, IgG^ and IgA) concentrations between calves fed a vitamin E
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deficient diet and calves supplemented with Ig vitamin E/day. Reddy et al (1986) 
found that supplementation of calves with 2800 mg vitamin E/week enhanced IgM 
concentrations but not IgG concentrations compared to unsupplemented calves. 
W hile Reddy et al (1987b) found that supplementation of calves with 125 lU  
vitamin E/day enhanced antibovine herpes-virus type 1 antibody production in 
response to a booster vaccination compared to unsupplemented calves, increased 
supplementation with 250 or 500 lU vitamin E/day did not significantly enhance the 
response. However Anderson et al (1986) found no increase in antibody titre to 
infectious bovine rh inotracheitis vaccine, tetanus toxoid or Johnes disease 
{Mycobacterium paratuberculii) in calves supplemented with 60 or 200 mg vitamin 
E/kg feed when compared to un supplemented calves on a low vitamin E diet despite 
increasing plasma vitamin E concentrations from < ljug /m l to > 1 .5  and > 3  
/Ag/ml respectively.
Supplementation with excess vitamin E, compared to normal levels, has also been 
found to further stimulate antibody production. Guinea pigs supplemented with 33 
lU  DL-ce-tocopherol/kg body weight by intramuscular injection, had significantly 
h igher hem agg lu tin a tio n -in h ib itio n  antibody titres  to V enezuelan equine 
encephalomyelitis virus than unsupplemented animals fed the same commercial 
ration containing 62 lU dl-a-tocopherol acetate/kg (Barber et al 1977). Likoff et al 
(1981) found that in chickens supplemented with 300 mg vitamin E/kg diet (six times 
current recom m endations), antibody titres to E .co li lipopolysaccharide were 
enhanced compared to nonsupplemented chickens on the same diet containing 40 to 
50 lU vitamin E/kg. Franchini et al (1987) found enhanced serum IgG and IgM 
responses in chickens supplemented with 300 mg vitamin E/kg feed immunized with 
emulsified and inactivated Newcastle disease virus and Pasteurella anatipestifer, 
compared to unsupplemented birds receiving only 20 mg vitamin E/kg feed from the 
diet.
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Ritacco et al (1986) found that lambs fed 476 mg all-rac-a-tocopherol acetate/kg 
feed had a significantly enhanced peak primary serum antibody titre compared to 
lambs fed 33 mg all-rac-a-tocopherol acetate/kg feed, while lambs fed 3000 mg 
vitamin E, in three treatments given 3 days apart, produced greater secondary peak 
anti-A ovis titres than unsupplemented controls. However no increase in antibody 
titre to SRBC was found in piglets supplemented with 550, 220, or 110 lU vitamin 
E /kg of feed com pared to piglets receiving only 11 lU  vitam in E /kg of feed 
(Bonnette et al 1990a & b), and cortisol concentrations were also unaffected by 
supplementation.
The number of plaque forming (ie. antibody producing) cells, and the concentrations 
o f circulating antibody are increased. To determ ine w hether the prim ary or 
secondary immune response is affected different substances are used. A mitogen to 
which the animal has not previously been exposed produces a primary immune 
response ie. initially IgM, whereas an antigen which has been met previously 
stim ulates both IgM and IgG due to im m unological memory (this is called a 
secondary immune response). To separate the immunoglobulins 2-mercaptoethanol is 
used to remove IgM. Vitamin E was found to stimulate the production of both IgM 
and IgG but it also favoured early conversion to IgG type production.
Attempts have been made to understand the mechanisms of action of vitamin E. 
Tengerdy (1980) suggested that the antioxidant action might create reducing 
conditions favourable for immunopoietic cellular developement and proliferation. 
Experiments comparing the action of vitamin E, versus antioxidants, suggest that 
this is so, but that vitamin E also has other effects. On separation of spleen into 
adherent (macrophage like cells) and non-adherent (lymphocyte like cells) Campbell 
et al (1974) found that vitamin E either bypassed the requirement for macrophage 
stimulation or enhanced it to such an extent that the few remaining cells were
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sufficient to stimulate the lymphocytes, they suggest a role for vitamin E in cell 
cooperation. Corwin and Shloss (1980) support this by suggesting that vitamin E 
affects the HIR by enhancing cell action and bypassing macrophage cooperation. 
In mice fed vitamin E deficient diets, macrophages were less able to present antigen 
to nonadherent cells than macrophages from vitamin E supplemented mice but they 
could act as suppressor cells instead (Gebremichael et al 1984).
Another possible effect of vitamin E, via its antioxidant action is the protection of 
ubiquinones, (or the stimulation of their synthesis). Ubiquinones are thought to 
stimulate the reticuloendothelial system leading to increased spleen weight due to 
increased lymphoproliferation and increased antibody production.
There is little doubt that selenium supplementation can also increase antibody 
synthesis. Spallholz et al (1973a, 1973b) found that supplementation of mice diets 
with selenium (0.7 or 2.8 mgSe/kg) increased antibody titres to SRBC 7-fold and 30- 
fold respectively compared to unsupplemented controls, but that unlike vitamin E 
supp lem entation , IgM  synthesis was prom oted  and not IgG p roduction ; 
supplementation with 30 mgSe/kg depressed antibody production. Supplementation 
of mice with selenite (0,3,5,10,20, 60 or 100 /ig), alone or with vitamin E (0, 0.15, 
0 .25, 0 .5 , 1,3 or 5 mg) stimulated anti-SRBC IgM and IgG, and differences in 
antibody titres were dependent upon the amount of selenium, and/or vitamin E 
administered (Spallholz et al 1974). Selenium injected prior to or simultaneosly with 
the SRBC antigen also enhanced antibody titres in response to SRBC, but not 
selenium injected 2 or 3 days later (Spallholz et al 1975). Marsh et al (1981) 
depleted chicks of vitamin E and/or selenium and found that the humoral response to 
SRBC was decreased in 2 week old chicks by a deficiency of either selenium or 
vitamin E but that in 3 week old chicks either vitamin E or selenium alone could 
prevent any adverse affects.
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Sheffy and Shultz (1978) observed depression of antibody synthesis in response to 
vaccination in vitamin E/selenium-deficient dogs. In ponies (Knight & Tyznik 1990) 
on a low selenium diet (0.02 mg/kg) addition of supplemental selenium (0.22 mg/kg) 
enhanced IgG concentrations in response to SRBC.
Jelinek et al (1988) found supplementation of selenium deficient sheep with an 
intraruminal selenium pellet increased antibody titres to killed Brucella abortus cells 
and rabbit red blood cells, but not to Corynebacterium pseudotuberculosis toxoid. 
Selenium supplementation (1 mg Se/kg as sodium selenite) also enhanced antibody 
response to tetanus toxoid in sheep on a basal diet containing 0.13 mgSe/kg (Larsen 
et al 1988b, Moksnes et.al 1988). Selenium supplementation (0.2 mg/kg diet) 
enhanced antibody response to infectious bovine rhinotracheitis virus compared to 
unsupplemented calves (0.03 mg Se/kg diet) (Reffett et al 1988). In weaned beef 
calves with an average blood selenium of 67.3jwg/l, free access to salt mineral licks 
containing 80, 120, 160 and 200 mg selenium/kg enhanced serum antibody titres to 
lysozyme compared to access to a lick containing only 20 mg selenium /kg (Swecker 
et al 1987/8). However selenium supplementation of marginally selenium-deficient 
lambs produced only a very slightly increased antibody response to S. dublin (Finch 
& Turner 1986 & Finch et al 1986) even when very large doses of selenium were 
given. Also increased IgG concentrations to sheep red blood cells were recorded 
(Knight & Tyznik 1990) with no effect on IgM, whereas Stabel et al (1989) found 
increased IgM concentrations following stress but decreased anti P. hemolytica 
titres.
Excess selenium decreased antibody production in the experiment by Marsh et al 
(1981), while Swecker et al (1987/8) found that concentrations of selenium optimal 
for antibody production were higher than those required to prevent nutritional 
myopathy. Selenium deficiency had no effect on IgG production in cattle (Stevenson
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et al 1991) and they suggest that this is because antibody production has a high 
priority for selenium. Overall excess selenium does not always provide additional 
benefits so bearing in mind the danger of toxicity care needs to be taken in 
recommending dietary allowances.
Spallholz et al (1975) suggest selenium affects ubiquinones, while Reffet et al 
(1988) suggest it increases efficiency of antigen processing in the cell via cells. 
These actions, and possibly an effect on prostaglandins are thought to be mediated 
via GSH-Px. Thus selenium and vitamin E affect the humoral immune system in 
different ways, as according to Larsen and Tollersrud (1981) and Reffet et al 
(1988), selenium favours IgM production, whereas vitamin E favours a fast shift to 
IgG production.
Langweiler et al (1981) measured antibody response to Pasteurella haemolytica. 
Injections of selenium or selenium and vitamin E increased antibody titre, but 
vitamin E alone had no effect.
Selenium and vitamin E increased IgM concentrations in sow colostrum (Hayek et al
1988), w hile IgA and IgG concen tra tions w ere unaffec ted . In itia lly  IgM  
concentration in the piglets were increased by selenium, while either selenium or 
vitamin E led to elevated IgG concentrations 14 days after birth. Marsh et al (1982 
& 1986) found deficiencies of either vitamin E or selenium to decrease bursa wieght 
in chicks, to affect the proportions of large and small lymphocytes, and to decrease 
the overall number of lymphocytes produced. Thus they think that vitamin E and 
selenium may exert many of their effects on the immune system by influencing the 
primary lymphoid organs and decreasing the number of lymphocytes. When given 
together vitam in E and selenium increased the antibody response o f steers to 
P. hemolytica (Droke & Loerch 1989).
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B. Cell Mediated Immune Response. (CMIR).
The actions of vitamin E and selenium on prostaglandins (including the coating of 
lymphocytes and suppression of cytotoxicity and T cell rosette formation, via cAMP) 
and ubiquinones, also affect the T lymphocytes. However generally the CMIR 
involves less cell cooperation than the HIR and this effect of vitamin E is not seen.
Vitamin E deficiency has been found to decrease T cell response to mitogens in rats 
(Bendich et al 1983 & 1986, Eskew et al 1985 and Gabriel et al 1984), guinea 
pigs (Bendich et al 1984), dogs (Sheffy & Shultz 1979), pigs (Bonnette et al 
1987/88 & Larsen & Tollersrud 1981), and calves (Cipriano et al 1982, Reddy et al 
1986, Reddy et al 1987b and Eicher-Pruiett et al 1992). Corwin and Shloss (1980) 
suggested that vitamin E affected T cell maturation. Vitamin E had no effect on 
mitogen induced stimulation indices in pigs (Bonnette et al 1990a), and no effect on 
cortisol concentrations. Increased concentrations of cortisol decrease PH A and Con A 
induced proliferation of porcine thymocytes, splenocytes and mononuclear cells in 
vitro (Westly and Kelley 1984).
Megadoses of vitamin E decreased mitogen induced lymphocyte transformations in 
humans (Prasad 1980), but had no effect on delayed hypersensitivity of skin to PHA 
compared to unsupplemented humans. In mice optimum stimulation was achieved 
with 5-20 lU/kg/day of vitamin E, 80 lU was inhibitory (Yasunaga et al 1982).
In vivo delayed type hypersensitivity skin tests suggest that selenium also modulates 
the CMIR. Selenium deficiency has been found to decrease T cell response to 
mitogens in rats (Eskew et al 1985), dogs (Sheffy and Shultz 1978), pigs (Larsen 
and Tollersrud 1981), lambs (Turner et al 1985 & 1986) and sheep, (Larsen et al 
1988a, Jelinek et al 1988 & Moksnes et al 1988). Excess selenium however
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decreased T cell response to mitogens (Moksnes et al 1988 & Larsen et al 1988a). 
Larsen et al (1988a) speculated that the effects of selenium on mitogen stimulation 
were not mediated via GSH-Px as results were not correlated with GSH-Px 
concentration. Immunological failure, including decreased mitogen responses in 
lambs, apparently resulted from nutritional myopathy and not simply selenium 
deficiency (Turner et al 1984 & 1986).
Neither vitamin E (150IU/kg) nor selenium (0.5 mg/kg) supplementation were found 
to affect macrophage function, killing of S.aureus or T lymphocyte blastogenesis in 
rats fed a diet deficient in both selenium and vitamin E (Eskew et al 1985).
Selenium was also found to affect soluble mediators, a deficiency in goats, lead to 
decreased concentrations of leucotriene B4 (Aziz and Klesius 1986), and the 
cytotoxic action of both T cells and NK cells (cited by Kiremidjian-Schumacher and 
Stotzky 1987). They suggest that selenium, by increasing the concentrations of GSH, 
H^Se and HSe", could alter the disulphide bonding on the cell surface making it more 
sensitive to stimulation.
Sheffy and Shultz (1979) and Langweiler et al (1981) working with dogs and Reddy 
et al (1986) using calves, found that during vitamin E deficiency serum factors coat 
the lymphocytes inhibiting their activity, this inhibition is removed by washing and 
resuspending in serum from vitamin E-sufficient animals. Serum from supplemented 
calves inhibited IBR virus replication by week 12, this effect is thought to be 
m ediated by a serum factor e .g . in terferon , c-reactive pro te in , beta-lysins, 
lysozymes or serum transferrins. However Sheffy & Shultz (1979) and Langweiler 
et al (1981) speculate that prostaglandins may be the serum factor responsible for 
inhibiting lymphocyte activity during vitamin E deficiency.
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c . Non-specific immunity, neutrophil responses.
Much of the work on immunity assesses changes in neutrophil function. Vitamin E 
deficiency leads to decreased chemotaxis to bacterial culture filtrate and decreased 
ingestion of IgG and C3b coated and unopsonized albumin coated paraffin oil 
droplets by rat PMN. Ingestion and killing of C3b coated S. aureus was not affected 
(Harris et al 1980). In large doses vitamin E decreased the bactericidal activity of 
human leucocytes (Prasad 1980). Vitamin E supplementation negated the adverse 
effects of vitamin C on neutrophil phagocytosis of Staphylococcus aureus in calves 
(Eicher-Pruiett et al 1992).
Vitam in E affects neutrophil lysosom al enzyme release and chem otaxis via 
prostaglandins and cAMP. Supplementation decreases prostaglandin concentrations 
leading to increased phagocytosis in chickens (Tengerdy and Brown 1977 and Likoff 
et al 1981). This may be due to an effect on membrane recognition of antigen and 
soluble mediators, or on binding and lysis of the cells. Impaired microtubules, due to 
membrane damage would alter receptor distribution and decrease chemotaxis. 
Ingestion of complement coated particles decreases during vitamin E deficiency; 
vitamin E maintains normal membrane function for direct movement and ingestion 
by phagocytic cells (Chow 1985). Vitamin E deficiency increases collagen induced 
platelet aggregation and serum PGE^ and PGF^^ action via membrane fluidity.
The protection, or stimulation of synthesis, of ubiquinones also leads to enhanced 
phagocytosis, and ubiquinones may promote the peroxidation of bacterial lipid.
Selenium/vitamin E injections were also found to affect bovine polymorphonucleated 
leucocytes, increasing the percent kill of Staphylococcus aureus (Gyang et al 
1984). Vitamin E was not given alone, and the controls were selenium-deficient, 
hence the effect was attributed to selenium.
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Selenium deficiency leads to decreased migration and chemotaxis in goats (Aziz et al 
1984), phagocytosis is not affected, but percent kill of C. albicans is decreased in 
rats, (Serfass and Ganther 1975) mice (Boyne & Arthur 1986) and cattle (Boyne and 
Arthur 1979 and 1981) and of 5. aureus in cattle (Gyang et al 1984); repletion 
increases % kill. However selenium deficiency has no effect on % kill of S. aureus 
or S, typhimurium by neutrophils from selenium-deficient rats (Boyne et al 1985).
After incubation in a H^O^ generating system PMN from selenium-deficient rats had 
a decreased ability to ingest particles (Baker & Cohen 1984) suggesting that 
selenium may have an effect on phagocytosis when the cell is under severe oxidative 
stress.
In selenium-deficient goats degranulation was impaired. This coincided with a 
reduction in leukotriene B^ production by PM N, which was thought to be 
responsible for the decreased neutrophil chemotaxis (Aziz & Klesius 1986) but was 
not thought to be mediated via GSH-Px.
The decreased killing ability of PMN is thought to be due to the decreased oxidative 
burst observed (Aziz et al 1984), the oxidative burst refers to the increased 
metabolic activity of neutrophils when they are phagocytosing foreign particles, 
which results in increased oxygen consumption. The neutrophils produce both 
hydrogen peroxide and superoxide during this phase of their metabolic activity, and 
these help to destroy ingested particles and microbes respectively. The decreased 
superoxide production is thought to be responsible for the decrease in reduction of 
the tétrazolium salt in vitro observed in the nitroblue tétrazolium test in neutrophils 
from selenium deficient steers (Boyne and Arthur 1979). This effect is thought to be 
mediated via GSH-Px, the decreased enzyme activity is insufficient to prevent
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damage to enzyme systems including the hexose monophosphate shunt, this leads to 
inadequate superoxide production (Arthur et al 1981, Grasso et al 1987 and 
Gyang et al 1984). Phosphohydrolase activity is also impaired, decreasing hydroxyl 
ion formation (Boyne and Arthur 1985), and also NADPH oxidase activity (cited by 
Baker and Cohen 1984) and glucose-6-phosphate dehydrogenase (G6PD) (Serfass 
and Ganther 1975), which all leads to a decreased killing ability. Baker and Cohen 
(1984) speculated that bacteria and fungi may be killed by different mechanisms, 
because the reduction in % kill is species dependent.
Turner et al (1985) suggest that selenium acts directly (and not via GSH-Px) on 
lymphocytes, since factors in the circulation following selenium supplementation, or 
sodium selenite in vitro, had the same stimulatory effect on mononuclear cells.
The effects of selenium on macrophages are less well understood, but deficiency 
does decrease their candidacidal activity  and GSH-Px activity, but not their 
phagocytic activity (Boyne and Arthur 1985b); however no effect of selenium 
deficiency on the very low capacity of macrophages to reduce nitroblue tétrazolium 
was demonstrated.
D. Resistance to disease.
D esp ite  affecting  many param eters used to asses im m unity, eg. an tibody 
concentrations, the only real test that supplementation will be worthwhile financially 
is whether it increases the animals resistance to disease.
Vitamin E supplementation (150-300 mg/kg, 3-6 times the normal requirement) 
decreased mortality in chicks infected with E. coli (Tengerdy and Brown 1977, 
Tengerdy and Nockels 1975 and Heinzerling et al 1974). Gill et al (1986) found 
that supplementation of recently transported, stressed cattle with 800 lU vitamin E/lb
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feed decreased the num ber of days illness suffered by stressed cattle, w hile 
supplementation of lambs with 2182 lU  vitamin E prior to chlamydia inoculation 
decreased the severity of pneumonia (Stephens et al 1979). Supplementation of 
lactating cows with 0 .74g vitam in E/day decreased the incidence of m astitis 
compared to unsupplemented cows receiving only 0.32g vitamin E/day from the diet 
(Smith et al 1984).
Work cited by Tengerdy (1980) suggests that vitamin E does not protect against M. 
tuberculosa, which is controlled by the CMIR. However he suggests that host 
parasite interactions may still be affected, but by mechanisms other than the CMIR. 
Droke and Loerch (1989) found no effect of a single vitamin E injection (340 lU) on 
the number of sick days per steer in a feedlot environment, as assessed by an 
average rectal temperature greater than 39.4 ®C, compared to unsupplemented 
animals, vitamin E status was not measured before or after supplementation.
L ikoff et al (1978 and 1981) found that supplem ental vitam in E or aspirin 
decreased mortality in chicks and also inhibited production of prostaglandins E  ^ E  ^
and in the spleen and bursa. Tengerdy and Brown (1977) found that vitamin E or 
vitamin A supplementation decreased mortality due to E. coli in chicks. Vitamin E 
depressed production of prostaglandins Ej and E^ in the bursa while vitamin A 
increased prostaglandin E  ^ production. If both vitamins were given together their 
effects were antagonistic. Meydani et al (1984) found that vitamin E decreased 
prostaglandin E^ production by the spleen and also enhanced the immune response of 
aged mice. Machlin et al (1975) found that vitamin E lowers platelet aggregation 
by inhibiting synthesis of prostaglandins from arachidonic acid. V itam in E 
deficiency led to increased concentrations of platelet activating factor in rat PMN 
(Fukuzana et al 1989) by increasing synthesis. Increased PU FA concentrations 
proved detrimental to E.coli infected chicks, however vitamin E overcame this effect
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(cited by Nockels 1988).
Tengerdy and Nockels (1975) suggest that vitamin E increased the protection of 
chicks against E. coli because of its effects on ubiquinone biosynthesis. Ubiquinones 
regulate redox processes in cells and have been found to increase phagocytic activity 
in rats. Vitamin E may protect ubiquinones from oxidation, thus raising their 
concentrations (Tengerdy 1980) and enabling them to promote peroxidation of 
bacterial lipid and hence the killing of bacteria, whereas vitamin E an antioxidant 
could not act directly.
Selenium supplementation in combination with vitamin E supplementation decreased 
mortality in chicks, due to coccidiosis (Colnago et al 1984), in pigs challenged 
with SRBC (Peplowski et al 1981) in preweaning lambs (Kott et al 1983) and 
decreased losses and increased weaning weights in calves (Spears et al 1986).
Atroshi et al (1986) suggested that as concentrations of prostaglandins in cows 
infected with mastitis are higher, prostaglandins might play a role in the control 
mechanisms, especially as prostaglandin concentrations are affected by vitamin E 
status of the host. They also noted that mastitic cows had lower concentrations of 
GSH-Px, which suggests a role for selenium in controlling mastitis. However in a 
separate experiment blood vitamin E concentrations were lower in cows suffering 
from mastitis (Atroshi et al 1988). Low selenium was correlated to chronic 
mastitis and muscle diseases (Braun et al 1991), but not to low fertility. Selenium 
supplementation (0.1 mg/kg bodywt) and/or vitamin E supplementation (0.74g/day) 
before parturition decreased the duration of mastitis infections (Smith et al 1984) 
but only vitamin E affected the incidence. Increased serum selenium correlated with 
decreased bulk tank somatic cell count (SCC), and clinical mastitis decreased as 
serum selenium and dietary vitamin E concentrations increased, but high ip takes of 
selenium were associated with increased mastitis unless vitamin E intakes were also
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high (Weiss et al 1990).
Combined vitamin E and selenium supplementation of dairy cows resulted in a 42% 
reduction in infected quarters at calving, a 59% reduction in infected quarters/day 
during lactation, a 32% reduction in clinical mastitis overall, and a 57% reduction in 
clinical mastitis within 4 days of calving. SCC were also decreased (Smith 1986). 
These effects were thought to be due to increased PMN function, increased immune 
responsiveness or altered arachidonic acid metabolism.
Selenium supplementation has been found to protect rats against Staphylococcus 
aureus, but not against Salmonella, typhimurium (Boyne et al 1985 and 1986) and to 
increase chicks resistance to coccidial infection (Jenson and Johnson 1978). 
Adequate selenium status delayed C. albicans infection in mice (Boyne & Arthur 
1985a &1986), and had a positive effect on Treponema hyodysenteriae infection in 
pigs (Teige et al 1982) but a single selenium injection (6 mg) had no effect on the 
incidence of pneumonia in housed calves (Phillipo et al 1987) nor did a single 
intraruminal selenium pellet increase resistance to H. contortus infection in sheep 
(Jelinek cf a/ 1988).
Murray & Murray (1985) suggest that selenium repletion may increase susceptibility 
to infection in humans, and to L. monocytogenes, P. bergeii & pseudorabies in 
mice; they suggest a requirement for selenium by the pathogens for growth and 
pathogenicity. Unavailability of selenium for growth appeared to protect against 
S.typhimurium. in rats (Boyne & A rthur 1986), but due to the im portance of 
neutrophil function and microbicidal activity in controling C, albicans selenium 
deficiency impairs protection against this organism. Reffet et al (1988) considered 
various infections in calves and concluded that enhanced resistance depended on the 
organism used.
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Selenium appears to play a role in lipid metabolism in platelets, GSH-Px is involved 
in the conversion of 12-HPETE to 12-HETE; the degradation products of 12- 
HPETE inhibit prostacyclin synthesis causing increased platelet aggregation (cited by 
Chesters & Arthur 1988).
E. Conclusions.
Both selenium and vitamin E affect the HIR by increasing antibody production to a 
variety of, but not all mitogens / antigens. Their effects appear to be slightly 
different, with selenium stimulating IgM and vitamin E stimulating early conversion 
to IgG production. Vitamin E stimulates cell cooperation, which has little effect on 
the CMIR, but probably via its action on prostaglandins and ubiquinone it affects not 
only the HIR but also the CMIR and phagocytes.
Selenium may have additional effects on the CMIR, affecting cell mediators and 
Tj^cell cytotoxicity; some of these effects may be mediated via GSH-Px but on 
several occasions this apparently was not the case. Supplementation with selenium is 
also complicated because excess selenium proved inhibitory on several occasions, 
and so an optimum concentration needs to be established. Both vitamin E and 
selenium also affect phagocyte activity, motility and % kill, by protecting the 
enzymes involved in forming the toxic substances. However far more research has 
been done on the mechanism of action of selenium than for vitamin E.
Both vitamin E and/or selenium supplementation decrease mortality in a variety of 
species, when exposed to a variety of pathogens, but there are a few recorded cases 
where supplementation in excess of current recommendations seemed detrimental. 
Although this suggests that supplementation above the absolute requirement may 
often give financial returns, care must be taken particularly in the case of selenium,
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and more work is required to find exactly which pathogens are affected. This may 
help to elucidate the exact mechanisms of action, and in which areas of the immune 
system selenium and vitamin E exert their effects.
1.2,7, Supplementation
Many experiments have been done to compare the effects of supplementation with 
vitamin E and selenium in different forms and by different routes.
The form and route of administration of vitamin E altered its effect on immunity in 
guinea pigs (Barber et al 1977). Oral administration of DL-a-tocopherol acetate had 
no effect. Intramuscular administration of an oil emulsion produced a severe local 
reaction whereas free a-tocopherol in an aqueous emulsion produced no such 
reaction, and increased antibody titres significantly. This suggests that guinea pigs 
have difficulty  hydrolysing the ester form of vitam in E, to produce free o l-  
tocopherol.
When given in bolus form less vitamin E is absorbed than if given by continuous 
infusion. Medium chain triglycerides increase vitamin E absorption, while long 
chain polyunsaturated fatty acids (PUFA) and retanoic acid are inhibitory. Long 
chain PUFA and alcohol may lead to loss of vitamin E activity due to oxidation. 
(Bjorneboe et al 1990). Addition of high concentrations of copper to diets also 
decreases the vitamin E concentration in serum (Dove & Ewan 1990).
A slow release pellet of vitamin E supplement, administered to pregnant ewes 
provided partial protection to the lambs against nutritional muscular dystrophy; when 
administered directly to the lambs protection was almost complete (Hidiroglou et al 
1972).
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The biological availability of D-ce [5-Me-^H]-tocopherol to sheep was greatest via 
the intravenous route, followed by the intramuscular route, the oral route and finally 
via intraruminal injection. Rate of elimination followed the same trend except that it 
was slowest for intramuscular administration (Hidiroglou & Karpinski 1987).
Free D-ce-tocopherol was absorbed more efficiently than the DL- form or the D- or 
DL-acetate, from the gut, as measured by peak absorbencies and the area under the 
ce-tocopherol plasma concentration curve (AUC) (Hidiroglou & Karpinski 1988, 
Hidiroglou et al 1988, Hidiroglou et al 1989, Reddy et al 1985). D-a-tocopheryl 
acetate was the more effective when given intravenously; because of the rapid 
elimination of free DL-a-tocopherol on intramuscular injection the unesterified form 
was superior (Charmley et al 1992) but the physiological state of the animal 
influenced the relationship of circulating vitamin E to stored reserves, thus plasma 
vitamin E may be an indicator of plasma lipid status rather than vitamin E status. 
When vitamin E was administered orally, very high supplementation concentrations 
led to a decreased proportion of the vitamin E being absorbed.
Intraperitoneal administration of DL-a-tocopheryl acetate led to increased vitamin E 
in tissues and greater AUC relative to intraruminal and Hidiroglou & Charmley
(1990) suggest that this could be due to the large numbers of mesenteric lymph 
vessels in the peritoneum, and deacetylation may also occur in the peritoneum. 
Alternatively it may be hydrolysed in the liver, by a hepatic vitamin E esterase. 
Transport to the liver would be rapid via the portal circulation.
Peak uptake of a single intraperitoneal administration by the tissues, especially the 
liver occured on day three, and therafter there was a steady decline (Hidiroglou et al 
1990), while on intramuscular administration the amount of vitamin E absorbed was 
proportional to the dose, although the increase in the tissues was greater than the
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increase in the plasma. Muscles demonstrated the slowest elimination rate, and 
Hidiroglou & Karpinski (1991) hypothesise that control of vitamin E concentrations 
in the blood and in the liver are mediated separately.
Ixwis and Kirkwood (1990) administered 12,500 i.u./day DL-a-tocopheryl acetate, 
for 8 months, followed by 12,500 i.u./day free DL-a-tocopherol in vegetable oil, for 
6 months, to a black rhinoceros. Neither supplement produced a rise in plasma 
vitamin E. This suggests either that rhinoceroses have a high requirem ent for 
vitamin E or that they are unable to utilise and/or absorb it in these forms. Later oral 
D-or-tocopheryl polyethylene glycol 1000 succinate was found to be an effective 
source of vitamin E for black rhinos (Kirkwood et al 1991) which lack bile and so 
fats and vitamin E are not properly emulsified and absorbed.
O verall D-ot-tocopherol was absorbed fastest; however when sm aller daily 
supplemental doses are concerned, hydrolysis of the acetate ester might not be rate 
limiting. For immediate response intraperitoneal or intravenous administration would 
be most efficient, but this would not be suitable on a day to day basis.
Calves from hay fed cows had decreased vitamin E status and elevated GOT 
concentrations relative to calves from silage fed cows (Lynch 1983) suggesting that 
the loss of vitamin E by oxidation was decreased in silage.
On administration of SeO^^' and SeO^^“ to dairy cows, 90% of the selenium was 
bound to TCA precipitable components within 2 minutes, this was cleared by the 
liver (40%) bound to a  and gamma globulins and released within 30 minutes. SeO^^ 
was more readily m etabolisable (Symonds et al 1981a). At low doses (5ug) 
selenium was more readily absorbed into tissues from SeO^^ in steers (Symonds et 
al 1981b).
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The absorption of selenium from organic versus inorganic sources has recently been 
considered. The bioavailability of selenium from organic sources (selenomethionine 
and a selenium containing yeast product) was twice that from inorganic sources 
(sodium selenite and cobalt selenite) (Pehrson et al 1989). Cobalt selenite was used 
because it is insoluble in the rumen but soluble in the abomasum, where pH < 5 , as it 
was hoped that this might protect it from reduction in the rumen. However no 
differences in availability of selenium to cattle from cobalt and sodium selenites 
were observed. On comparison of sodium selenite with plant selenium (produced by 
spraying the crop with sodium selenite) Ekholm et al (1991) found that plant 
selenium was more effective at increasing the selenium content of all tissues, 
particularly muscle. Similar results have been found in sheep (Van Ryssen et al
1989) however the percentage of selenium incorporated into GSH-Px was lower for 
the selenium treated wheat than for sodium selenite.
When incubated with rumen microbes, selenite was converted to selenocysteine, 
whereas selenomethionine (the main selenium containing component in the wheat) 
was unchanged. In goats (Aspila et al 1988) organic selenium as selenomethionine is 
far more readily absorbed and incorporated into milk than inorganic selenium. 
However Aspila (1991) concluded that true absorption from inorganic verses organic 
selenium was sim ilar but organic selenium increased plasm a selenium more 
efficiently. Twice as much selenium was excreted in the urine after inorganic 
supplementation; overall organic supplementation was more efficient and safer.
Addition of selenium to the feed is only feasible if a concentrate ration is being fed. 
If the animals are housed, selenium could be added to the water or sprinkled on the 
food. Treatment of the pasture with selenium, or salt licks have been used for 
grazing animals. A more direct method involves using an intraruminal bullet or 
direct subcutaneous injection. Oral dosing causes increased handling of the animals,
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however incorporation of selenium into anthelmintics has proved fairly successfull 
(MacPherson et al 1987c and MacPherson 1988). The choice of method depends on 
what fits into the current management programme. Care must be taken if selenium is 
sprayed onto the land, as initially highly toxic concentrations may occur, before 
selenium is taken up by the plants and soil.
Year round supplementation of dairy cows is required and particularly precalving as 
selenium does cross the placenta and protects the foetus whereas vitamin E does not 
(Van Saun 1989). Adequate selenium status leads to improved transfer of dietary 
tocopherol to milk (Nicholson et al 1991), although this only led to improved 
flavour of milk when copper was added to the milk to catalyse oxidation.
Jenkins and Hidiroglou (1972) suggested that animal feeds in Canada should be 
routinely supplemented with selenium and vitamin E, or that cattle and sheep should 
have free access to a selenized salt lick containing 26ppm Se. Other possibilities 
include fertilizers, boluses, implants, and injections.
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CHAPTER 2
MATERIALS AND METHODS
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2.1. Sampling Techniques.
2.1.1. Collection of Blood Samples.
Blood samples were taken by jugular venepuncture and collected into appropriate 
evacuated tubes. These were silicone coated for serum, coated with 143 USP units 
o f lithium  heparin for plasm a or whole blood, or with 15% EDTA for the 
differential cell counts, and 10 ml tubes to which 1 ml of 1.5% EDTA solution (pH 
6.8) had been added, for whole blood for use in the neutrophil function tests.
Serum was obtained by retracting the clots onto wooden sticks in a waterbath at 
37®C. The sticks were then withdrawn along with the clot and the serum centrifuged 
at 3,000 r.p.m. for 10 minutes to separate any remaining debris.
Serum and plasma were stored frozen (at -20°C) for analysis, but the neutrophil 
function tests, differential cell counts and the erythrocyte stability test were carried 
out on the day the samples were taken. SCOT and plasma CK determinations were 
done within a week of sampling.
2.1.2. Rumen sampling.
Rumen samples were taken from goats and sheep by passing a tube down the 
oesophagus and into the rumen. A perforated metal weight on the end of the tube 
filtered the fluid removing any large particles. Rumen fluid was drawn through the 
tube by suction using a syringe and a valve. 30 ml of this fluid was then preserved 
by adding to 750^1 of saturated mercuric chloride solution and centrifuging at 3000 
rpm. for 20 minutes to remove any debris before being frozen for determination of 
succinate and VFA's at a later date.
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2.2. Analytical Procedures.
2.2.1. Serum Vitamin
Serum vitamin B^  ^concentrations were determined using the microbiological method 
o f Taylor and G reer (1982). Test sam ples, aqueous vitam in Bj^ standards or 
standard sera of known vitamin B^  ^ content, were diluted 1:9 in acetate buffer (pH 
4.5) containing 20 mg/1 potassium cyanide, and heated for 30 minutes at 108°C. 
After cooling all samples were 'ringed' with a wooden applicator to release particles 
stuck to the sides of the tube, and then centrifuged at 3,000 rpm. for 10 minutes. 
This caused the precipitated serum proteins to form a pellet while the vitamin B^ ,^ 
which had been converted to the stable cyanocobalamin form remained in the 
supernatant. The supernatant was then diluted 1:4 with assay broth (B^  ^ Assay 
Medium USP, Difco Laboratories, Detroit, Michigan) and sterilised at 121°C for 5 
minutes prior to inoculation with the vitamin Bj^ requiring bacteria, Lactobacillus 
leichmanii ATCC7830. After incubation at 37°iC for 18-24 hours, growth was 
measured spectrophotometrically and a standard curve plotted from the results, 
sample concentrations were obtained by reading off from the curve.
2,2.2, Methylmalonic Acid and Succinic Acid.
Standards were prepared by diluting methylmalonic acid, MMA (Purum, Fluka) and 
ethylmalonic acid, EM A (Purum, Fluka) initially to give a 10 /xmol/ml stock in 
acetone (AnalaR BDH) and then by further dilution to give a 0.5 jumol/ml MMA 
working standard and a 1 /xmol/ml EMA working internal standard.
500 jxl of sample, or 100 jul of standard made up to 500 jul with distilled water, was 
placed in a 5 ml glass tube, 100 //I of internal standard, (EMA in acetone) was added
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followed by 500 fxl of acetone while vortex mixing, to precipitate the proteins. To 
this 2 ml of saturated sodium chloride (AnalaR BDH) containing 0.5 M sulphuric 
acid (AnalaR BDH) was added and the tubes were capped and inverted. 1 ml of 
ethyl acetate (AnalaR BDH) was added and the tubes were once more capped and 
mixed by inversion for 20 seconds before centrifugation at 2000 rpm. for 10 
minutes. The ethyl acetate layer was then transferred to a glass 1 ml microtube and 
evaporated to dryness on a Dri-block heater at 60°C under oxygen free nitrogen 
(BOC gases). This stage was repeated with a further 1 ml of ethyl acetate. This 
process extracted the EMA and MMA from samples into ethyl acetate under acidic 
conditions. The extracted acids were then converted to their butyl esters by addition 
of 100 //il of a 1:10 mixture of acetyl chloride (AnalaR BDH):Butanol (Aristar 
BDH), followed by incubation in a waterbath at 70°C for 20 minutes. After being 
allowed to cool 320 /xl of hexane (Rathburn) and 600 fxl of distilled water were 
added and the tubes were mixed by inversion for 10 seconds. The hexane layer 
containing the butyl esters was then transferred to a 300 (jlI autosampler vial.
The esterified MMA was measured by capillary gas chrom atography, as in 
McMurray et al (1986), using a 'Packard 439' GC and a flame-ionisation detector. 
The column was a 25 by 0.32mm i.d. RSL150BP (Alltech). 2.5 pi of the esterified 
sample was injected onto the column using a splitter injector set at a split ratio of 
1:30, with helium as carrier gas. The injector temperature was 200°C. and the 
detector was at 250°C. The oven temperature profile during the run was as follows :-
1. 120*^0. for 2 mins.
2. Rise of 5°C. min'^ for 7 mins.
3. Rise of 40®C. min'^ until 230°C. reached.
4. 230°C. for 10 mins. (to remove any components with higher boiling points
from the column).
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Results were collected and integrated by a Shimadzu CR6A Chromatopac integrator 
and the concentration of MMA in the samples calculated from that in the standards 
as follows:-
Area EMA in Std./Area MMA in Std x Cone. MMA in Std. =  RF (response factor) 
Area MMA in sample/Area EMA in sample x RF =Conc. MMA in sample.
This method was later adapted for measurement of both MMA and succinic acid in 
both serum and rumen fluid; changes involved the inclusion of succinic acid 
(AnalaR, BDH) as a standard at 10 ^umol/ml in the stock. The working standards 
were all more dilute, giving concentrations of O.ljumol/ml MMA and succinic acid 
in the mixed standard and of 0.1 jumol/ml EMA for the internal standard. The 
sample preparation remained the same except that the hexane for the final extraction 
was replaced with the same quantity of octane (Purum, Fluka) to shorten the run 
time. This was because its lower boiling point required less cooling of the column 
before it would condense. For rumen samples lOOpl sample and 400/^1 distilled 
water were treated as for serum.
The GC separation was also modified considerably as follows :-
2.5 /Lcl of esterified sample was injected onto a capillary column (30m by 0.32 mm
i.d. SE-54, Alltech U.K., 6-7 Kellet Rd. Industrial Estate, Kellet Rd. Carnforth, 
Lancashire) with a 5m by 0.32m m  precolum n (Restek, supplied by Belmont 
Instruments, 4 Park Gardens, Glasgow.) using a splitless injection technique. The 
injector temperature was increased to 250°C the same as the detector, and after 30 
seconds a vent flow of 50 ml/minute (Helium, BOC gases) flushed the liner. The 
oven temperature profile was as follows :-
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1. 105°C for 1 minute
2. Rise 17.5®C/minute for 2 minutes,
3. Rise 2°C/minute for 8.5 minutes
4. Rise 40°C/minute until final temperature reached 230°C.
5. 230°C for 10 minutes.
The lower initial temperature was to allow the octane to condense in the precolumn 
focusing the injection into a narrow band. The slightly longer rise time was to allow 
the succinate to elute. Concentrations were calculated by the same technique.
2.2.3. Vitamin E.
Plasma sample preparation :-
Vitamin E standard (Kodak Chemical Co. Liverpool) 2 jug/ml in ethanol (0.5 ml) 
and internal standard (lOO/ t^l of 2.5 jug/ml tocol in ethanol) were diluted with (0.5 
ml) distilled water. Plasma samples (0.5 ml) and internal standard (as above) were 
precipitated with ethanol (0.5 ml). The vitamin E was extracted from samples and 
standards into hexane (Rathburn) (2.5 ml) by vigorous mixing follow ed by 
centrifugation at 1500 rpm. for 5 minutes. As much as possible of the hexane layer 
was taken off and dried on a Dri-block heater under oxygen free nitrogen (BOC 
gases) at 50®C and then redissolved in methanol (BDH)(300jLtl) before being 
transferred to autosampler vials for vitamin E determination.
Feed samples were prepared as foliows:-
1.5 g of milled sample was weighed into a 50 ml polypropylene conical bottomed 
centrifuge tube to which was added 10 ml of 10% pyrogallol (AnalaR BDH) in 
ethanol (BDH). The tubes were placed in a 70^C w aterbath for 5 m inutes to
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equilibrate before addition of 2.5 ml 60% aqueous potassium hydroxide (BDH) and 
then left for 30 minutes at 70°C to saponify. Finally 22.5 ml of distilled water and 
10 ml of hexane (Rathburn) were added and the tubes were mixed by inversion to 
extract the tocopherol. Once the layers separated 1 ml of the hexane layer was 
transferred to a 5 ml glass tube and evaporated to dryness on a Dri-block heater at 
50°C under oxygen free nitrogen (BOC gases). The residue was redissolved in 300 
fxl methanol (Rathburn) and transferred to an autosampler vial.
Separation of the end products of both the plasma and the feed sample preparations 
was achieved by HPLC, using a 15cm by 4mm i.d. Superspher 4/j.m RP18 column 
with a Lichrocart 4-4 guard column. Degassed Methanol: water 98:2 was used as 
eluent, flowing at 1.5 ml/min from a Spectra Physics SP8770 isocratic pump. A 
Gilson 232Bio autosampler was used to inject 110 /xl through the 20fxl loop the 
contents of which were then flushed onto the column. Detection was achieved using 
a Jasco 821-FP flu o rim eter with 295 nm excita tion  and 330 nm em ission 
wavelengths and results were collected and integrated using a Spectra Physics 
ChromJet integrator. Retention times for tocol and vitamin E were about 3 and 5 
minutes respectively. To validate the results obtained a large number of duplicate 
samples were also analysed at the Animal Diseases Research Institute (Moredun) and 
the results compared. The correlation between our vitamin E results and those of the 
Moredun was 0.976 (or R^—95.3), and the relationship between the two values was,
Auchincruive result =  0.017 +  (1.1 x Moredun result).
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2.2.4. Serum Glutamic oxalacetic transaminase (SGOT).
Serum glutamic oxalacetic transaminase (SGOT) concentrations were measured 
using a colourimetric kit obtained from SIGMA (procedure No. 505). The kit is 
based on the reaction
Aspartic Acid +  GOT Oxalacetic acid +
 >
alpha-ketoglutaric acid Glutamic acid
The oxalacetic acid can then be determined colorimetrically at 505nm, after reaction 
with 2,4-dinitrophenylhydrazine.
2.2.5. Plasma Creatine Kinase (CK).
Plasma CK activity was measured using a colourimetric kit (Boehringer Mannheim 
cat. No. 126322). This method is based on the N-acetylcysteine activated UV- 
system, using CK to convert creatine phosphate and ADP to creatine and ATP; the 
ATP generated is reconverted to ADP by reacting with glucose in the presence of 
hexokinase, producing glucose-6-phosphate. This in turn reacts with NADP^ in the 
presence of glucose-6-phosphate-dehydrogenase forming gluconate-6-phosphate, 
and NADPH. The production of NADPH can be measured spectrophotometrically at 
365nm in a kinetic assay at 30°C and related back to the activity of CK.
2.2.6. Whole blood Glutathione peroxidase.
Glutathione peroxidase was measured in heparinised whole blood, using an enzyme 
coupled colourimetric method, (based on Paglia and Valentine 1967 and Anderson et 
al 1978) as used by the Veterinary Investigation Centre, SAC. This assay relies on 
the activity of GSH-Px to convert cumene hydroperoxide substrate to free radicals, 
in the presence of reduced glutathione, glutathione reductase and NADPH, and the
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rate of NADPH oxidation can be measured spectrophotometrically at 365nm, in a 
kinetic assay at 30®C. This can be related to the activity of GSH-Px in the red cell 
fraction.
2.2.7. Serum Copper, Calcium and Magnesium.
Serum copper, calcium  and magnesium were analysed by atom ic absorption 
spectroscopy according to standard methods used by the Biochemical Sciences 
Department SAC.
2.2.8. Rumen fluid Volatile fatty acids.
Separate stock standards were made up by weighing Acetic acid (3g AnalaR, BDH), 
Propionic acid (3.7g Sigma), Butyric acid (4.4g Sigma), Isobutyric acid (0.44g 
Sigma), Valeric acid (0.5Ig Sigma), and Isovaleric acid (0.5Ig Sigma) and making 
each up to 50ml with distilled water. A single mixed working standard was then 
prepared from 5ml acetic, and 2ml of each of the other stock standards, made up to 
100 ml. This gave final molarities for the acids of 0.05, 0.02, 0.02, 0.002, 0.002 
and 0.002 respectively.
Thawed samples were centrifuged at 1000 r.p.m . for 10 minutes to remove any 
remaining debris, 2.5 ml of sample was then added to a screw capped centrifuge 
tube and 1.1 ml of IM sodium hydroxide (AVS) was added. For the standards 1.1 
ml of water was added to the 2.5 ml of working standard. 0.5 ml of pivalic acid 
solution (0.22g pivalic acid Sigma, in 100 ml water) and 2ml oxalic acid solution 
(4.725g oxalic acid AnalaR, in 500 ml water) were added to each tube. The tubes 
were then capped and mixed before being centrifuged at 3000 r.p.m. for 10 minutes, 
and the supernatants were transfered to 2ml autosampler vials.
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Separation was achieved by injecting 1 jxl onto a 2m by 2mm i.d . glass column 
packed with 4% carbowax 20M on carbopack B-DA 80/120 mesh (Supelco Inc.) 
using an AMS GC with a flame-ionisation detector. Column flow rate was 24 
ml/minute with hydrogen at 30 ml/minute and air at 300 ml/minute. Injector and 
detector temperatures were both 200°C and the oven temperature was 175°C.
2.2.9. Neutrophil Function Test.
The neutrophil function test used was a modification of the candidacidal test used by 
Boyne and Arthur (1979). The neutrophils were isolated by a series of washing and 
centrifugation steps, according to the method of Carlson and Kaneko (1973). Fresh 
blood with EDTA as anticoagulant, was centrifuged at lOOOG for 20 minutes and the 
plasma portion was removed by aspiration. 4 ml of isotonic (0.8%) PBS was added 
to resuspend the remainder before transferring to a 50 ml conical based centrifuge 
tube. Distilled water (20 ml) was added, mixed gently and left for 1 minute to lyse 
the red cells. To prevent lysing of the more resistant white cells isotonicity was 
restored by the addition of 10 ml 2.7% sodium chloride in PBS. The tubes were then 
centrifuged at 500C for 10 minutes to form a white cell pellet, the remaining 
supernatant being discarded by aspiration. The cell pellet was washed three times by 
suspending in 25 ml PBS mixing by gentle inversion and recentrifuging and 
aspirating the supernatant as before. Finally the cell pellet was resuspended in 1ml 
PBS.
For the C. albicans neutrophil function test the neutrophils were then incubated for 
an hour at 37®C. with the yeast Candida albicans. Dead C. albicans were stained 
blue by incubating in the presence of methylene blue dye for 15 minutes, which 
enabled them to be identified. Using a haemocytometer, the number of neutrophils 
containing dead C. albicans were then counted and expressed as a percentage of the 
number of neutrophils containing ingested C. albicans, which is then referred to as
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the percentage kill.
For the other neutrophil function tests incubation with E.coli and S,aureus was done 
by a modification of the method described by Hogan et al. (1990). Neutrophils were 
incubated with either E.coli or S.aureus at 37*^0. for 90 mins. After incubation the 
assay suspension was diluted 2:1:1 with acridine orange (14mg/100mlPBS) and 
crystal violet (50mg/100ml PBS). Wet mount slides were prepared and examined 
under a fluorescence microscope, using a 1,000 x oil immersion lens. % kill was 
calculated as for the Candida.
2.2.10. ELISA for Clostridium tetani antitoxin.
This ELISA was carried out according to the method of Keith Wood (1990 personal 
communication, unpublished) using pre-coated Dynateck M129B micro-ELISA 
plates (coated with Cl. tetani toxin; K.Wood). These were washed three times with 
phosphate buffered saline containing 0.1 % Tween (PBST) before being incubated 
with 250 )ul PBS containing 0.1% bovine serum albumen (BSA)(BDH)/well, for Ih 
at 37‘^ C. The plates were then re-washed three times.
A standard dilution series was set up using goat serum known to contain 2.5 lU/ml 
Cl. tetani antitoxin (K.Wood). The unknown samples were also diluted, either 1/250 
for pre-vaccination samples, or 1/2000 or 1/3000 for post-vaccination samples. The 
standards and samples were plated out and a row of blank wells was also included on 
each plate. The plates were then incubated for Ihr at 37°C and thereafter washed a 
further three times. Rabbit anti-goat IgG-horseradish peroxidase conjugate (K.Wood) 
diluted 1/500 in PBST was added to each well and incubated for Ihr at 37°C. The 
plates were then washed three times again.
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250 pi of substrate solution, made up per plate from:- 
25 ml of O.IM sodium-acetate-citric acid buffer (pH 6.0)
25 pi (30%)
250 pi tetramethyl benzidine soln. (4.2mM TMB in DMSO from K.Wood) 
was added to each well and the colour was allowed to develop for 5-10 mins. The 
reaction was then stopped by adding 50 pi sulphuric acid (AnalaR BDH) (IM) to all 
wells, and gently agitating.
The absorbance at 450 nm was measured using a Titertek plate reader, and the 
concentrations in the samples calculated from the standard calibration curve. All 
samples and standards were measured in duplicate and mean values calculated.
2.2.11. Erythrocyte stability test.
Detergent sensitivity was assessed essentially as described by Stevenson and Jones 
(1989), using Polyoxyethylene Sorbitan Monolaurate, Tween 20 (Sigma). Whole 
blood (0.2ml) was washed in phosphate buffered saline (5ml PBS) pH7.4 containing 
0.5m m ol/l ethylenediaminetetraaceticacid (disodium salt) (PBS/EDTA). After 
centrifugation (lOOOG for 10 mins) the supernatant was aspirated and the cell pellet 
was resuspended in PBS/EDTA (5ml). Phosphate buffered saline contained 6.8g 
sodium chloride (AnalaR, BDH), 1.48g di-sodium  hydrogen orthophosphate 
(anhydrous, AnalaR, BDH), 0.43g potassium dihydrogen ortho-phosphate (AnalaR, 
Hopkin and Williams Ltd. England) per litre adjusted to pH 7.4 using O.IN sodium 
hydroxide (GPR BDH).
0.5 ml aliquots of the above suspension were mixed 1:1 with dilutions (0.5, 2 and 
6%) of Tween 20 in 0.9% saline. This mixture was incubated in a waterbath at 37 
for 15 mins. Ice cold PBS (2 ml) was added, and the mixture recentrifuged. 
Supernatant absorbances were read at 415 nm. Percentage haemolysis was calculated
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by comparison with the absorbance of a 100% haemolysate, obtained by adding 10 
ml distilled water to 50 pi of whole blood.
This method was modified for use with the calves to overcome several problems that 
were experienced with the goats.
Modifications.
1. Tween 20 dilutions used were 1, 3 and 5 %.
2. Incubation time was increased to 18 minutes.
3. 10 ml of ice cold PBS was added after incubation.
4. 100% haemolysed sample was obtained by adding 0.5 ml of washed cells
(resuspended in PBS/EDTA) to 10,5ml of distilled water.
The effect of these changes was to give a larger end volume, which increased 
precision of absorbance measurements. The supernatant was more dilute and so had 
a lower absorbance which meant that readings were now in the more sensitive range 
of the instrument and no longer in danger of going off scale. Another unexpected 
effect of dilution was to decrease the percent haem olysis. This suggests that 
previously the reaction was not entirely stopped by the addition of PBS. Incubation 
time was extended slightly to compensate for this.
During the modification process, very small differences in incubation time were 
found to affect results greatly which may explain the large week to week differences 
observed previously.
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2.2.12. Differential cell counts.
Whole blood was drawn into a vacutainer containing EDTA to prevent clotting. 
Differential cell counts were carried out as described by Scholm et al (1975). The 
blood was inverted gently to obtain a homogeneous sample, one drop of which was 
placed on a standard glass slide, a second slide modified to have a narrow edge was 
then used to smear the drop to give a film approximately one cell thick. The slide 
was then allowed to dry before being flooded with Wright's Giemsa stain (Sigma) 
for 15 seconds, this was followed by flooding with distilled water for 2 minutes, and 
then a thorough rinse in distilled water. Once the slide was dry it was then examined 
under a light objective m icroscope (Kyowa O pticals, Japan) using a x 550 
m agnification, and one hundred white cells were counted by the battlem ent 
procedure. The number of each cell type was recorded and expressed as a 
percentage of the total.
2.2.13. Single Radial Immunodiffusion (SRID) for goat IgG.
Standards were prepared by reconstituting 10 mg of lyophilised salt free goat IgG 
(product N°. 15256 Sigma) in 250 p\ distilled water to give a concentration of 4000 
mg/100 ml. Serial dilutions 1:2, 1:4, 1:8, 1:16 and 1:32 were prepared in normal 
saline.
SRID plates were prepared as follows:-
Sodium barbitone (5g AnalaR BDH) and sodium acetate (3.25g AnalaR BDH) were 
dissolved in 32.2 ml of HCl (0.1 N) and the solution made up to 500 ml by addition 
of distilled water. 150 ml of this O.IM barbitone-acetate buffer (pH8.6), was then 
used to prepare a 1.2% agar solution (1.8g Agar-Purified Difco) incorporating 6g 
polyethylene glycol 4000 (BDH) and was boiled to dissolve the agar. 5.6 ml aliquots
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were transferred to test tubes. On cooling to 56°C an aliquot (amount depending on 
the concentration of antibody used) of anti-goat IgG whole molecule (product 
G5518 Sigma; lyophilised form raised in rabbits, titre 2.0 mg antibody/ml), was 
diluted with sodium barbitone buffer to 1 ml and this was added to the agar and 
mixed thoroughly before pouring into a plate. Plates were allowed to set on a 
perfectly flat surface and then stored at 4°C before use.
Seventeen 5 (jiX capacity wells were cut using a template and 2mm well cutter. 4 fû of 
standard or sample was added to each well, standards being distributed among the 
plates which were then incubated overnight at room temperature.
Results were obtained from a standard curve plotting IgG concentration on the log 
(y-axis) of semi-log paper, against ring diameter in mm (x-axis).
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CHAPTER 3
THE REQUIREMENT OF GOATS FOR COBALT, TO MAINTAIN GROWTH
AND IMMUNE FUNCTION.
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3.1. Introduction.
Very l i t t le  is know n to d a te  ab o u t the  p re c ise  re q u irem en ts  o f goats  fo r 
micronutrients. Recommendations are based on the requirements of sheep and cattle 
and are generous enough to allow for some error. However distinct differences are 
apparent between sheep and cattle, and although goats have survived to date on this 
system, a better understanding of their specific needs would be beneficial. This is 
true not only from the scientific viewpoint but also from an economic one, as it 
could lead to saving on mineral/vitamin supplements.
W ith the prospect o f an open European m arket goats could becom e far m ore 
popular. They are highly suited to poor grazing conditions, being small and having a 
split upper lip, which allows them to be highly selective about the vegetation they eat 
and enables them to derive more nutrients than the average analysis of a crop would 
suggest. They are also leaner than sheep, which, in this calorie conscious age, 
should increase their popularity. Currently it is the consumer resistance which the 
British public has to eating goat meat that prevents them from being marketable.
For research purposes goats are more suitable than sheep as a model for cattle. A 
model is generally required for economic reasons because the cost of purchasing and 
feeding large animals like cows is high. Goats are generally very similar to sheep in 
their metabolism. However, possibly because they have also been bred for milking 
purposes in many areas, in some characteristics they resemble cows more closely 
than sheep do.
Finally very little of the research on relating micronutrients supply to immunity has 
been done on goats and so it is not known whether the effects of deficiencies or 
excesses are common to all ruminants, or are species specific.
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The first objective was to investigate cobalt requirement in the goat, and to attempt 
to establish a precise dietary cobalt requirem ent. There is not a great deal o f 
l ite ra tu re  on this subject. H ow ever F latten  (1951) suggests that the cobalt 
requirement of the goat may be greater than that of sheep, while Clark et al (1987) 
suggest that it may be as low as 0.035 mg/kg DM, and Mgongo et al (1984) found 
that levels as low as 0.01 mg/kg DM definitely produced symptoms of vitamin 
deficiency. Thus initially it was necessary to consider a range of dietary cobalt levels 
based around the known requirements of sheep and cattle for this element.
To establish the dietary requirement for cobalt the minimum dietary concentration 
which caused no symptoms of deficiency such as loss of appetite, weepy eyes or 
decreased liveweight gain would be identified, with an attempt being made to assess 
the relationship between dietary cobalt level and immune function as this has been 
shown to be affected by cobalt/vitamin Bj^ deficiency before liveweight gain in 
sheep and cattle (Fisher 1988 & Paterson and MacPherson 1987 & 1990). It is also 
necessary to establish parameters for diagnosing deficiency. In sheep serum vitamin 
B ^ 2  ^nd MMA concentrations used in conjunction give the best indication of 
deficiency and concentrations indicative of marginal vitamin B^  ^status are well 
established. It is well known that vitamin Bj^ concentrations can be misleading in 
cattle as much of the vitamin B^  ^is bound to transcobalamin 1 and is consequently 
not measured by most conventional methods. Thus as well as establishing the critical 
concentrations for these parameters, it was necessary to assess the usefulness of each 
for diagnosing cobalt/vitamin B^ deficiency. More recently (Kennedy et al 199Id) 
suggested that serum succinate concentrations become elevated during vitamin B^  ^
deficiency and this could be used as an aid to diagnosis. Increased concentrations of 
the liver enzyme aspartate aminotransferase (or glutamic oxalacetic transaminase, 
GOT) in serum are indicative of liver damage such as occurs during white liver 
disease, or during fatty infiltration of the liver without white liver disease, thus
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SGOT concentrations might also help to identify animals suffering from cobalt 
deficiency.
The effect of vitamin E status, and intake on the health of goats is also unrecorded 
and so we aimed to consider the effects of vitamin E supplementation with two 
different forms of vitamin E. Vitamin E deficiency in other ruminants leads to 
elevated concentrations of the liver enzyme GOT in serum and also to elevated 
concentrations of the muscle enzyme creatine kinase in plasma. Because of the close 
link between the effects of vitamin E, and selenium, an indicator of the selenium 
status of the goats was required. Glutathione peroxidase (GSH-Px) activity of whole 
blood is commonly used as an indicator of selenium status.
Another long term aim of this work was to study effects of cobalt on the immune 
system, using, in the initial experiment, a neutrophil function test similar to that 
described by Boyne and Arthur (1979). This assesses neutrophil function as the 
percentage of Candida albicans killed, (as opposed to those merely ingested). This 
does ensure that all aspects of phagocyte function, chemotaxis, phagocytosis, and 
microbicidal ability, are functioning. It is however an in vitro test and so cannot be 
said to represent exactly what would occur in vivo, and it also considers only those 
aspects of immunity which involve phagocytes. It does not inform us of any effects 
on lymphocytes or antibodies etc.
Other aspects of immunity which might be affected by vitamin Bj^ and/or vitamin E 
deficiency include changes to the white cell populations, which can be assessed by 
differential cell counts, and direct effects on the humoral immune response which 
can be measured by antibody titres and antibody response to vaccination.
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3.2. Experimental Design.
In each of the three trials a very similar experimental procedure was used and 
differences between them will be discussed in each section.
3.2.1. Animals.
Twenty four six month old goats of feral x Tasmanian, Russian or Australasian 
cashm ere strain, were used in each trial. They were worm ed, deloused and 
vaccinated as required, in experiment 1, wormed on day -27 and vaccinated with 
Heptavac P on either day 64 or 70. In experiment 2 they recieved Fasinex for fluke 
on day -89, one goat died very early on and was replaced before supplementation 
commenced, a second goat allocated to group 2 died later on in the trial, but was not 
replaced. In experiment 3 all goats were treated with Parosol pour-on for lice on day 
42. The goats were housed throughout the trial.
3.2.2. Treatments.
The goats were fed a cobalt-deficient diet for two to three months until their serum 
vitamin concentrations suggested that they were depleted of vitamin B^ .^ They 
were stratified on the basis of comparable liveweight and vitamin Bj^ status and 
randomly allocated into groups, 4 groups of 6 (experiments 1 and 3) and 6 groups of 
4 (experiment 2). The date of the first cobalt treatment has been termed day zero for 
all experiments, and from this time all groups received the appropriate supplement 
weekly; in each case group one was the control and received no additional cobalt.
The first experiment was aimed at gaining a general idea of the dietary cobalt 
concentration required to maintain growth and normal immune function and so the 
differences in cobalt concentrations received by the different groups were quite
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large. The following two experiments attempted to use these initial findings to 
pinpoint the requirement much more precisely. Treatment effects were monitored by 
weekly liveweight recording, and analysis of fortnightly blood samples.
EXPERIMENT 1 During this experiment the goats were randomly allocated into
4 groups of 6 and supplementation was as follows:-
Group 1, the control group, received no cobalt supplementation.
Group 2, the low cobalt group, received 0.35 mg of cobalt per head per week.
Group 3, the medium cobalt group, received 0.525 mg of cobalt per head per week. 
Group 4, the high cobalt group, received 0.7 mg cobalt per head per week.
These are equivalent to dietary concentrations of:- 
Group 1 - 0.04 mgCo/kgDM
Group 2 - 0.11 falling to 0.09 "
Group 3 -  0.14 " " 0.12
Group 4 -  0.18 " " 0.15
changes are due to increasing feed intake (particularly of maize) during the trial.
The cobalt was in the form of hydrated cobalt sulphate, which contains 20.96 % 
cobalt by weight, from which a stock solution containing 0.7 gCo/1 was made. 0.5, 
0.75 or 1 ml of this was further diluted to approximately 15 ml and administered to 
all goats in groups 2, 3 and 4 respectively, orally using a dosing bottle once a week.
Groups 3 and 4 thus received a dietary supply which was greater than that 
recommended for sheep (0.11 mg Co/kg DM, Underwood 1981). The concentration 
received by group 2 was approximately equal to the requirement of sheep as given 
by Marston (1952), between 0.08 and 0.1 mg/kgDM. While the basal diet supplied 
group 1 with less than the requ irem ent of ca ttle  (0 .05 to 0 .0 7  m g/kgD M  
(MacPherson, Moon and Voss 1973).
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On day 163 group 1 were given 1ml of Neo-Cytamen (Glaxovet Ltd) injection 
(containing Img of hydroxocobalamin BP.) intramuscularly. By this stage they were 
all losing weight and some of them were showing other signs of vitam in B^  ^
deficiency, (not eating concentrates, pale mucous membranes and weepy eyes). 
From then on they received the same cobalt dose as group 4, to try and correct their 
condition by the end of the trial.
From day 169 until the end of the trial on day 182, half the goats (numbers 1, 2, and 
4 from group 1, number 8 from group 2, numbers 15, 16, 17, and 18 from group 3 
and numbers 20, 21, 22, and 24 from group 4) were given 100 lU DL-a-tocopheryl 
acetate supplement (as Rovimix E50 Roche) per head sprinkled on the food daily.
All goats received 3mg selenium as sodium selenite solution on day 105.
EXPERIMENT 2 During experiment 2 the goats were randomly allocated into 
six groups of four and supplementation was as follows:-
G roup 1 again received  only the basal d iet, con ta in ing  on average 0 .055 
mgCo/kgDM.
Groups 2-6 received an oral supplem ent weekly which supplied 0 .01-0 .05  
mgCo/kgDM respectively (thus after taking the diet into consideration they were 
receiving a total of 0.055-0.105 mgCo/kgDM).
The exact amount of cobalt in the dose was increased monthly to take the increasing 
DM intakes into consideration as follows :-
A stock solution of cobalt sulphate was made up monthly, as DM intakes increased 
the concentration of cobalt in the stock solution was increased such that 0.5 ml 
contained 0.01 mgCo/kgDM intake/week. Groups 2-6 received 0.5, 1, 1.5, 2, and
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2.5 ml respectively.
DM Intake (kg/day) Stock Cobalt Solution (mgCo/ml)
0.7 0.10
0.75 0.105
0.9 0.126
0.95 0.134
1.0 0 .1 4 2
It was decided to increase the level of cobalt given to group 5 to 0.07mg/kgDM (3.5 
ml of stock solution) on day 97, in case we had underestimated the requirement of 
the goats. On day 104 half the goats (numbers 3, and 4 from group 1, numbers 5, 6, 
and 8 from group 2, numbers 11, and 12 from group 3, numbers 17, and 19 from 
group 5, and numbers 21 and 23 from group 6) received an injection of vitamin E 
(3ml injectable vitamin E preparation, Stuart Products Inc) containing 300 lU D-ce- 
tocopherol/ml. Towards the end of the experiment on days 146 & 147 goat 1, from 
Group 1, received 1ml of injectable vitamin (1 mg/ml hydroxocobalamin Neo- 
Cytamen, Glaxovet Ltd.), and goats 1-4, in Group 1, received oral cobalt doses 
from day 154, containing 0.05 mgCo/kgDM intake.
All goats received 3mg selenium as sodium selenite solution on day 35.
EXPERIMENT 3 During Experiment 3 the goats were randomly allocated into 4 
groups of 6, offered the basal diet and supplemented orally as follows 
Group one received no additional cobalt.
Groups 2,3 and 4 received additional supplem ents of 0 .01 , 0 .02 and 0.06 
mgCo/kgDM respectively. Thus in total the combined dietary and supplementary 
cobalt received by each group was:-
group 1, 0.04, group 2, 0.05, group 3, 0.06, group 4, 0.10 mgCo/kgDM.
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Again a stock solution of cobalt sulphate was made up monthly, and as DM intakes 
increased the concentration of cobalt in the stock solution increased such that 0.5 ml 
contained 0.01 mgCo/kg DM intake per week. Thus groups 2-4 received 0.5, 1 and 
3 ml respectively.
DM Intake (kg/day) Stock Cobalt Solution (mgCo/ml)
0.5 0.07
0.55 0.08
0.65 0.09
0.7 0.098
0.75 0.1
All goats received 3 mg of selenium as sodium selenite solution on day 154.
3.2.3. Diets.
The diet used in these experiments aimed to mimic the normal ruminant diet as 
closely as possible, and consisted of concentrate (maize except for the second half of 
the first trial which incorporated propcorn barley) with forage (hay, except for trial 
three when a hay : straw, 1:1 mix was used). SAC rationing software was used to 
formulate diets containing adequate protein and energy, but to be deficient in cobalt. 
Rations were calculated to allow for liveweight gains of 50g/day. Urea was added to 
the forage to provide adequate nitrogen, and calcium, magnesium and sodium were 
supplemented when required. Details of the nutritional composition of the feeds are 
included in tables 3.2.1 to 3 .2 .6 , Appendix I. In the first trial the overall diet 
supplied 0.04 mg Co/kg DM, for the second trial the basal diet contained more 
cobalt, 0.06 falling to 0.05 mg/kg DM as intake of the concentrate increased during 
the trial, with an average of 0.055 mgCo/kgDM. In the third trial, because of the 
high levels o f cobalt in the hay it was mixed with straw , and the ra tio  of 
hay:straw:m aize was maintained at 3:3:4 throughout the trial giving an overall 
concentration of 0.04mg/kg DM. The goats were housed in two pens and group fed,
106
so individual feed intakes were not measured.
3.2.4. Experimental Parameters.
Serum vitamin MMA, succinate and GOT concentrations were monitored to 
investigate their relationship to cobalt intake of the animal. Plasma vitamin E, 
creatine kinase (CK) activity and whole blood GSH-Px activity were monitored to 
investigate their relationship with the vitamin E intake of the goats. Additionally 
from day 163 of experiment 1, erythrocyte stability was monitored weekly to see if 
there was a link between this and vitamin E supplementation.
To ensure that the results observed were due to the imposed treatments, and not to 
confounding effects, concentrations of various other micronutrients were also 
monitored. When these fell below accepted levels, as was the case with selenium in 
all three trials, suitable remedial action was taken. Concentrations of copper, 
magnesium and calcium, were also measured for this reason.
Vitamin B^  ^concentrations and other blood parameters were measured fortnightly, 
while liveweights (LWT)were recorded weekly, using a weigh crate (Ritchie Farm 
Equipment) zeroed before use.
Neutrophil function was assessed fortnightly during experiment 1, and blood samples 
were taken before and after vaccination with Heptavac-P for determination of the 
antibody response of the goats by ELISA. During experiment 2 differential cell 
counts were carried out fortnightly and at the end of experiment 3 total IgG titre was 
measured by single radial immuno diffusion (SRID).
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3.2.5. Statistical analysis.
Statistics were carried out on the results using the Genstat V programme (Lawes 
Agricultural Trust 1988). Analysis of variance or covariance was used unless 
otherwise stated.
3.3. Results:- Experiment 1
3.3.1. Serum Vitamin Concentrations.
The basal diet proved inadequate to maintain serum vitamin Bj^ concentrations above 
100 ng/1, see F ig.3.1. and Tkble 3.7 in Appendix I. Concentrations in the control 
group fell as low as 30 ng/1. All three oral cobalt supplementation levels showed a 
significant increase in serum vitamin B^  ^ concentrations maintaining them above 100 
ng/1 but not, except in the case o f group 4, ra ising  them  above 200 ng/1. 
Concentrations for group 4 were significantly higher than those for groups 2 and 3 
on 4 occasions. Vitamin E treatment did not affect vitamin B^  ^ concentrations. The 
injection of vitamin Bj^ administered to the animals in the control group on day 163 
increased serum vitam in B^  ^ concentrations beyond the range of the assay 
(>2500ng/l) by day 168.
3.3.2. Serum MMA Concentrations.
The control group MMA concentrations rose continually from below 2 jnmol/1 at the 
outset to over 120 jwmol/1 just prior to supplementation, see Fig.3.2. and Tkble 3.8 
Appendix I. Concentrations for the other groups rose prior to supplementation but 
decreased rapidly thereafter returning to below 10 /xmol/1. Concentrations for groups 
2,3 and 4 were consistently significantly lower than those for group 1 but there were
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Group 1 goats received Oytamen on day 163
no significant differences in concentration among groups 2,3 and 4. The vitamin 
injection administered to group 1 on day 163 caused serum MMA concentrations in 
these goats to decrease from 121 to < 1 jumol/l by day 168.
The relationship between vitamin Bj^ concentration and MMA concentration can be 
seen in F ig.3.3. Despite the low correlation coefficient (-0.292) it can be seen that 
for most values of vitam in Bj^ above 200ng/l, MMA concentrations are low 
< lO^mol/1. W hile for all MMA concentrations >  10 /xmol/1, vitam in B^  ^
concentrations are, with one exception below 200 ng/1. There are a great number of 
points showing instances where both vitam in B^  ^ concentrations and MMA 
concentrations are low (< 2 0 0 n g /l and <  10/imol/l respectively). V itam in E 
treatment had no significant effect on MMA concentration,
3.3.3. Serum GOT Activity.
Results, seen in Fig.3.4. and Ikble.3.9. in Appendix I, show significantly elevated 
GOT concentrations in group 1 animals at the end of the trial, suggesting that they 
were suffering some liver damage. Vitamin E treatment had no significant effect on 
serum GOT.
3.3.4. Liveweight.
The basal diet failed to maintain liveweight gain in the control group; liveweights of 
the other three groups increased steadily and by day 105 they were all significantly 
heavier than those animals in group 1,(Fig.3.5. and Ihble 3.10 Appendix I). There 
were no significant differences however among the 3 supplemented groups even 
when using liveweight on day zero as a covariate in the analysis. On regressing the 
results for each goat individually and comparing the derived constants there were no
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significant differences, this may be partly due to the poor fit of the lines representing 
group 1, as in itia lly  they lost w eight, and then began to gain w eight a fte r 
supplementation. On day -63 the animals later supplemented with vitamin E, which 
were unevenly distributed amongst the cobalt treatment groups (as described in 
section 3.2.2, experiment 1) had a significantly greater liveweight than those which 
were not later supplemented with vitamin E, however this was a chance effect as 
vitamin E treatments did not start until day 169. The difference in size, at the end of 
the trial, between a group 1 goat and a group 4 goat can be clearly seen (Plates 1 
and 2).
3.3.5. Plasma Vitamin E Concentration.
Supplementation with vitamin E produced a significant effect, raising the plasma 
vitamin E concentration from 1.8 ^umol/l to 4.4 jumol/l, see Fig.3.6. and Thble 3.11. 
Appendix I. Plasma vitamin E concentration was unaffected by cobalt treatment.
3.3.6. Whole Blood GSH-Px Activity.
Despite some significant differences in whole blood GSH-Px activity among groups, 
and some values (day -14) indicating deficiency, all remained adequate until day 56 
when all groups were low (although group 2 was significantly less so), see Table 
3.12 Appendix I. After supplementation with selenium on day 105 concentrations 
rose until all groups were again sufficient. The vitamin E supplemented group had 
significantly lower GSH-Px activity on days 70, 84 and 100, however as vitamin E 
supplementation did not commence until day 169 this is unlikely to have affected 
response to vitamin E treatment.
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3.3.7. Plasma CK Activity.
Group 1 showed elevated CK activity compared to the cobalt supplemented groups 
but this was only significant on day 161 due to the large spread in values, (Fig.3.7. 
and Table 3.13 Appendix I). These results suggest that goats in group 1 had some 
muscle damage. However, vitamin E treatment did not significantly affect plasma 
CK activity.
3.3.8. Serum Copper, Calcium and Magnesium Concentrations.
Despite some differences among groups all had adequate concentrations of copper, 
calcium and magnesium, see Thble 3.14. Appendix I.
3.3.9. Neutrophil Function.
There was no clear significant effect of treatment on neutrophil function, see 
Fig.3.8. and Thble 3.15. Appendix I.
3.3.10. ELISA for Clostridium, tetani.
There was no significant effect of cobalt treatment on antibody titre in response to 
vaccination, see Table 1. There w ere small apparent d ifferences in response 
according to the day of vaccination, see Table 2, but once the difference in initial 
titre was taken into account this was barely significant even at the 10% level. Thus it 
is unlikely that a difference between cobalt treatment groups was masked by the 
different vaccination dates.
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Table 1. Clostridium tetani Antibody Titre (lU/ml)
Day No. Cobalt Treatment Group Number 
1 2  3 4
S.E.D P
63 0.182 0.133 0.253 0,383 0.1929 0.601
84 9.345 5.348 5.710 7.905 3.24 0.575
154 2.775 0.653 0.717 1.00 1.08 0.193
Table 2. Clostridium tetani Antibody Titre (lU/ml)
Day No. Vaccination Date 
63 69
S.E.D P
63 0.149 0.327 0.1308 0.188
84 5.116 8.99 2.13 0.084
154 0.572 2.00 0.758 0.073
Table 3. Erythrocyte Stability (% Haemolysis)
Day No. Vitamin E Treatment S.E.D. P
+ E -E
0.5% TWEEN
163 5.9 6.4 1.858 0.767
168 1.9 1.2 0.459 0.197
175 9.1 11 3.16 0.482
182 7.0 10 2.78 0.292
2% TWEEN
163 33 19 10.68 0.197
168 2.0 1.4 0.716 0.411
175 12 21 6.76 0.191
182 4.8 6.2 1.881 0.455
6% TWEEN
163 65 75 12.99 0.453
168 47 54 14.4 0.638
175 99 99 0.442 0.528
182 48* 82k 12.16 0.011
Table 4. Erythrocyte Stability (% Haemolysis)
Day No. Cobalt Treatment Group Number 
1 2  3 4
S.E.D P
0.5% TWEEN
163 5.6 6.2 5.7 7.0 2.739 0.955
168 1.2» 2.6k 1.4»k 1.0» 0.590 0.063
175 13 13 7 7 4.34 0.309
182 4.4» 1 5 k 8.8“k 5.5» 3.29 0.016
2% TWEEN
163 31 42 19 13 14.93 0.261
168 1.2» 3 .7 k 1.0» 1.0» 0.791 0.005
175 20*k 30k 8.8» 11» 9.04 0.103
182 3.2 8.7 4.5 5.0 2.525 0.196
6% TWEEN
163 7 Qab 8?k 'yyab 46» 17.09 0.142
168 53*k 78k 34» 37» 18.3 0.092
175 99 99 100 99 0.654 0.407
182 55» 92k 72»k 40» 16.99 0.036
3.3.11 Erythrocyte Stability,
Vitamin E supplementation significantly decreased % erythrocyte haemolysis in the 
presence of 6% Tween on day 182, there were no other apparent effects of vitamin 
E treatm ent, see Table 3. Significant differences between the response o f the 
different cobalt treatment groups were observed, see Thble 4, with group 2 showing 
an increased % erythrocyte haemolysis.
3.4. Results:- Experiment 2
3.4.1. Serum Vitamin Concentration.
Once again the basal diet failed to maintain serum vitamin Bj^ concentrations above 
100 ng/1; and in the present trial, values fell as low as 30 ng/1, (Fig.3.9. and Ihble 
3.16 Appendix I). In relation to values for group 1 receiving no supplementary 
cobalt, concentrations for the supplemented groups were slightly greater but group 2 
was only significantly greater on 2 occasions, groups 3 and 4 on 3 occasions, group 
5 on 5 occasions and group 6 on all occasions after supplementation. Group 5 was 
also significantly greater than groups 2 and 3 on 2 occasions, and group 6 was 
significantly greater than all other groups on three occasions. All these differences 
w ere s ig n if ic a n t w hen c o n ce n tra tio n  at day 0 was used as a c o v a r ia te . 
Supplementation of group 1 goats with oral cobalt from day 154, (one animal also 
recieved vitamin B^  ^ injections) increased serum vitamin Bj^ concentrations in these 
animals to > 200 ng/1 within a week. Vitamin E treatment had no significant effect 
on vitamin B^  ^concentration.
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3.4.2. Serum MMA Concentration.
MMA concentrations for all groups rose slowly until day 0, see Fig.3.10. and Tkble 
3.17. Appendix I. Concentrations for group 1 continued to rise and reached a peak 
of 85 jumol/l on the day they received their first oral cobalt supplement. For groups 
2 to 6  concentrations returned to <20 jumol/1, for groups 2 and 3, and <  10/^mol/l 
for groups 4 to 6 . Even when concentrations on day 0 were used as covariates the 
differences between groups 2 to 6  were not significant. The difference between 
group 1  and all other groups was highly significant from the first supplementation. 
Supplementation of the group 1 goats with oral cobalt (and of one animal with 
vitamin injections) returned their serum MMA concentrations to < 3 0  /xmol/1 
within a week.
The relationship between vitamin Bj^ and MMA concentration is shown in Fig.3.11 
and shows a similar pattern to that for the first experiment, except that this time 
elevated MMA concentrations (>5/xmol/l) seem to be associated with vitamin B^  ^
concentrations below 1 0 0  ng/ 1 , however in this experiment there was only one 
vitamin B^  ^ concentration between 100 and 200 ng/1. The correlation coefficient on 
this occasion was -0.283.
3.4.3. Serum Succinate Concentration.
Serum succinate concentrations for all groups seem to follow similar trends with a 
large peak between days 40 and 100, see F ig .3.12. and Ihble 3.18. Appendix I. 
W hen concentrations on day 0 were used as covariates significantly  low er 
concentrations were observed for group 1  than for all other groups on at least 2  
occasions. No other group was consistently higher or lower than the rest.
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The correlation between succinate concentration and vitamin Bj^ concentration is 
even lower than that for MMA (-0.017) and indeed the correlation coefficient for 
succinate concentration versus MMA concentration is also extremely low (-0.037).
3.4.4. Serum GOT Activity.
Serum GOT activities of goats, seen in F ig .3.13 and Table 3.19 Appendix I, show 
no particular trend in relation to cobalt intake. Group 1 was significantly higher than 
2 other groups on day 0, group 6  was significantly higher than group 4 on day 42, 
and was significantly higher than groups 3,4 and 5 on day 56. Group 1 was 
significantly higher than group 4 on day 69, while group 5 was significantly higher 
than groups 3 and 4 on day 97. However if you count the number of occasions on 
which each group mean has exceeded 100 SF units, group 1 has 7, group 2 has 4, 
group 5 has 1 and group 6  has 4. This may suggest group 1 had the most liver 
damage but the evidence is not very convincing. Vitamin E treatment had no 
significant effect on serum GOT.
3.4.5, Liveweight.
All groups gained steadily in weight throughout the trial, see F ig .3.14. and Fkble 
3.20 Appendix I. When liveweight on day 0 was used as a covariate in the analysis, 
group 1 gained significantly less weight during the trial than groups 2, 3 and 6 . 
Group 2 was the first group to show a significant improvement over the other 
groups. On regressing the liveweights for each goat individually and comparing the 
derived constants there were no significant effects of either cobalt or vitamin B 
supplem entation on the in tercept, but cobalt supplem entation group 3 had a 
significantly greater slope than group 1, all other groups being intermediate. Vitamin 
E treatment had no effect on liveweight.
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Fig 3.13 Serum GOT A c t iv i ty  of Goats, Exp t 2
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Fig 3.14 Liveweights of Goats, Expt 2
3.4.6. Plasma Vitamin E Concentration.
V itam in E in jection  had a h ighly  s ig n ifican t e ffec t on plasm a v itam in  E 
concentrations which peaked at over 50 jLtmol/l, the day after injection, but fell 
rapidly to 7 /xmol/1 within 7 days, see Fig.3.15 and Thble 3.21 Appendix I. Cobalt 
treatment had significant effects on vitamin E status on day 69 when group 1 was 
significantly lower than groups 3 and 6 , on day 97 when group 1 was significantly 
lower than groups 2 and 3, on days 111, 125, 139, and 153 when group 2 was 
significantly greater than all other groups. This last effect was due however to an 
uneven distribution of goats between treatments as all goats in group 2  received 
vitamin E supplementation. This was because vitamin E supplementation was given 
to one pen of goats but the cobalt treatment groups were not equally distributed 
between the pens. Hence two animals from groups 1 , 3 , 5  and 6 , and all 3 remaining 
animals from group 2 recieved the vitamin E supplement, while no animals from 
group 4 were supplemented.
3.4.7. Whole Blood GSH-Px Activity.
Group 3 GSH-Px activity tended to be significantly greater than that of group 4, but 
all groups were adequate until day 28, see Table 3.22 Appendix I. On day 35 all 
anim als were supplem ented and from this date all values rapidly returned to 
adequacy. Vitamin E treatment had no significant effects on GSH-Px activity.
3.4.8. Plasma CK Activity.
High CK activity was found in animals from each group, see F ig .3.16 and Tkble 
3.23 Appendix I. Group 2 CK activity was significantly greater on day 56, group 5 
on day 97, but group 1 was significantly greater on days 125 and 153 suggesting that
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Fig 3,16 Piasma OK Ac tiv ity  of Goats, Expt 2
this group may have experienced significantly more m uscle dam age as the 
experiment progressed. Vitamin E treatment had no significant effect on CK.
3.4.9. Serum Copper, Calcium and Magnesium Concentrations.
There were some small but significant differences in copper, magnesium and 
calcium concentrations, see Thble 3.24. Appendix I. However as all groups were 
always within the normal range for these parameters these differences are unlikely to 
have had any confounding effects.
3.4.10. Whole Blood Differential Cell Counts.
Group 1 had a significantly higher proportion of neutrophils than groups 3,5 and 6  
on day 153, and a significantly lower proportion of lymphocytes than group 2 on day 
125 and groups 3 and 6  on day 153, see Table 3.25 Appendix I. Group 1 had a 
significantly lower proportion of monocytes than groups 3,4 and 5 on day 28 and 
lower than group 2 on day 56. Group 4 had a significantly higher proportion of 
basophils on day 125 than any other group.
3.4.11. Rumen Succinate Concentrations.
GOAT Days Post Supplementation
- 1 0 1 2 3 7 8
1 6 6 1 0 2 54 24 2 2 140 19
2 312 1 2 2 64 33
3 312 42 2 0 15
4 138 6 8 8 6 2 1 0
Mean 2 1 1 72 46 95
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Rumen succinate concentrations, measured for group 1 goats during supplementation 
(from day 154), were much greater than serum concentrations (ranging from 20 to 
300 jumol/1 as opposed to 1 to 100 jumol/l). C oncentrations decreased after 
supplementation but this was not consistent.
3,5. Results:- Experiment 3
3.5.1. Serum Vitamin Concentration.
Once again the basal diet failed to maintain concentrations above 100 ng/1, (Fig.3.17 
and Table 3.26 Appendix I). Concentrations for group 1 fell as low as 30 ng/1. 
Despite this they were only significantly lower than those of group 4, and on 2 
occasions of group 3, even when concentrations on day 0 were used as covariates.
3.5.2. Serum MMA Concentration.
Concentrations for groups 1,2 and 3 rose even after day 0 with group 1 peaking at 
136 jumol/1 group 2 at 57 jnmol/1 and group 3 at 79 jumol/l, group 4 concentrations 
were significantly lower remaining below 20 jumol/1, see F ig .3.18 and Table 3.27 
Appendix I. When concentrations on day 0 were used as covariates there were some 
significant differences between groups 1,2 and 3 with group 1 concentrations being 
the highest.
The relationship between vitamin Bj^ concentrations and MMA concentrations 
(Fig.3.19) was similar to the previous results with MMA concentrations >  10 jumol/1 
co rrespond ing  to v itam in B^^ concen tra tions < 1 0 0  n g / 1  and v itam in  Bj^ 
concentrations >  lOOng/1 corresponding to MMA concentrations < 10 fxmoVl. The 
correlation was again low (-0.296).
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Fig 3.17 Serum Vitamin B12 C oncentra tions  of Goats, Expt 3
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Fig 3.18 Serum MMA Concentrations of Goats, Expt 3
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Fig 3.20 Serum Succinate Concentrations of Goats, Expt 3
3.5.3. Serum Succinate Concentration.
G enerally  trends for all g roups follow  the same p attern  a lthough group 3 
concentrations were significantly lower than all other groups (when concentrations 
on day 0 were used as covariates) on day 118, see F ig .3.20 and Table 3.28 
Appendix I. The correlation between succinate concentration and vitamin 
concentration was very low (0.124) and that between succinate concentration and 
MMA concentration was even lower (0.022), suggesting that there was no strong 
relationship with either.
3.5.4. Serum GOT Activity.
The elevated serum GOT activities seen for group 1 in F ig .3.21 and Table 3.29 
Appendix I, were only significantly greater than those of group 3 on day 133 as they 
are the result of very high values in one or two animals. In practical terms 2 out of 6  
goats in group 1  were showing signs of severe liver damage.
3.5.5. Liveweight.
Group 1 goats did not show steady growth at all and by day 84 they began to lose 
weight, see Fig.3.22. and Tkble 3.30 Appendix I. Groups 2 and 3 grew significantly 
more than group 1 (using liveweight on day 0 as a covariate) while group 4 grew 
significantly better than groups 1, 2 and 3, although on the very last day of the 
experiment the differences in liveweight between groups 2,3 and 4 were just below 
significance. The difference in size between group 1 goats and group 4 goats at the 
end of the experiment can be seen in plates 3 and 4.
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Fig 3,21 Serum GOT A c t iv i ty  of Goats, Exp t 3
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Fig 3,22 Liveweights of Goats, Expt 3
PLATE 3
Group 1 goat (left) compared to a Group 4 goat (right)
PLATE 4
Group 1 goat (right) compared to a Group 4 goat (left)
Ii  m
On regressing the individual results for each goat and com paring the derived 
constants there were no significant differences between groups. This may be due to 
the poor fit of the lines for group 1  due to the loss of weight.
3.5.6. Plasma CK Activity.
Group one had elevated CK activity on days 133 and 161, see F ig .3.23 and Thble 
3.31 Appendix I, but this was only significant on day 133 as 1 or 2 very high values 
influenced the group 1 mean. In effect 2 of the 6  goats had moderate muscle damage 
(C K > lOOjLtl at 30°C) and 2 others had severe muscle damage (C K > lOOOjul at 
30°C).
3.5.7. Whole Blood GSH-Px Activity.
GSH-Px activity was normal for all groups, see Tkble 3.32 Appendix I. Nevertheless 
supplementation was carried out on day 154 as 2 goats had below adequate activity.
3.5.8. Serum Copper, Magnesium and Calcium Concentrations.
Plasma copper concentrations fell considerably during the trial but remained at the 
lower limit of normality. Magnesium and calcium concentrations remained adequate, 
see Tkble 3.33 Appendix I.
3.5.9. Plasma IgG Concentration.
No significant differences in IgG concentrations between groups, as measured by 
SRID, were observed, see Table 3.34 Appendix I.
119
CK (U/I at 300)
600
Gr o u p
500
400
300
200
100
0
0 50 100 150 200
Time (days).
Fig 3,23 Plasma CK A c t iv i ty  of Goats, Expt 3
3.6. Discussion
From experiment 1 it was clear that group 1 were cobalt/vitamin deficient, as 
they had very low serum vitamin concentrations (30ng/l), elevated MMA 
concentrations (120/Amol/l), some elevated serum GOT activity (> 140  SF/ml) and 
they lost weight over the trial. All of the other three groups had vitam in B^  ^
concentrations above lOOng/1, MMA concentrations below 10 jumol/l, serum GOT 
activities < 100 SF/ml and they all gained weight. Some animals in group 1 also had 
watery eyes and pale mucous membranes. From this it was concluded that the 
requirement for dietary cobalt lay between 0.04 and 0.10 mg/kgDM.
Experiment 2 aimed to define the requirement more precisely, although this was 
complicated slightly as the basal diet contained more cobalt. Again group 1 had low 
vitamin B^  ^ concentrations (30ng/l) and elevated MMA concentrations (80 jumol/1), 
although vitamin B^  ^concentrations for the other 5 groups were not much greater 
(40-150 ng/1) their MMA concentrations remained below 20 ^mol/1. Serum GOT 
activities were not significantly greater for group 1 than for the cobalt supplemented 
groups and liveweight differences were not significant. However, at the end of this 
trial it was noticed that 3 of the 4 goats in group 1 were eating hay in preference to 
concentrates at feeding times. This symptom of cobalt deficiency had been 
recognised by MacPherson (1982) in sheep and cattle. From these results it appeared 
that cobalt concentrations of <0.06 mg/kgDM were inadequate.
The results of experiment 2 were not as clear cut as we had hoped because of the 
change in concentration of cobalt in the basal diet and because of the small group 
sizes. For these reasons the third experiment was carried out and straw was used to 
decrease the concentration of cobalt in the basal diet. Once again group 1 were 
deficient, showing low vitam in B^  ^ concentrations (30 ng/1), elevated MMA 
concentrations (>  130 jumol/1), elevated serum GOT activity and liveweight loss. In
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this experiment groups 2 and 3 also had elevated MMA concentrations (> 5 0  /umol/l) 
although their vitamin concentrations rose to 90ng/l. Once more it appeared that 
0.06 mgCo/kgDM was insufficient to prevent elevated MMA concentrations.
Figures 3.24 to 3.27 summarise the data for the marginal groups from the three 
experiments. Clearly 0.04 mgCo/kgDM was insufficient to prevent liveweight loss, 
and these two groups also had elevated serum GOT activity. Concentrations up to 
0.06 mgCo/kgDM maintained liveweight gain although possibly not at maximal 
rates, but did not prevent elevation of MMA concentrations. Concentrations above 
0.06mgCo/kgDM  maintained MMA concentrations below 20/umol/l, but only 
supplementation at 0. lOmgCo/kgDM caused vitamin B^  ^concentrations to rise above 
100 ng/1.
Overall 0.06 mgCo/kgDM is probably insufficient while 0.07 mgCo/kgDM would 
probably prevent deficiency. This is higher than the minimum of 0.04 mg/kgDM 
quoted by Andrews (1970a) for cows, but very similar to the minimum of 0.06 to
0.07 mg/kgDM quoted by MacPherson et al (1973). It is also similar to the 0.07 
mg/kgDM (Underwood 1981) and the 0.08 mg/kgDM (Andrews 1970a) minimums 
quoted for sheep.
These results contradict Platten (1951) who considered that goats required more 
cobalt than sheep, however this opinion was not based on scientific trials merely on 
observations of one goat herd. These results confirm the findings of Mgongo (1984) 
who reported 0.01 mg/kgDM to be insufficient, and suggest that had Clark et al 
(1987) continued their trial beyond 4 months they would have found 0.035 
mgCo/kgDM to be insufficient.
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Fig 3,27 Liveweight Gains of Goats During Supplementation
MMA concentrations of up to 15 fxmol/l occurred when no other symptoms of 
deficiency were apparent. In the deficient groups concentrations in excess of 100 
mol/1 were recorded. Thus it is suggested that for diagnostic purposes serum MMA 
concentrations between 15 and 20 jttmol/l are indicative of marginal cobalt/vitamin 
status. This is higher than comparable values for sheep (10-15 jttmol/1) and cattle 
(2-4 jLtmol/1).
Vitamin concentrations as low as 30 ng/1 were measured in all three experiments 
and concentrations between 50 and 100 ng/1 were common in groups experiencing 
only slightly decreased liveweight gain, thus it is suggested that this probably 
represents marginal deficiency. This is much lower than the concentrations regarded 
as indicative of marginal vitamin Bj^ status in cattle (150-200ng/l) and sheep (200- 
400ng/l).
As far as diagnostic parameters are concerned, a combination of serum vitamin B^  ^
and MMA measurement seems to offer the best solution as in cattle and sheep. 
However MMA concentrations seem to be a more reliable indicator than serum 
vitamin Bj^ values alone. There are some animals which had low ( <  100 ng/1) 
vitamin B^  ^ concentrations and low (< 1 0  /xmol/1) MMA concentrations. There are 
two possible explanations for this:-
a) the animal is suffering marginal deficiency and blood vitamin B^  ^ concentrations 
are low but there is still sufficient vitamin in the liver to prevent functional 
deficiency and the build up of MMA.
b) Alternatively it could be explained by adequate circulating concentrations of 
vitam in B^^, some of which is bound to Transcobalam in 1. If Tel in goats is 
resistant to dénaturation in current assay systems, as it is in cattle, vitamin 
associated with this binder may not be detected, leading to underestimation of total
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vitam in in goat serum. Tel has been found in goat serum (Price personal 
communication 1991) but the suitability of current vitamin Bj^ assay systems has not 
been validated for application to goat plasma.
Contrary to the results of Kennedy et al (1991) and Young et al (1991) serum 
succinate did not increase during cobalt deficiency nor did serum concentrations of 
succinate appear to be a good indicator of cobalt status, being poorly correlated to 
both MMA and vitamin Bj^ concentrations. Rumen succinate results on the other 
hand showed some suggestion of decreasing during supplementation, however due to 
the small number of samples analysed (20) this was not conclusive. In addition to the 
expected elevated serum GOT activity in deficient goats, plasma CK activity was 
also elevated. There was no evidence that this was correlated to plasma vitamin E 
concentrations or to GSH-Px activity. CK activity in plasma is seen as a sign of 
muscle damage (as in white muscle disease). However there is frequently some 
muscle wasting during cobalt deficiency and this could be the cause of the elevated 
activity.
Overall the requirement of goats for cobalt is between that of sheep and cattle but 
more similar to that of sheep. Their marginal vitamin Bj^ concentrations are lower 
than either but more similar to cattle, while their marginal MMA concentrations are 
higher than either but more similar to sheep. Thus goats should be classified neither 
as cattle, nor as sheep for diagnosis of cobalt deficiency, but should be considered 
separately in their own right.
Vitamin E supplementation in either oral or injectable forms led to increased plasma 
vitamin E concentrations. The injection caused an immediate massive increase (to 
>  50 jumol/1) which dropped (to < 7 jumol/1) within a week, this concentration still 
indicates sufficiency however. The oral supplement resulted in a slower increase, but
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still resulted in concentrations above adequacy. There was no evidence of a GSH-Px 
(or selenium) interaction as all animals were adequate in this respect. Elevated CK 
activity was associated with cobalt status not vitamin E treatment. There was some 
sign that erythrocyte stability was increased by vitamin E supplementation, but the 
results were not conclusive. However as supplementation only commenced on day 
169, this result suggests that vitamin E supplementation of cobalt/vitamin 
deBcient-goats may be worthy of further investigation. Some apparently significant 
effects of cobalt treatment seem to indicate that erythrocytes from group 2 animals 
w ere more unstable. Of the 6 goats in group 2, only 1 received vitam in E 
supplementation, thus this is probably a vitamin E treatment effect and not a cobalt 
treatment effect. There was a great deal of day to day variation between results 
which needs to be decreased if this method is to be used as an estimate of vitamin E 
status as suggested by Stevenson and Jones (1989).
T he im m une fu n c tio n  te s ts  used show ed no s ig n if ic a n t e ffe c ts  o f  co b a lt 
supplementation on neutrophil function, antibody response to Clostridium tetani 
vaccination, or total IgG. There was a slight effect of cobalt treatment on differential 
cell count (increased neutrophils, decreased lymphocytes and decreased monocytes) 
however the changes involved were very small and not consistent, thus with this 
number of data points being tested, some are bound to show up as significant. 
Overall despite highly significant differences in cobalt status no effect on immune 
function was observed. This might be due to using incorrect measures of immune 
function, although, the neutrophil function test has shown differences related to 
cobalt/vitamin B^  ^ status in both cattle and sheep. Alternatively it could be due to 
difficulties inherent in the techniques, since the neutrophil function test is highly 
subjective, or there may simply be no effect of cobalt deficiency on these immune 
parameters in goats. It is suggested that further work in this area would be justified 
using different immunological tests.
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CHAPTER 4
TH E INTERACTION BETW EEN VITAMIN E AND VITAMIN 
SUPPLEMENTATION IN CALVES.
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4.1. Introduction.
Until recently there has been no commonly available form of injectable vitamin E, In 
guinea-pigs (Barber et al 1977) an injection of an oil em ulsion o f vitam in E 
produced a severe local reaction whereas a free aqueous emulsion had no such 
effect. Experim entally it has been found that vitam in E given by intravenous 
injection has the greatest availability, followed by intramuscular injection; however 
elimination of vitamin E from tissues after an intramuscular injection is slower 
(Hidiroglou & Karpinski 1987). Much work has also been done on the availability of 
d ifferent forms of vitam in E and it is generally agreed that the free D -alpha 
tocopherol form is more available than either the DL mixture or the acetate form. 
(Hidiroglou & Karpinski 1988, Hidiroglou et al 1988, Hidiroglou et al 1989 and 
Reddy et al 1985).
It has long been known that vitamin E supplementation may affect erythrocyte 
stability and recently Stevenson and Jones (1989) proposed a simple functional test 
for vitamin E deficiency, based on the sensitivity of erythrocytes to the detergent 
Tween 20.
Vitamin E has been found to affect almost all aspects of immunity, including % kill 
by neutrophils (Prasad 1980), while some authors (Beisel 1982 & Prasad 1980) 
suggest that megadoses of vitamin E have an increased effect on other parameters. 
Cobalt deficiency has also been found to affect % kill by neutrophils. Thus the aims 
of this trial are threefold :-
1. To study the effects of two com m ercially available vitam in E supplem ents 
(fo rm ulated  for adm in istra tion  by d iffe ren t routes) on p lasm a v itam in  E 
concentrations, and plasma CK activity in cattle fed a low vitamin E diet .
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2. To investigate the usefulness of the erythrocyte stability test as a functional 
indicator of vitamin E deficiency.
3. To study the effects of vitamin E supplementation on immune function and 
investigate the interaction between vitamin E and vitamin status.
4.2. Experimental Design.
4.2.1. Animals.
For this trial we used 12 Freisian bull calves, aged approximately 5 months. Half the 
animals received clamoxyl treatment for bovine rhinotracheitis virus between days 
-65 and -56, and all animals recieved Griseofulvin for ringworm from day -35 to day 
-28.
4.2.2. Treatments.
The calves were maintained on a vitamin E deficient diet until their plasma vitamin 
E concentrations suggested that they were deficient whereupon they were randomly 
allocated into three vitamin E treatment groups each containing 4 animals:-
Group C, the controls received no vitamin E supplement.
Group O, received 2g of oral vitamin E supplement (Rovimix E50 Roche) on day 
zero, and thereafter received Ig/day in the feed (containing 500 mg of DL-ce- 
tocopheryl acetate, 500 lU vit E); from day 57 this dose was halved, to see if the 
lower level could maintain an adequate plasma vitamin E concentration.
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Group I, received a 5ml intramuscular injection of vitamin E (Stuart Products Inc.) 
providing 1500 lU of D-a-tocopherol on days 0 ,21  and 70.
These groups were then further subdivided into 2 vitamin treatment groups with 
two animals from each vitamin E treatment receiving injections of vitamin B^  ^ (3ml 
of Neo-Cytamen, Glaxovet Ltd. containing 3mg of hydroxycobalamin BP) on days 
14, 42 and 70, and also 7mg of cobalt orally on days 70, 77 and 85.
Treatm ent effects were m onitored by weekly livew eight (Ampac electronic 
Livestock weigher zeroed before use) and blood analysis.
4.2.3. Diets.
All calves received the same basal diet which was form ulated using the SAC 
rationing software to provide sufficient protein and energy to support liveweight 
gains of Ikg/day, but to be deficient in vitamin E. Calves were fed individually and 
generally finished their food, however refusals were not measured. Initially the diet 
consisted of hay, barley, soya bean meal and a calcium phosphate supplement. 
Fifteen days before supplementation was started this was changed to urea treated hay 
w ith m oist (propcorn) barley  and the m ineral supplem ent, as v itam in  E 
concentrations in the plasma were not as low as was desired. The propcorn barley 
was later (between days 54 and 80) partly replaced by sodium hydroxide treated 
barley, to try and further decrease vitamin E concentrations in the diet. The cobalt 
content of the diet fell from 0.055 mgCo/kgDM to 0.045mg/kgDM  as sodium 
hydroxide treated barley replaced propcorn treated barley, thus although the diet was 
not form ulated intentionally  to be low in cobalt, it m ight be expected that 
cobalt/vitamin Bj^ deficiency would also result from prolonged feeding. Detailed 
analysis of all constituents of the diet are included in Tkbles 4.1 to 4.3 of Appendix
II.
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The sodium hydroxide treatment was carried out according to a modification of the 
method used by Rice et al (1985) and Rice and McMurray (1986). Whole barley 
was treated in batches of 25kg (wet weight) in a cement mixer. Sodium hydroxide 
(30% soln.) was added to give a final concentration of 3%/kgDM of the barley. 
After mixing the treated barley was left on a cement floor for one week (to allow the 
sodium hydroxide to react and form harmless carbonates) before being slowly 
introduced into the diet.
SUMMARY OF TREATMENTS 
Day No.
-72 Vitamin E deficient diet introduced.
-15 Barley replaced with propcorn barley.
0 Start vitamin E treatments.
14 P* vitamin Bj^ treatment.
21 2"  ^vitamin E injection.
42 2"  ^vitamin Bj^ treatment.
54 Sodium hydroxide treated barley began to be introduced.
57 Oral vitamin E dose halved.
70 3‘'‘* vitamin E injection,
3*’'* vitamin B^  ^ treatment.
Start weekly cobalt treatment.
4.2.4. Experimental Parameters.
Plasma vitamin E concentrations, whole blood erythrocyte stability, plasma CK and 
serum GOT were monitored to assess the effects of the vitamin E treatment on these 
parameters. Vitamin B^ ,^ MMA and succinate concentrations were measured in
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serum to monitor the changes in vitamin status. Liveweight was monitored to 
determine whether vitamin E or vitamin Bj^ treatments influenced growth rate. 
W hole blood GSH-Px activity, and plasm a calcium , magnesium and copper 
concentrations were monitored to check for other possible deficiencies that might 
affect the results. Neutrophil function tests were carried out on days 70 and 85 using 
E. coli and S. aureus and on days 77 and 91 using C. albicans.
4.2.5. Statistical analysis.
Statistics were carried out on the results using the Genstat V programme (Lawes 
Agricultural Trust 1988). Analysis of variance or covariance was used unless 
otherwise stated.
4.3. Results
4.3.1. Plasma Vitamin E Concentrations.
The basal diet did not deplete the animals of vitamin E as much as expected below 
normal values which are > 3^m ol/l. Marginal vitamin E deficiency in calves is 
associated with plasma vitamin E concentrations between IfxmoVl and 3 jumol/1, 
clinical vitamin E deficiency is associated with plasma vitamin E concentrations 
below ljLtmol/1. The plasma vitamin E concentration in the un supplemented group 
was 1.70 ^mol/1 on day 0 (F ig .4.1 and Table 4.4 Appendix II), and thereafter 
remained at or near this level despite the introduction of sodium hydroxide treated 
barley  in p lace o f some o f the p ropcorn  barley. This suggests that these 
unsupplemented calves were marginaly deficient in vitamin E. Sodium hydroxide 
treated barley was not a success when fed alone, as it was not very palatable; 
however a 75 % mix with propcorn barley seemed to be fairly acceptable.
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The oral supplementation raised vitamin E concentrations steadily to between 8 and 
9 jumol/l. When the dose was halved these concentrations fell to around 6 /xmol/1, 
which is however still well above the lower limit of normality, 3jLtmol/l.
The vitamin E injections produced a very rapid increase in blood plasma vitamin E 
concentrations (to >30 /nmol/l) but this dropped down to around 5.5 fxmol/l within a 
week and within 4 weeks concentrations were bordering on deficient. The second 
injection, given 3 weeks after the first, produced some form of adverse anaphylactic 
reaction (loss of appetite, hyperventilation and sweating) on the day it was given, in 
some animals. The third injection 7 weeks later produced no such response.
Vitamin treatment appeared to have a significant effect on plasma vitamin E on 
day -21, and the interaction between the two treatments was significant on days 28, 
35, 77, 85, and 91 (see Table 4.5 Appendix II), with vitamin E concentrations 
apparently being greater for the vitamin supplemented group on the oral vitamin 
E treatm ent, but being low er for the vitam in Bj^ supplem ented group on the 
injectable vitamin E treatment. Because of the number of statistical tests carried out, 
some apparently significant results may arise due to chance. This is probably the 
case on day -21, however the interaction result is more consistent and so may be a 
true effect.
4.3.2. Erythrocyte Fragility.
The erythrocyte stability test (EST) did not show any significant differences between 
groups in the fragility of erythrocytes challenged (in vitro with detergent at 3 
concentrations E S T l, EST2 and EST3 (F igs.4.2 to 4.4 and Tables 4 .6  to 4.8 
Appendix II). The mean values for vitamin E supplemented groups were, however, 
consistently lower than those of the vitamin E deficient controls but between animal 
and between assay-batch variability was large, making it difficult to detect any
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treatment effects.
The correlation coefficients for the relationship between values obtained with the 
individual Tween concentrations and plasma vitamin E concentrations were:- 
ESTl = -0.008, EST3 = -0.233 and EST5 = -0.340. Thus there were no strong 
relationships. Correlations between the results obtained with the different Tween 
concentrations were high:-
ESTl V EST3 = 0.81, ESTl v EST5 =  0.685 and EST3 v EST5 =  0.862.
4.3.3. Plasma CK Activity.
CK activity remained in the normal range throughout, apart from group I on day 1 
when levels were significantly elevated (124 iu/1), see F ig .4.5. and Table 4.9 
Appendix II. Samples were not assayed on the day following subsequent injections, 
so it is unclear whether this is a side effect of the injection. Vitamin treatment 
apparently had a significant effect on day 28, but its biological significance is 
questionable.
4.3.4. Serum GOT Activity.
SCOT values were generally between 50 and 70 for all groups throughout the trial 
and thus close to or just above the upper limits of the normal range of 20-60 SF/ml, 
see F ig .4.6 and Table 4.10 Appendix II. However neither serum vitamin nor 
plasma vitamin E status correlated with SOOT values. Only the interaction on day 
-14 was statistically significant and this is probably spurious. Group C had an 
elevated mean value on day 91 but this was in fact due to only one animal.
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4.3.5. Serum Vitamin Concentrations.
The three injections of vitamin Bj^ produced an immediate response in serum 
concentrations (>  1250 ng/1 by the afternoon on day 14, but not shown in Fig.4.7). 
Concentrations dropped back very quickly to around 200 ng/1 by a week later 
although the values remained significantly greater than those of the corresponding 
control groups (Fig.4.7. and Thble 4.11 Appendix II). Vitamin E treatment had no 
effect.
4.3.6. Serum MMA Concentration.
Vitamin B^  ^ supplementation decreased MMA concentrations significantly, while 
MMA concentrations for the unsupplemented group exceeded the upper limit of 
normality (2 jitmol/l) from day 49 (Fig.4.8. and Thble 4.12 Appendix II). Vitamin E 
treatment had no effect on serum MMA concentration although the interaction was 
apparently significant on days -70 and 42; once more these are probably spurious 
results.
Although the correlation between vitamin Bj^ concentration and MMA concentration 
is not very high (-0.370) it is noticable from the graph (Fig.4.9) that for all vitamin 
Bj^ concentrations above 150 ng/1 the MMA concentrations are below 2 fxmol/l, 
while for all MMA concentrations greater than 2 /iinol/l corresponding vitamin B^  ^
concentrations are below 150 ng/1. However of the 168 results plotted 70 had 
vitamin B^  ^ concentrations below 150 ng/1 with MMA concentrations below 2 
fjt.mol/1. Of these most of those with MMA concentrations above 1 /zmol/1 were 
unsupplemented while most of those with MMA concentrations below 1 jumol/1 were 
supplemented.
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4.3.7. Serum Succinate Concentrations.
Vitamin treatment only had a significant effect on succinate concentration on 
days 70 and 85 and in fact vitamin E treatment was significant on days -21 and 14 
and the interaction was significant on days -70 and 14 all of which could be spurious 
(see Fig.4.10 and Thble 4.13 Appendix II). However there does seem to be a slight 
trend for the vitamin supplemented group to have elevated concentrations of 
succinate over the last 8 weeks. Succinate concentration was not highly correlated 
with either vitamin Bj^ concentrations (0.053) or MMA concentrations (-0.246).
4.3.8. Liveweight.
All three groups grew steadily, although the desired Ikg/day liveweight gain was not 
obtained (Fig.4.11 and Thble 4.14 Appendix II). Group O seemed to grow slightly 
better towards the end of the trial and on days 49 and 77 the difference between 
groups was significant when liveweight on day zero was used as a covariate. When 
regression coefficients were calculated and these in turn were analysed, vitamin E 
treatment was found to have a small but significant effect on the slope of the line. 
Oral treatment gave a greater slope than injection, while the control group was not 
significantly different from either. Despite the large differences in vitamin B^  ^
concentrations no effect on growth was observed.
4.3.9. Neutrophil Function Tests.
Vitamin B^  ^supplementation significantly increased % kill of E. coli on day 70, and 
of C. albicans on day 77, see F ig.4.12 and Table 4.15 Appendix II. Vitamin E 
injection decreased % kill of E. coli on day 70, compared to the control, and oral 
supplemented groups. However the differences were small and not consistent.
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4.3.10. Whole Blood GSH-Px Activity.
GSH-Px values remained normal (>  15u/ml) apart from one animal which was dosed 
with 5mg of selenium on day 7, see Thble 4.16 Appendix II.
4.3.11. Serum Copper, Magnesium and Calcium Concentrations.
Calcium, magnesium and copper levels were within the normal ranges, see Table 
4.17 Appendix II.
4.4. Discussion.
Due to the failure of the basal diet to deplete the animals of vitamin E the results of 
this experiment are less informative than had been hoped. This was probably due to 
the propcorn barley being too recently treated, and the fairly high concentration of 
vitamin E found in the hay. The sodium hydroxide treated barley was found to be 
low in vitamin E, but it was only fed for 40 days.
One possibility for overcoming these problems in future would be to feed hay and 
propcorn barley that was a year old, as vitamin E concentrations should drop during 
storage. Treating large quantities of barley with sodium hydroxide would be 
difficult, and it is doubtful whether the animals would eat much of it on its own. 
Mouth ulcers were found in some calves after only 24 days on a 75% ration, and 
this might be a serious problem if long term feeding was required.
Both levels of oral vitamin E maintained blood concentrations significantly higher 
than those of the controls, and also above deficiency levels (3jumol/l). Injectable 
vitamin E produced a rapid response ideal for treating severe deficiency symptoms,
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but not suitable as a long term measure. Repeating the injection cannot be relied 
upon as problems seem to arise if the interval between administration is short, and 
yet concentrations dropped very quickly suggesting that frequent injections would be 
required if concentrations were to be maintained by this method alone. The elevated 
CK values for group I on day 1 might indicate local muscle damage due to the 
injection, some signs of local damage were also apparent at the injection site. 
Although SCOT values tended to be slightly elevated, concentrations were 
unaffected by treatments.
The lack of significant treatment effects on erythrocyte stability was unexpected. The 
calves were not as vitamin E deficient as the sheep used by Stevenson and Jones 
(1989) and the test may be more inform ative in severe vitam in E deficiency. 
However as a test for marginal deficiency in cattle it proved insufficiently sensitive. 
Despite improvements made to the method there was still a lot of variation between 
individuals and between sampling dates, and this was particularly noticable when the 
1% Tween solution was used. Further improvements might be made if each animal 
was compared to its own 100% haemolysed blood, or if packed cell volumes were 
used to correct for differences in red cell numbers. However there are many other 
factors involved in red cell fragility. Glutathione peroxidase might be thought to play 
a role, although Stevenson and Jones (1989) found no relationship  between 
erythrocyte glutathione peroxidase and detergent sensitivity in marginally selenium 
deficient sheep. The calves in this trial were not deficient in selenium, although their 
GSH-Px activities decreasd to fall within the marginal range (15-25 /x/ml) by the end 
of the trial.
Although the erythrocyte stability test is simple in that it requires no complicated or 
expensive equipment except for a spectrophotometer, the results obtained in this trial 
suggest that it is not a very robust technique. Vitamin E analysis by HPLC is 
quicker, more samples can be analysed in a day, and the results are more reliable.
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Therefore as the availability of HPLC equipment continues to increase it seems 
likely that direct analysis of vitamin E will become the method of choice.
V itam in  su p p lem en ta tio n  s ig n if ic a n tly  e lev a ted  serum  v itam in  B^^ 
concentrations, above those of the unsupplemented animals which were deficient 
(<  150 ng/1 in cattle). MMA concentrations in the unsupplemented animals were 
also elevated above the upper lim it o f norm ality, ( > 2  jxmol/l Paterson and 
MacPherson 1990); supplementation rectified this. Vitamin B^  ^deficiency was not 
severe enough to affect liveweight, or at least no significant differences could be 
detected between the small numbers of animals in each group (2) and this may also 
explain why serum succinate concentrations were not significantly increased. 
H ow ever serum MMA was affected, and as it is the breakdow n o f the same 
biochemical pathway which is involved in each case it might have been expected that 
serum succinate would also be affected. However vitamin Bj^ may be available in 
the rumen for conversion of succinate to methylmalonyl coenzyme A in greater 
quantities than it is in the blood for conversion of methylmalonyl coenzyme A to 
succinate, because it is initially formed in the rumen and there may be little available 
for absorption in the ileum. Thus the trend for vitamin B^  ^ supplementation to 
increase succinate concentrations in the final weeks of experimentation might have 
been significant under more severe deficiency conditions.
The results of the neutrophil function tests were inconclusive. They gave some 
suggestion that the vitamin E injection decreased % kill of E, coli compared to oral 
vitamin E or no treatment, while vitamin Bj^ injection stimulated % kill of both E. 
coli and C. albicans, compared to animals not supplemented with vitamin B^^, 
however these results were not consistent and the % changes involved were very 
small. Paterson and MacPherson (1990) found vitamin Bj^ deficiency affected 
neutrophil function adversely in calves, before serum concentrations of vitamin B^ ^
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or MMA were affected, thus if more tests had been carried out it is possible that a 
positive effect of supplementation with vitamin would have been observed. The 
unexpected effect of vitamin E injection, reducing % kill o f E. coli on day 70, 
com pared to the oral supplem ented an im als, could be because vitam in  E 
concentrations in this group had dropped to nearly as low as the unsupplemented 
animals, although this does not explain why % kill should be lower in these animals 
than in the unsupplemented ones.
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CHAPTER 5
AN INVESTIGATION OF THE EFFECTS OF COBALT DEFICIENCY ON 
THE APPETITE PREFERENCE OF SHEEP.
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5.1. Introduction.
During the second goat experiment (described in chapter 3) it was observed that 
some o f the cobalt d efic ien t goats developed a p re fe ren ce  for fo rage over 
concentrate. This symptom of cobalt deficiency has previously been observed in 
other ruminants (MacPherson 1982), however no data was published to confirm or 
quantify the observation. This experim ent was designed to investigate this 
phenomenon, and attempt to quantify the preference for forage, and to try to clarify 
the possible mechanisms responsible. Animals were to be maintained on a diet low 
in cobalt until they were deficient in serum vitam in and such behaviour 
occurred, wherupon a variety of treatments would be given to attempt to alleviate the 
symptoms. It was decided to use sheep, as they dem onstrate symptoms of 
cobalt/vitamin B^  ^ deficiency more easily than cattle, are more economical to keep, 
and were also more readily available. There are many possible explanations for the 
decrease in appetite seen in this deficiency and for the preference for forage:-
a) an ability to detect and correct for the low cobalt concentration in the maize, by 
increasing intake of roughage which tends to have, and in the case of our goats, did 
have a higher cobalt content.
b) small increases in propionate concentration in the blood due to im paired 
conversion of propionate to succinate. The decreased activity of the methylmalonyl 
CoA mutase enzyme during cobalt/vitamin B^  ^ deficiency is thought to lead to a 
build up of propionate in the tissues, as well as a build up of methylmalonic acid, 
and it is thought that this increase in propionate concentration may be the main cause 
of the decrease in appetite (M arston et al 1961 and 1972). As yet there is no 
evidence to suggest that increased propionate concentrations in the tissues leads to a 
preference for forage, only that it could cause a decrease in appetite. However 
concentrate diets favour a shift towards propionic acid production by the rumen
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microbes, while forage diets stimulate acetic/butyric acid production in the rumen.
c) amino acid imbalance due to the failure of methionine recycling. The breakdown 
of methionine recycling due to lack of 5-methyltetrahydrofolate-homocysteine 
methyltransferase activity could result in an amino acid imbalance such as is found 
to cause loss of appetite in non-ruminants. Again there is as yet no evidence that 
amino acid imbalance leads to a preference for forage, only that it can lead to loss of 
appetite.
d) avoidance of the concentrate because eating it was associated with discomfort, 
possibly indigestion, while eating forage caused no discomfort.
e) a combination of b) with d). The discomfort resulting in the animal avoiding the 
concentrate could be caused by unusually high propionate concentrations. Eating 
more forage, and less concentrates would favour a shift towards acetate/butyrate 
production and away from propionate production in the rumen, leading to lower 
propionate concentrations in the tissues and so relieving discomfort. Overall this 
might result in a conscious shift towards eating more forage by the animal.
f) some other factor associated with the deficiency, acting either d irectly  or 
indirectly.
Because there were a number of possibilities to explore there were two main parts to 
the experiment. The first aim was to determine whether in fact animals Team' to 
associate eating concentrate with discomfort during cobalt/vitamin Bj^ deficiency, 
and hence eat forage instead. To do this two cobalt deficient diets would be fed, the 
normal concentrate/forage diet permitting choice and a complete pelleted ration 
permitting no choice. Once the animals became depleted of vitamin Bj., the animals
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on the pelleted ration would be offered the normal diet to see if they demonstrated 
the same feeding behaviour as those which had been given a choice throughout.
The second part of the experiment aimed to establish whether supplementation with 
m eth ionine in jec tio n s, which w ould com pensate for the fa ilu re  o f the 5- 
methyltetrahydrofolate-homocysteine methyltransferase enzyme, could reverse this 
sym ptom  o f c o b a lt/v ita m in  d e fic ien cy . A d d itio n a lly  by co m p arin g  
supplementation with oral cobalt or with vitamin B^  ^ injections, or with oral 5,6- 
dimethylbenzimidazole (a precursor of vitamin Bj^) to see which was more effective 
at restoring the appetite to normal it was hoped to confirm whether cobalt acted 
directly, or via increased vitamin B^  ^ synthesis.
5.2. Experimental Design.
5.2.1. Animals.
13 mature castrate Suffolk cross sheep were used, their liveweights ranged from 64 
to 112 kg at the start of the experiment. One animal received treatment for lice on 
1:5:92.
5.2.2. Treatments.
All the sheep were offered a cobalt deficient ration designed to induce vitamin B^  ^
deficiency and eventually it was hoped that the sheep would develop typical 
symptoms of vitamin B^  ^ deficiency including the decrease in appetite and the 
p reference for forage. In itially  it was intended that six sheep would be fed a 
complete diet also deficeint in cobalt, until the remaining sheep on the conventional 
concentrate plus forage diet showed a marked change in appetite. The sheep on the 
complete diet would then be given the same choice of concentrate and forage and
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their comparative intakes of the two components would be recorded, and compared 
to that of the 7 sheep which had been offered this diet throughout. This was to 
demonstrate whether any preference for the type of feed developed as a result of 
learning which feed caused discomfort. Unfortunately this part of the experiment 
was discontinued because the complete diet, although formulated with and pelleted 
from cobalt deficient feeds, was insufficiently low in cobalt to deplete the animals of 
vitamin
The second part of the experiment consisted of treating the animals once they had 
developed a change in appetite. Three treatments were initially chosen, 
-supplementation with oral cobalt (20mg/week),
-supplem entation  with a v itam in  B^^ in jection  (2ml con tain ing  250 jug/ml 
cyanocobalamin),
-supplementation with a methionine injection (2g of L-methionine in 40 ml sterile 
physiological saline every 2 days) as used by Smith et ol (1974).
The animals did not all develop symptoms at the same time, and as one animal in 
particular became very ill it was decided to treat the animals in two batches. 6 
animals were treated in the first batch, including the seriously ill animal which died 
on the following day, leaving 5 animals in batch 1, death was confirmed as being 
due to cobalt deficiency at post mortem (VIC Auchincruive) by liver vitamin B^  ^
concentrations and visual examination of the liver (plate 6) which revealed that it 
was exceedingly fatty, compared to a normal sheep liver (plate 5).
The remaining 7 animals were treated 5 weeks later and will be referred to as batch 
2. With the second batch a fourth treatment was given to the 2 animals allocated to 
the methionine treatment. During the second two weeks of treatment they received 
5,6-dimethylbenzimidazole (200mg per day, twice the dose used by Rickard et al
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PLATE 5
Liver from a healthy sheep
PLATE 6
Fatty liver from a cobalt deficient sheep

1975) in place of methionine. By this time it was apparent that the methionine 
tre a tm e n t was hav ing  l i t t le  or no e ffe c t. By su p p lem en tin g  w ith  5 ,6 -  
dimethylbenzimidazole, a precursor of vitamin B^^, we hoped to improve the 
efficiency of utilization of cobalt in the rumen, promoting vitamin Bj^ formation and 
reducing formation of «-analogues; this would have a sparing effect on the cobalt 
p resent in the diet, and hence should partia lly  reverse the effects of cobalt 
deficiency.
Summary of Treatment groups
B atch 
1 (n) 2 (n)
Treatment
Vitamin B_ B1 (2/1)' B2 (3)
Cobalt Cl (2) C2 (2)
Methionine M l (2) M2 (2)"
* one animal from this group died the day after the first treatment 
"  received 5,6-dimethylbenzimidazole during the second two weeks of treatment in 
place of methionine.
5.2.3. Diet.
The diet used consisted of 60% forage (a 1:1 mix of hay and straw by weight) and 
40% concentrate (maize) with urea and minerals balanced to provide maintenance 
rations for the sheep. The diet which was fed unpelleted was basically the same as 
that given to the goats in the third experiment and was deficient in cobalt (supplying 
only 0.04 mg/kgDM); for detailed analysis see tables 3.5 and 3.6 in Appendix I. 
Once the animals had become depleted (mean serum vitamin B^  ^concentrations 
below 150ng/i) they were divided randomlly into two groups, and one group, of six 
sheep, was fed a complete pelleted ration. Pellets contained 40% flaked maize, 60%
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alkali treated straw with added urea and minerals as for the original diet, and 
contained < 0 .0 4  mgCo/kgDM as calculated based on the raw ingredients (for 
detailed analysis of the straw pellet see Ihble 5.1. Appendix III). Use of the pelleted 
ration was discontinued after 5 weeks, and replaced by the original forage/maize 
diet, because serum vitamin concentrations in these six sheep became elevated to 
above 1000 ng/1. Subsequent analysis (also in table 5.1 Appendix III) revealed the 
true cobalt content of the pelleted ration to be 0.13 mg/kgDM. The source of the 
cobalt in this diet is unknown, but is presumed to have come from the pelleting 
equipment. The remaining seven sheep continued to receive the original ration 
throughout. Treatments were not started until the animals were showing symptoms 
of cobalt deficiency, including loss of appetite. Batch 1 were treated 11 weeks after 
feeding with the pelleted diet was discontinued, and batch 2, 5 weeks later. Only one 
of the six sheep which recieved the pelleted ration was in batch 1.
5.2.4. Experimental Parameters.
A fter in troducing  the low cobalt d ie t, blood sam ples w ere taken fo r the 
determination of vitamin B^^, MMA and succinate in serum. Feed intake and 
liveweight were monitored and succinate and volatile fatty acids determined in 
rumen fluid. Serum GOT, whole blood GSH-Px ans plasma copper, magnesium and 
calcium concentrations were also analysed periodically.
Feed preference was assessed, for one week periods at 4 weekly intervals and 
continually after treatments commenced. This was carried out by giving lOOg of 
chopped hay/straw mix and 265.5g maize simultaneously and weighing refusals of 
each after 5 minutes. The feed refused and the remainder of the forage were then 
returned to the animal until the next feeding.
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5.2.5. Statistical analysis.
Statistics were carried out on the results using the Genstat V programme (Lawes 
Agricultural Trust 1988). Analysis of variance or covariance was used unless 
otherwise stated.
5.3. Results.
5.3.1. Feed Preference.
There were no significant differences between maize refusals for the different 
treatment groups prior to treatment, although refusals rose from very low (5% or 
less) to high (> 5 0 % ) for all groups (see F igs.5.1 & 5.2 and Tables 5.2 & 5.3 
Appendix III). The 6 animals in batch 1 did have significantly greater concentrate 
refusals (78.2 ±  13.1 % of total concentrate offered), than the 7 animals in batch 2 
(16.3 ±  10.9 % of the total concentrate offered), during the month prio r to 
treatment of batch 1.
After treatment the 4 sheep receiving vitamin (group B —B1+B2 in tables and 
graphs) ate significantly more concentrate than the 4 sheep receiving methionine 
(group M = M 1+M 2) in week 1. During weeks 2,3 and 4 the 4 sheep receiving 
cobalt (group C = C 1+C 2) also ate significantly more concentrates than those 
receiving methionine. Examples of the feed residues from a sheep which had eaten 
all its co ncen tra te  versus one which had not can be seen in p lates 7 and 8 
respectively. There was little difference between groups in the amount of hay eaten 
during this first 5 minute period. On returning the uneaten feed to the animal it could 
be seen that during deficiency some animals left a considerable amount of maize 
despite eating quite a lot of hay (plate 9).
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Hay intake, during the first 5 minutes, was not significantly different between the 
two batches, nor was it affected by treatment, although an apparent decrease in 
refusals by group B occured in February during the period when some of the sheep 
were offered the pelleted diet and could not have seperate concentrate and forage 
intake assessed. Overall hay intake was not measured so this can only be used as an 
indicator of preference not of total intake.
5.3.2. Serum Vitamin Bj^ Concentration.
Prior to treatment serum vitamin B^  ^ concentrations fell in all groups, see F ig .5.3. 
One animal, later assigned to group M had elevated vitamin B^  ^ concentrations due 
to being moved into a d ifferent pen which had not been mucked out. When 
concentrations were regressed for each sheep and the regression coefficients were 
compared there were no significant differences between treatment groups.
After treatment, group B and C serum vitamin Bj^ concentrations were significantly 
elevated compared to those of group M by day 1, but group B concentrations were 
also significantly greater than those of group C (Fig.5.4 and Table 5.4 Appendix 
III). However the vitamin B^^injection produced a rapid increase in serum vitamin 
Bj^ which quickly declined toward pretreatment levels, while the oral cobalt dose 
produced a steady rise in serum vitamin Bj^ concentrations. This pattern was 
repeated after each weekly treatment although basal concentrations on the injectable 
treatment rose gradually too. Concentrations of vitamin Bj, in group M animals 
were slightly higher on days 21 and 28 due to the two animals which received 5,6- 
dimethylbenzimidazole during the second treatment period. However it was not a 
significant effect possibly due to the short treatment period (2 weeks) and the small 
number of animals involved (2).
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5.3.3. Serum MMA Concentration,
Prior to treatment serum MMA concentrations rose in all groups, see F ig.5.5, and 
when an exponential curve was fitted to the data for each sheep and the coefficients 
were compared there were no significant differences among treatment groups. After 
treatment serum MMA concentrations for groups C and B fell gradually while those 
for group M continued to rise. The difference became significant after 9 days of 
treatment, see Fig.5.6 and Table 5.5 Appendix III. There was some evidence of a 
drop in MMA concentrations for group M during the final 2 weeks, again this was 
due to the 2 sheep receiving 5,6-dim ethylbenzim idazole (M2) but was not 
significant.
5.3.4. Serum Succinate Concentration.
Prior to treatment there were 4 occasions when there were significant differences in 
serum succinate concentrations between 2 groups, see Fig.5.7; however the groups 
involved and the differences between them varied, (O B & M , M > C&B, M <C& B 
and M <C ). No significant differences were found on regression since the regression 
equation did not account for a great deal of the variation in the data 
(R2 =  20%).
After treatment mean succinate concentrations for group C were consistently greater 
than those of the other two groups but the only significant difference found was 
between groups C and M on day 14, see Fig.5.8 and Thble 5.6 Appendix III.
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5.3.5. Rumen Succinate Concentration.
Samples of rumen contents were only taken after treatment commenced, and no 
significant differences between treatments in succinate concentrations in the rumen 
were recorded, see F ig.5.9 and Tkble 5.7 Appendix III. From the graph it can be 
seen that there was a large but short-lived increase in mean rumen succinate in group 
C, and an earlier but smaller peak in group B, followed by a consistently elevated 
level. The peak for group C is due to 2 anim als w ith excep tionally  high 
concentrations on consecutive days, both of which were in the first group to be 
treated. The rise in group B concentrations involved all 4 sheep but each reacted 
differently. One sheep peaked in the first week and then returned to normal while 
another sheep had elevated concentrations throughout the second and third weeks. A 
third sheep peaked on days 9 and 10, while the last sheep peaked in the final week. 
Thus at any one time only one or at most two sheep had elevated rumen succinate 
concentrations.
5.3.6. Serum GOT Activity.
Serun GOT activity remained within the normal range except for a slight elevation at 
the end of the trial, see Fig.5.10 and Ikble 5.8 Appendix III. At the beginning of the 
experiment there was a significant difference in serum GOT activity between the 
first and second treatment groups (group 2 being higher) but as the animals were 
within the normal range this was not of practical importance.
5.3.7. Liveweight.
Liveweights fell at the start of the trial as the animals were becoming accustomed to 
the new diet, they were also shorn during this period. Once they levelled out they 
remained steady until towards the end of the trial when the effects of decreased
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S = s h e a r i n g ,  B l = b a t c h  1, B 2 = b a t c h  2 t r e a t m e n t  d a t e s
appetite were noticed, see F ig .5.11 and Table 5.9 Appendix III. Group M 
liveweights continued to fall after treatment but groups C and B started to regain a 
little weight.
5.3.8. Whole Blood GSH-Px Activity.
There were no significant differences in GSH-Px activity, which remained adequate 
and fa irly  constan t th roughou t the tr ia l, an oral selenium  supplem ent was 
administered slightly prior to treatments and this caused a rise in the last 3 months, 
see Tkble 5.10 Appendix III.
5.3.9. Serum Copper, Magnesium and Calcium Concentrations.
Copper concentrations dropped considerably during the trial, particularly for group 
B with the result that in the last month they fell to just below the 'normal' range, see 
Table 5.11 Appendix III. Magnesium concentrations remained stable, and calcium 
concentrations rose slightly during the trial.
5.3.10. Rumen Volatile Fatty Acids.
After treatment rumen acetate as a percentage of total volatile fatty acids decreased 
in group C relative to group M, from 65 to 60 %, and this was significant from the 
second week, acetate percentages for group B were only significantly lower, 63%, 
on the last day, see Tkble 5.12 Appendix III. Rumen propionate, as a percentage of 
total volatile fatty acids, behaved in an inverse fashion, increasing in groups C and B 
towards the end of the tria l, from 20 to 22 and 26% respectively; propionate 
percentages for group C were also significantly higher than those for group B on one 
occasion, see Table 5.13 Appendix III. Rumen butyrate, as a percentage of total
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volatile fatty acids, appeared to rise from 9 to 11 % in group M after the first week, 
but rapidly returned to normal, see Tkble 5.14 Appendix III. On comparison of the 
ratio of acetate to propionate in the rumen, see Table 5.15 Appendix III, this 
decreased on treatments C and B from > 3  to < 2 .5 . The ratio of acetate plus 
butyrate to propionate followed the same pattern, falling from > 3 .5  to < 3 , see 
Tkble 5.16 Appendix III.
5.4. Discussion.
There were many problems during the course of this trial which have complicated 
the interpretation of the results and made it difficult to draw conclusions, not least of 
which was the length, and particularly the difference in length, of time taken for the 
sheep to develop the decreased appetite. It had been hoped to complete a second 
round of treatments during the year, which would have answered more questions but 
unfortunately this proved to be impossible.
From the pre treatment data concentrate refusals began to increase from April which 
corresponds to day -50 for group 1. At this point vitamin B^  ^ concentrations were 
below lOOng/1 and MMA concentrations had risen to between 10 and 200jumol/l 
suggesting that the animals were very deficient. Liveweight loss was also apparent in 
some sheep from this time.
Treatment with vitamin Bj^ restored appetite within a week, and by the end of the 
month these sheep were eating all their concentrate within 5 minutes. Their serum 
vitamin B^  ^ concentrations were very high and their MMA concentrations were 
below 5 jumol/1. Cobalt treatm ent had a very sim ilar effect rapidly reducing 
concentrate refusals, although not quite to original levels within the month. Again 
vitam in B^  ^ concentrations were restored to their orig inal level, and MMA
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concentrations fell to within the normal range (<  10/onol/l). Methionine treatment 
had no effect on concentrate refusals, serum vitamin or MMA concentrations. 
Both vitamin Bj^ and cobalt treatments halted and to some extent restored liveweight 
loss. Treatment with 5,6-dimethylbenzimidazole showed hopeful preliminary signs 
of increasing vitamin Bj^ concentrations and reducing MMA concentrations.
These results are much as might have been expected, the findings that vitamin Bj^ 
and cobalt supplementation alleviate the symptoms of cobalt deficiency are not 
surprising, and these results appear to support the suggestion (Rickard et al 1975) 
that 5,6-dimethylbenzimidazole may be used to replace cobalt at least partially, 
presumably through its action of sparing cobalt by increasing the proportion of true 
vitamin B^  ^relative to ce-analogues produced and so reducing wastage of what cobalt 
is available.
This trial did not suggest, as had been thought possible, that deficient animals 
develop a preference for forage. On the contrary the results suggest the development 
of a dislike of concentrates, as the percentage of hay eaten remained unchanged by 
deficiency and treatment. However as only the intake during the first five minutes 
was recorded, it is impossible to speculate on total forage intake.
Methionine supplementation (sufficient to restore elevated FIGLU concentrations to 
normal according to Smith et al 1974) failed to restore appetite for concentrates. 
This is not particularly surprising but it tends to confirm our original suggestion that 
lack of appetite is connected with the malfunction of the methylmalonyl CoA mutase 
enzym e, and not w ith fa ilu re  o f the m ethy lte trah y d ro fo la te -h o m o cy ste in e  
methyltransferase enzyme upsetting methionine recycling and causing an amino acid 
imbalance.
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Because of the speed of appetite recovery after treatment it is considered unlikely to 
be a 'pain taught' response. However due to the failure of the experiment with the 
pelleted ration it was impossible to confirm this.
Serum succinate did not appear to be correlated with vitamin B^  ^ status in this 
experiment although there was some evidence that supplementation with either cobalt 
or vitamin Bj^ increased rumen succinate concentrations, contrary to the work of 
Kennedy et al (1991c & d) and Young et al (1991) which suggested that rumen 
succinate concentrations increase during deficiency. Each sheep seemed to respond 
after a different time interval, and for a different period of time however. This 
variation could have been exacerbated by the short time interval between feeding 
(8.30am) and sampling (10.30am). However, these times were maintained constant 
throughout. No mention of feeding time relative to sampling time is made by 
Kennedy et al (1991c or d) or by Young et al (1991) but they did find that 60 
minutes after oral administration of sodium succinate, a rise in portal vein succinate 
was observed (Kennedy et al 1991c & d, & Young et al 1991). This suggests that 
once formed rumen succinate would be absorbed fairly rapidly.
The rumen volatile fatty acid data suggests that treatment had some effect. As 
treatments C and B increased concentrate intake, the percentage of propionate 
increased, and the percentage of acetate decreased leading to a decreased acetate to 
propionate ratio. This is what would have been anticipated from the consumption of 
more concentrates as they favour a propionic type fermentation. Group M had a 
m ore acetic/butyric type ferm entation than groups C and B by the end of the 
experim ental period. It is not clear why group C has a more propionic type 
fermentation than group B and yet group Bs' appetite for concentrates was restored 
earlier and more successfully.
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During cobalt deficiency Young et al (1991) associated decreased rumen propionate 
concentrations with increased rumen succinate and attributed it to decreased formation 
of propionate from succinate. Despite finding increased propionate concentrations on 
supplementation, no concomitant decrease in rumen succinate was observed, and so it 
is thought to be due to the change in diet and not to increased conversion of succinate 
to propionate.
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CHAPTER 6
D IS C U S S IO N
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6.1. Defining Cobalt Deficiency in Goats.
The results of the three experim ents reported in chapter 3 indicate that 0.04 
mgCo/kgDM of the diet was insufficient to prevent liveweight loss in growing goats. 
Goats receiving less than 0.04 mgCo/kgDM showed an elevation in serum GOT 
activity indicating that some damage to the liver had occured. Concentrations up to 
0.06 mgCo/kgDM maintained liveweight gain although possibly not at maximal 
rates, but did not prevent development of a preference for forage, pale mucous 
membranes or elevation of MMA concentrations. Concentrations above 0.06 
m gCo/kgDM  m aintained MMA concentrations below 20 jumol/1, but only 
supplementation at 0.10 mgCo/kgDM caused vitamin concentrations to rise 
above 100 ng/1.
Overall 0.06 mgCo/kgDM is probably insufficient while 0.07 mgCo/kgDM would 
probably prevent deficiency. This is higher than the minimum of 0.04 mg/kgDM 
quoted by Andrews (1970a) for cows, but very similar to the minimum of 0.06 to 
0.07 mg/kgDM quoted by MacPherson et al (1973). It is also similar to the 0.07 
mg/kgDM (Underwood 1981) and the 0.08 mg/kgDM (Andrews 1970a) minimums 
quoted for sheep.
These results contradict Flatten (1951) who considered that goats required more 
cobalt than sheep, however this opinion was not based on scientific trials merely on 
observations of one goat herd. These results confirm the findings of Mgongo (1984) 
who reported 0.01 mg/kgDM to be insufficient, and suggest that had Clark et al 
(1987) continued their trial beyond 4 months they would have found 0.035 
mgCo/kgDM to be insufficient.
MMA concentrations of up to 15 jumol/l occurred when no other symptoms of 
deficiency were apparent. In the deficient groups concentrations in excess of 100
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^mol/1 were recorded. Thus it is suggested that for diagnostic purposes serum MMA 
concentrations between 15 and 20 jumol/l are indicative of marginal cobalt/vitamin 
status. This is higher than comparable values for sheep (10-15 jwmol/l) and cattle 
(2-4 jumol/1). Concentrations below 15jumol/l are normal while concentrations above 
20jnmol/l are indicative of cobalt/vitamin B^  ^deficiency.
Vitamin B^  ^concentrations as low as 30 ng/1 were measured in all three experiments 
and concentrations between 50 and 100 ng/1 were common in groups experiencing 
only slightly decreased liveweight gain, thus it is suggested that this probably 
represents marginal deficiency. Concentrations below 50 ng/1 indicate deficiency, 
while concentrations above lOOng/1 suggest that the goat is not suffering from cobalt 
deficiency. This range is much lower than the concentrations regarded as indicative 
of marginal vitamin Bj^ status in cattle (150-200ng/l) and sheep (200-400ng/l).
Initial vitamin B^  ^concentrations in the goats were high (600-800 ng/1) and although 
they depleted to very low levels (30ng/l), supplementation with cobalt failed to 
restore them to anywhere near their original levels. Post treatment levels were 
200ng/l maximum. There are several possible explanations for this. Prior to the 
experiment the goats were newly weaned, thus the initially high serum vitamin B^  ^
concentrations may be unrepresentative of adult goats. Alternatively the availability 
of vitamin B^  ^directly from milk may be greater than the availability of vitamin Bj^ 
which must first be synthesised from cobalt in solid feed, particularly as synthesis of 
vitamin Bj^ from cobalt is known to be inefficient (Underwood 1981). A third 
possibility is that preruminant goats may have a smaller requirement for vitamin B^ .^ 
It has recently been found that before weaning, lambs with a plasma vitamin Bj^ 
concentration of 350 ng/1 do not show reduced growth rates compared to those with 
higher plasm a vitam in B^  ^ concentrations, however after weaning a plasm a 
concentration in excess of 650 ng/1 is required for optimum growth (MacPherson et
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al In press). Thus it seems reasonable that goats may be similar.
Alternatively in vitamin deficient animals cobalt supplementation might possibly 
result in binding of absorbed vitamin B^  ^onto Transcobalamin 1 and it is not known 
w hether the m icrobiological assay used is suitable for m easuring vitam in Bj^ 
associated with this binder in goat plasma. Transcobalamins TcO, Tel and Tc2 are 
know n to be p re sen t in the  serum  o f goats and c a ttle  (P r ic e , p e rso n a l 
communication, 1991). Although vitamin B^  ^ bound to Tel does not present any 
assay problems, current assay procedures do not measure all of the vitamin bound to 
cattle TcO and Tel because of the unique therm ostability  of these binder/B^^ 
complexes (Price et al, 1992). Thus if the TcO/Bj^ and Tcl/Bj^ complexes in goat 
serum are as thermostable as those of cattle, total vitamin B^  ^ concentration in goat 
serum may be underestimated. This explanation is, however, highly speculative and 
requires further investigation.
Supplementation of cobalt deficient sheep with 0.7 mg oral cobalt /week resulted in 
serum vitamin B^  ^ increasing from <200 ng/1 to >700 ng/1 (Fisher & MacPherson 
1990), while supplementation of cobalt deficient cattle with a mixture of oral dosing 
(10 or 125 mg cobalt/week), Cosecure boluses and vitamin B^  ^ injections resulted in 
an increase in serum vitamin B^  ^ from < 100 to >200 ng/1 (Paterson & MacPherson 
1990), both trials used diets similar to those used in the present study. These results 
suggest that it is easier to influence the serum vitamin Bj^ concentrations of sheep.
A third explanation could be that high energy diets favour synthesis of «-analogues 
of vitamin Bj^. Thus Sutton and Elliot (1972) found that on a high energy diet 'true' 
vitamin B^  ^amounted to only 86% of total analogs, whereas on an all hay diet it was 
112%, in which case more of the supplemented cobalt might be bound in this form 
and so be unavailable to the host.
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Overall the requirement of goats for cobalt is between that of sheep and cattle but 
more similar to that of sheep. Their marginal vitamin concentrations are lower 
than either but more similar to cattle, while their marginal MMA concentrations are 
higher than either but more similar to sheep. Thus goats should be classified neither 
as cattle, nor as sheep for diagnosis of cobalt deficiency, but should be considered 
separately in their own right.
6.2. The relationship between serum vitamin MMA concentrations with
respect to diagnosing cobalt deficiency in ruminants, and the lack of a 
relationship with succinate concentrations.
In sheep it has been observed that some instances occur where both serum vitamin 
Bj2  and MMA concentrations are low, suggesting that the animal is vitamin B^  ^
deficient but as yet does not have elevated concentrations of MMA. This appears 
contradictory, however Fisher & MacPherson (1990) thought this might be due to 
MMA being a functional marker of deficiency, while serum vitamin is a marker 
o f how much vitam in B^  ^ is being transported around the body. Upon first 
introducing a cobalt deficient diet, the amount of vitamin B^  ^ absorbed would drop 
markedly decreasing the amount found in the circulation; however initially there 
would still be sufficient vitamin B^  ^ in the liver for conversion of propionate to 
succinate and hence MMA would not start to build up. Only when liver vitamin B^  ^
stores had been decreased would propionate metabolism be affected and MMA 
concentrations begin to rise. This is likely to be the case in mature animals which 
have sufficient stores of vitamin B^  ^ to withstand cobalt deficient diets for some 
months. Such was the case for the sheep on the appetite trial where serum vitamin 
Bj2  concentrations took 150 days to drop from over 2500 ng/1 to below 400 ng/1 but 
MMA concentrations only became elevated after 200 days on the cobalt deficient 
diet.
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In cattle Paterson & MacPherson (1990) attributed the same phenomenon to the 
decreased feed intake resulting from the loss of appetite which would lower the 
metabolic rate and slow down MMA production. Loss of appetite, for the majority 
of our sheep, was not severe until they had been on the cobalt deficient diet for 300 
days by which time their serum MMA concentrations were already elevated. Less 
severe loss of appetite m ight delay the rise in MMA concentrations slightly, 
particularly as some individual animals appetites were affected long before the 
majority. Selective refusal of concentrates by vitamin deficient animals would 
further decrease propionate production, and hence MMA concentrations but like loss 
of appetite this symptom of deficiency is only apparent during clinical deficiency. 
However if marginal deficiency in goats is indeed signified by serum vitamin 
concentrations between 50 and 100 ng/1 and MMA concentrations between 15 and 
20 jumol/1 then this phenomenon was not apparent during any of our three trials.
Contrary to the results of Kennedy et al (1991a & b) and Young et al (1991) serum 
succinate was not found to increase during cobalt deficiency in calves, sheep or 
goats, and day to day variation was considerable. Rumen concentrations of succinate 
in the sheep were even more variable than serum succinate concentrations, with 
some suggestion that supplementation with cobalt or vitamin B^  ^ led to rapid but 
very short lived increases. One major dissadvantage with rumen samples however is 
the lack of homogeneity of the rumen contents and the difficulty in obtaining a 
representative sample. These sheep were not fistulated which increases problems 
when trying to ensure that the sample is taken from the same portion of the rumen. 
Additionally the nature of the samples is very dependent on how much feed or water 
the sheep has consumed immediately prior to sampling although an attempt was 
made to reduce this variability by always sampling at the same time of day.
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Overall it appears that in goats as in sheep and cattle, the use of serum vitamin 
concentrations in conjunction with MMA concentrations would be the most reliable 
method of detecting marginal cobalt deficiency. All the goats exibiting severe 
symptoms of cobalt deficiency, liveweight loss, loss of appetite, and pale mucous 
membranes, could easily be identified as having elevated MMA concentration or low 
serum vitamin B^  ^ concentrations. However to identify those goats with reduced 
growth rates but no clinical deficiency, serum vitamin Bj^ concentrations alone are 
difficult to interperet, as many of the supplemented goats showed no reduced growth 
but their serum vitam in B^  ^ concentrations remained very low. Serum MMA 
concentrations were easier to interpret although as explained earlier there could be 
some delay in response such that serum vitamin B^  ^analysis m ight suggest a 
requirement for supplementation before MMA concentrations had been affected, but 
this was not the case for these goats. Additionally as feed intake decreases during the 
development of severe cobalt deficiency, the formation of MMA might slow down 
resulting in a decrease in serum concentrations during severe deficiency. This might 
result in some false negatives if MMA concentrations alone were used for diagnostic 
purposes.
Rumen samples are not as easy to obtain as blood samples and rumen succinate in 
this trial was not suitable for diagnostic purposes. Because of the lack of relationship 
found between serum succinate and vitamin B^ or MMA concentrations, or reduced 
growth rates or feed intakes, it would not appear to be a reliable marker of cobalt 
deficiency.
In future, research into the nature and role of the transcobalamins deserves closer 
attention because if a reliable and accurate method of measuring total serum vitamin 
Bj2  were to be developed it would im prove the diagnosis of m arginal cobalt 
deficiency in both cattle and goats. The serum vitamin B^  ^ response of goats to 
cobalt supplem entation on d ifferent types of diets is also w orthy o f further
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investigation. These two aspects need to be considered together to determine whether 
diet does indeed affect the transport and metabolism of vitamin in the goat and in 
cattle.
6.3. The effect of cobalt deficiency on feed intake in sheep and goats.
Our observations of the goats in experiment 2 led us to try to quantify the effects of 
cobalt/vitamin B^  ^ deficiency on preference for forage or concentrates. A preference 
for forage over concentrate had previously been noted by MacPherson (1982) in 
ruminants and Ferguson (1990) in sheep.
In the present study in sheep, low cobalt intake resulted in a decrease in concentrate 
intake while forage intakes remained stable in the appetite assessment protocol used 
here. Supplementation with vitamin B^ ., produced a rapid response, markedly 
increasing concentrate intake within a week; cobalt supplementation produced a 
similar but slower response in concentrate intake. This supported our preliminary 
observations in goats where vitamin B^  ^ injection was seen to produce a visible 
response in feed intake by the following day, whereas cobalt supplementation 
required a week to produce a similar effect. This suggests that it is absorbed vitamin 
Bj2  which is required to correct appetite failure as opposed to cobalt itself in the 
rumen. Methionine supplementation failed to increase concentrate intake suggesting 
that appetite failure in cobalt/vitamin Bj^ deficiency may be related to impaired 
conversion of succinate to propionate.
A build up of propionate in the tissues could cause this effect according to Marston 
et al (1961 and 1972), although Kennedy et al (1991b & c) and Young et al (1991) 
suggest that propionate would not build up in the tissues because succinate from the 
rum en would be absorbed d irec tly  and u tilized  by the liv e r bypassing  the
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requirement for conversion to propionate in the rumen and back to succinate in the 
liver, this bypass would prevent any ill effects due to increased propionate in the 
tissues. Kennedy et al (1991b & c) and Young et al (1991) claim that impaired 
propionate metabolism in the liver is not the primary metabolic defect in ovine 
cobalt deficiency, but suggest instead that the accumulation of branched chain and 
odd-numbered fatty acids affects the fluidity of membranes. Hence the defect in 
methionine synthase activity may be more important than the defect in propionate 
metabolism, because it is the failure of this pathway which results in increased 
concentrations of branched chain and odd-numbered fatty acids. From our work it 
would appear that as far as appetite is concerned the primary defect is not located in 
the methionine synthase pathway. This was also the conclusion of Price (1990) who 
reported elevated MMA concentrations in sheep well before any impairment in 
methyltransferase metabolism which occured only when the animals were severely 
deficient.
6.4. A comparison of vitamin E supplementation protocols in calves and goats.
In goats and calves supplementation with either oral vitamin E (100 lU /day for 
goats, or 500 lU/day, later reduced to 250 lU/day for calves as DL-tocopheryl 
acetate, Rovimix E50, Roche) or injectable vitamin E (900 lU for goats, 1500 lU for 
ca lves, as D -ce-tocopherol, S tuart P roducts In c .)  raised  plasm a v itam in  E 
concentrations from inadequate (< 2  jumol/1) to sufficient (> 3  /imol/1). Injection of 
vitam in E resulted in a rapid rise in plasm a vitamin E concentrations by the 
fo llow ing day (20-50 jitm ol/l), but this was short lived and w ithin  a week 
concentrations returned to < 7  ^mol/1. As a long term measure, injection alone 
would not be suitable as some adverse effects on calves temperatures and appetite 
were noted when vitamin E injections were repeated within 3 weeks and yet by this 
time plasma vitamin E concentrations were marginal. Also injections, particularly 
with the large doses administered to the calves caused abscesses, and farmers would
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also find repeated injections unacceptable on a routine basis. However as a one-off 
treatment for a deficient animal together with a change to a vitamin E sufficient diet 
this could be very useful. Oral administration of vitamin E did not cause any adverse 
reaction.
6.5. The relationship between vitamin E  status and erythrocyte stability.
The preliminary trial in goats suggested that the erythrocyte stability technique might 
be useful as an indicator of vitamin E status if it could be modified to reduce day to 
day variation between results for the same animal. Although supplementation with 
vitamin E was only introduced two weeks before the end of the goat experiment, the 
results using 6% Tween looked promising as there was a small decrease in % 
haemolysis in the supplemented goats during the second week of supplementation.
In the calf trial, although day to day variation was much lower, particularly with the 
3 and 5 % Tween so lu tions, due to changes to the m ethod, there  was s till 
considerable variation between animals. This variation could be due to differing 
concentrations of red cells in the blood samples in which case haematocrit reading 
could be used as a correction factor. However there are many other factors which 
could affect the results which would need to be considered such as preventing 
premature haemolysis of blood samples due to careless sampling, vigorous mixing, 
or being left around too long. Additionally an assessment of the within and between 
assay variation should be made. Within assay variation was not measured during this 
experiment as processing 12 samples in one day proved problematical without doing 
duplicates. Between assay variation is further complicated due to the fact that fresh 
blood samples are required, and that these cannot be stored or frozen without 
affecting the results. It would be neccessary to assume that provided no changes in 
diet or treatment were made the result from one animal would be the same on two
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different days.
The variability encountered may have made it difficult to detect treatment effects if 
they occurred. The degree of vitamin E deficiency in the calves was not as severe as 
in the sheep used by Stevenson and Jones (1989) so differences between severely 
vitamin E-deficient animals and vitamin E-sufficient calves might be more readily 
detected. It is also possible that sheep are inherently less variable in this respect than 
cattle or goats.
From work reported in sheep (Stevenson & Jones 1989) it appeared that 2% Tween 
might be the optimum concentration for detecting erythrocyte fragility. However in 
the goats 6% Tween apparently showed up differences better than 2% Tween and in 
the calves there was little to choose between 3 and 5% Tween. Further work on the 
erythrocyte stability test, possibly comparing different Tween 20 concentrations 
might result in development of a more reliable measure of erythrocyte fragility and it 
may be possible to use this as an indicator of vitamin E status. However unless 
variability between animals of similar vitamin E status can be minimised, then this 
test is unlikely to replace plasma vitamin E concentrations as an indicator for vitamin 
E deficiency, especially as HPLC techniques for vitamin E analysis are more rapid 
and cheaper. To be of use as a diagnostic test reliable estimates would be required of 
the % haemolysis representing deficiency, marginal deficiency and adequacy, but 
until variation is decreased critical diagnostic values cannot be established for this 
parameter.
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6.6. The relationship between cobalt status and immune function in ruminants.
Cobalt deficiency has been associated with impaired neutrophil function (particularly 
% kill) in humans (Kaplan and Basford 1976) calves (Wright, M acPherson and 
Taylor 1982, MacPherson et al 1987, Paterson and MacPherson 1986) and in ewes 
(Fisher and MacPherson 1986) and with decreased IgG concentration (Fisher & 
MacPherson 1991) and response to clostridial vaccination in lambs (Ferguson 1990).
In the calf experiment, chapter 4, vitamin B^  ^ injections given to cobalt deficient 
calves caused a small but significant increase in % kill of E. coli on day 70 and of 
C. albicans on day 77, but not of S. aureus. These trends were not evident on the 
second date of sampling. While in the goat experiment, neutrophil function tests, 
antibody response to Clostridium, tetani vaccination and measurements of total IgG 
failed to show any significant effects of cobalt deficiency or cobalt supplementation 
on immune function of goats.
The results from the calves do not provide convincing evidence that cobalt 
supplementation improved the killing ability of neutrophils. Repetition of the 
experiment with a larger number of animals might clarify the results, since the work 
of others (Wright et al 1987, Paterson & MacPherson 1986, Fisher & MacPherson 
1986 & 1991 & Ferguson 1990) in both cattle and sheep suggests that there is likely 
to be an effect, if only a relatively small one.
In the goat experiments all three tests used indicated that immune function was not 
adversely affected by cobalt deficiency. Responses have been observed in sheep 
and/or cattle to all these tests suggesting that we did not choose the wrong tests. 
However other tests might still show up impaired immune responses. Very little 
work has been done on the immune response of goats although Aziz et al (1984) 
found depressed neutrophil function in selenium deficient goats as assessed by
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polymorphonuclear leucocyte migration and phagocytosis of opsonised zymosan, and 
Aziz & Klesius (1986) found lower concentrations of leucotriene produced by 
selenium deficient goats which would lead to decreased leucotriene B  ^ mediated 
neutrophil chemotaxis.
The mechanism of action of selenium  on the immune system is much better 
understood than that of cobalt, and without specific knowledge of the mode of action 
it is difficult to speculate whether goats might indeed differ from calves and sheep in 
this respect. Ferguson (1990) speculated that the effect of cobalt deficiency on 
resistance to worms in sheep might be partly explained by a decreased protein intake 
due to loss of appetite. Such an indirect mode of action could be affected by many 
other factors such as the nature of the diet, for instance in this case urea was used as 
a supplem entary nitrogen source and this was applied to the forage. During 
deficiency the decreased concentrate intake may have resulted in a greater 
proportional intake of nitrogen.
In future it would be useful to know whether cobalt deficiency affects goat kid 
viability and resistance of goats to worms or resistance to any other common 
diseases of goats eg. pneumonia. Experiments in sheep (Fisher and MacPherson 
1991 & Ferguson 1990) found that lambs born to cobalt deficient ewes were more 
likely to die than lambs born to cobalt sufficient ewes, and that cobalt deficient sheep 
had less resistance to worms than cobalt sufficient sheep. Findings such as these help 
to persuade farmers that it will be financially sound to supplement their animals,
A more scientific approach would be to try and pinpoint the mode of action of cobalt 
in the other ruminants. Both selenium and vitamin E have been used successfully at a 
cellular level. Supplementation of neutrophils from selenium deficient goats at a 
cellular level stimulated neutrophil function similarly to supplementation of the
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whole animal (Aziz et al 1984). Cobalt/vitamin is thought to act indirectly on 
cell function and supplementation of cell cultures with vitamin Bj^ might clarify this. 
Thus indirect effects of cobalt deficiency such as decreased protein intake due to 
inappetance would be eliminated if supplementation was carried out on cell cultures.
Use of alternative immune function tests such as mitogen induced lymphocyte 
proliferation responses or Tj^  versus T  ^ differential cell counts might help to identify 
the mode of action, because if only certain parts of the immune system are affected 
then only specific tests involving these areas will demonstrate an effect.
Fisher and MacPherson (1991) attributed the decreased resistance of cobalt deficient 
lambs to bacterial infections to decreased intake of colostrum during the first few 
hours after b irth , and this in turn was due to a lack of vigour in the lambs. 
Presumably the lack of vigour of the lambs was due to the inadequate supply of 
vitam in B^  ^ in the ewe during pregnancy, however this could have been the 
consequence of an indirect action of cobalt deficiency on appetite. MacPherson et al 
(1989) proposed that the effects of deficiency on cell mediated immunity (neutrophil 
function) and humoral immunity (antibody response to clostridial vaccination) were 
primary effects and not dependent on reduced food intakes. Certainly the effects of 
vitamin B^  ^ deficiency on cell mediated immunity in humans and mice (cited by 
Gershwin et al 1985) were not due to impaired propionate metabolism affecting food 
intake. Kaplan and Basford found a decrease in phagocytosis-associated hexose 
monophosphate shunt activity in vitamin Bj^ deficient humans and they speculated 
that impaired protein or DNA synthesis had resulted in decreased concentrations of 
some of the enzymes involved. Thus experiments to confirm changes in hexose 
monophosphate shunt activity, or changes in concentration of specific enzymes could 
clarify the role of vitamin B^  ^ in immune function.
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APPENDIX I 
Table 3.1. Experiment 1 Hay.
1
Contents
2 3 Mean (S.D.)
DM g/kg 806 846 876 843 20.3
Co mg/kg 0.03 0.06 0.04 0.04 8.8*10-^
Se mg/kg - - 0.06 - -
CP g/kg 68 79 68 72 3.67
OM g/kg 952 961 956 956 2.60
IVOMD % 54.3 53.8 56.2 54.8 0.73
In vitro D 57.5 51.8 53.7 54.3 1.68
M/D 8.6 7.9 8 8.2 0.22
Ca g/kg 4.4 3.6 3.0 3.7 0.41
P g/kg 1.3 1.4 1.4 1.4 0.03
Mg g/kg 1.1 0.9 1.2 1.1 0.09
K g/kg 12.3 12,1 11.5 12.0 0.24
Na g/kg 0.88 0.28 0.73 0.63 0.18
Cu mg/kg 3.46 3.14 3.26 3.29 0.09
Mo mg/kg 0.48 0.35 0.24 0.36 0.07
S g/kg 1.27 1,19 0.87 1.11 0.12
Zn mg/kg 20.4 19.9 21.5 20.6 0.47
Fe mg/kg 47.3 69.1 52.8 56.4 6.55
Mn mg/kg 83.4 36.0 74.4 64.6 14.53
Available Cu 
mg/kg
3.46 0.29 - 0.30 5*10^
N.B. Urea contains <0.01 mg/kgDM Cobalt.
Table 3.2. Experiment 1 Concentrates
MAIZE
Content 1
BARLEY
2 Mean (S.E.)
DM g/kg 856 766 808 787 21
Co mg/kg 0.04 0.03 0.06 0.04 0.015
Vitamin E 
lU/kg
0.56 1.68 1.47 1.58 0.105
Se mg/kg - - 0.02 0.02 -
CP g/kg 87 98 96 97 1
OM g/kg 998 976 973 974 1.5
IVOMD % 94.2 84.8 82.6 83.7 1.1
In vitro D 94.1 82.8 80.4 81.6 1.2
M/D 15.0 13.2 12.9 13.05 0.15
Ca g/kg < 0.2 0.5 0.6 0.55 0.05
P g/kg 1.3 3.6 3.5 3.55 0.05
Mg g/kg 0.4 1.2 1.1 1.15 0.05
K g/kg 2.13 4.79 4.7 4.74 0.045
Na g/kg 0.11 0.01 0.13 0.07 0.06
Cu mg/kg 1.37 6.05 5.6 5.82 0.225
Mo mg/kg 0.11 0.41 0.4 0.40 5*10'^
S g/kg 0.23 1.11 1.7 1.40 0.295
Zn mg/kg 11.2 30.20 29.8 30 0.2
Fe mg/kg 35.8 89.00 138.00 113.5 24.5
Mn mg/kg 3.03 12.5 12.4 12.4 0.05
Available Cu 
mg/kg
0.08 0.61 - - -
11
Table 3.3. Experiment 2 Hay
1
Contents
2 3 Mean (S.E.)
DM g/kg 838 813 879 843 19.24
Co mg/kg 0.06 0.09 0.1 0.08 0.01
Vitamin E 
lU/kg
11.07 10.11 - 10.6 0.48
Se mg/kg - 0.04 0.07 0.06 0.02
CP g/kg 88 130 61 93 20.1
OM g/kg 940 940 940 940 0
IVOMD % 51.8 52.3 52.6 52.2 0.23
In vitro D 48.7 49.2 49.4 49.1 0.21
M/D 7.4 7.5 7.5 7.5 0.03
Ca g/kg 3.8 2.7 2.8 3.1 0.35
P g/kg 2.0 1.7 1.8 1.8 0.09
Mg g/kg 1.0 0.8 0.9 0.9 0.06
K g/kg 17.0 14.2 14.5 15.2 0.89
Na g/kg 2.12 1.64 1.88 1.88 0.14
Cu mg/kg 3.94 3.17 3.38 3.50 0.23
Mo mg/kg 0.19 0.57 0.49 0.42 0.12
S g/kg 1.14 1.34 1.44 1.31 0.09
Zn mg/kg 22.7 20.0 21.1 21.3 0.78
Fe mg/kg 73.7 73.6 126.0 91.1 17.4
Mn mg/kg 244 204 169 205.7 21.7
Available Cu 
mg/kg
0.38 - 0.29 0.34 0.04
N.B. Urea contains <0.01 mg/kgDM Cobalt.
m
Table 3.4. Experiment 2 Maize
1
Contents
2 3 4 Mean (S.E.)
DM g/kg 875 878 884 885 880.5 2.40
Co mg/kg 0.01 0.01 0.00 0.02 0.01 4.1*10-^
Vitamin E 
lU/kg
1.24 - 6.57 - 3.9 2.66
Se mg/kg - 0,07 0.04 0.02 0,04 0.01
CP g/kg 96 90 99 91 94 2.12
OM g/kg 988 989 974 992 986 4.01
IVOMD % 90.2 94.6 90.1 94.8 92.4 0.31
In vitro D 89.1 93.6 87.8 94 91.1 1.57
M/D 14.3 15.0 14.0 15 14.6 0.25
Ca g/kg 0.8 0.5 3.8 0.2 1,32 0.83
P g/kg 2.2 1.3 2.8 1.7 2 0.32
Mg g/kg 0.8 0.5 1,1 0.5 0.7 0.14
K g/kg 2.91 2.42 3.65 2.48 2.86 0.28
Na g/kg 0.28 0.1 0.02 0.02 0.10 0.06
Cu mg/kg 1.82 1.64 2.20 1.37 1.76 0.17
Mo mg/kg 0.13 0.10 0.14 0.09 0.12 0.01
S g/kg 0.90 0.63 1.03 0.99 0.89 0.09
Zn mg/kg 17.5 13.1 22.1 12.0 16.2 2.30
Fe mg/kg 30.8 24.3 34.7 67.0 39.2 9.5
Mn mg/kg 4.63 3.6 7.08 3.94 4.81 0.79
Available 
Cu mg/kg
0.18 0.16 0.22 0.14 0.18 0.02
IV
Table 3.5. Experiment 3 Hay:Straw Mix
1 2
Contents
3 4
Mean (S.E.)
DM g/kg 820 833 857 804 828 11.2
Co mg/kg 0.1 0.05 0.05 0.05 0.06 0.01
Se mg/kg 0.02 0.03 0.01 0.02 0.02 4.1 * 10"
CP g/kg 106 84 84 77 88 6.3
OM g/kg 949 946 948 951 948 1.04
IVOMD % 45 46.6 44.4 47.1 45.8 0.64
In vitro D 42.7 44.1 42.0 44.8 43,4 0.64
M/D 6.3 6.5 6.2 6.7 6.4 0.11
Ca g/kg 3.1 3.2 3.2 3.2 3.2 0.02
P g/kg 1.5 1.6 1.2 1.1 1.4 0.12
Mg g/kg 0.9 1.1 1.0 1.1 1.0 0.05
K g/kg 15.5 16.5 16.3 16.4 16.2 0.23
Na g/kg 1.34 1.05 0.97 1.20 1.14 0.08
Cu mg/kg 3.51 3.62 3.18 3.09 3.35 0.13
Mo mg/kg 0.44 0.23 0.22 0.45 0.34 0.06
S g/kg 1.22 1.25 1.09 1.11 1.17 0.04
Zn mg/kg 21,5 15.8 13.3 15.2 16.4 1.77
Fe mg/kg 121.0 58.8 68.0 74.6 80.6 13.8
Mn mg/kg 73.3 76.8 61.7 79.9 72.9 3.98
Available 
Cu mg/kg
0.31 - - - - -
N.B. Urea contains <0.01 mg/kgDM Cobalt
Table 3.6. Experiment 3 Maize
Contents Mean (S.E.)
1 2 3 4 5
DM g/kg 885 881 884 886 888 885 1.16
Co mg/kg <0.02 0 0.01 0.01 0.01 0.01 3.2 * 10"
Se mg/kg 0.02 0.02 0.01 0.05 0.08 0.04 0.01
CP g/kg 91 93 88 97 99 94 1.99
OM g/kg 992 992 992 992 989 991 0.6
IVOMD % 94.8 92.5 92.5 88.7 88.5 91.4 1.22
In vitro D 94 91.8 92.1 87.9 87.6 90.7 1.26
M/D 15.0 14.7 14.7 14.1 14.0 14.5 0.19
Ca g/kg < 0 .2 < 0 .2 < 0 .2 < 0 .2 < 0 .2 < 0 .2 0
P g/kg 1.7 1.7 1.6 2.4 3.0 2.1 0.27
Mg g/kg 0.5 0.6 0.5 0.8 1.0 0.7 0.10
K g/kg 2.48 2.41 2.21 3.29 3.76 2.83 0.30
Na g/kg 0.02 - 0.01 0.05 0.02 0.025 8.7 * 10 "
Cu mg/kg 1.37 1.37 1.39 1.81 1.82 1.55 0.11
Mo mg/kg 0.09 0.09 0.12 0.14 0.16 0.12 0.01
S g/kg 0.99 1.02 1.00 0.85 0.81 0.93 0.04
Zn mg/kg 12.0 12.2 13.4 17.5 21.1 15.2 1.77
Fe mg/kg 67.0 31.0 32.2 26.6 34.7 38.3 7.29
Mn mg/kg 3.94 3.85 3.56 5.57 5.57 4.50 0.44
Available 
Cu mg/kg
0.14 0.14 0.14 - - 0.14 0
VI
Table 3 .7 . Serum Vitamin B ,2 Concentration u ig/')
Day No.
1
Cobalt Treatment Group Number 
2 3 4
S.E.D P
-63 281 365 344 285 90.4 0.775
-47 16T 255“ 217*’“ 19T*’ 26.6 0.018
-27 98“^ 137*’ 124"*’ 123“*’ 18.5 0.234
-14 180 176 198 190 32.2 0.885
0 (108) (8 8 ) (78) (104) - -
14 50" I I P 123*’ 129*’ 13.5 < 0 .0 0 1
35 <50" 116*’ 108*’ 153“ 16.6 < 0 .0 0 1
56 59" 157*’ 150*’ 167** 24.2 < 0 .0 0 1
70 32" 154*’ 137*’ 149*’ 2 0 .2 < 0 ,0 0 1
84 50" 158** 163*’ IBP 2 2 .6 < 0 .0 0 1
1 0 0 60“ 157*’ 137*’ 166*’ 17.0 < 0 .0 0 1
1 1 2 44" 115*’ 1 1 0 *’ 162“ 21.7 < 0 .0 0 1
126 79" 133*’ 140*’ 162*" 16.0 < 0 .0 0 1
140 63" 134*’ 143*’ 2 1 2 “ 2 1 .2 < 0 .0 0 1
154 62" 113*’ 1 2 0 *’ 161“ 14.5 < 0 .0 0 1
168 >2500* 168*’ 153*’ 208*’ 34.3 < 0 .0 0 1
182 458" IS P 168*’ 257*’ 53.4 < 0 .0 0 1
Table 3.8. Serum MMA Concentrations (/xmol/1)
Day No.
1
Cobalt Treatment Group Number 
2 3 4
S.E.D P
-63 1 .8 1 .6 < 3 2 1.346 0.809
-47 10 3 8 8 4.0 0.330
-14 6 11 13 10 3.26 0.259
0 (28) (18) (31) ( 12) - -
14 49" 9*’ 5*’ 10*’ 5.73 < 0 .0 0 1
35 48" 6 *’ 6*’ 6 *’ 3.08 < 0 .0 0 1
56 40" 5*’ 5*’ 4*’ 5.51 < 0 .0 0 1
70 58" 5*’ 2 *’ 12*’ 15.16 0.004
84 60" 4*’ 2 *’ T 5.47 < 0 .0 0 1
1 0 0 1 0 0 “ 15*’ 4*’ 15*" 18.32 < 0 .0 0 1
1 1 2 94" 8*’ 8*’ 5*’ 9.85 < 0 .0 0 1
126 107" T 6 *’ 6 *’ 14.32 < 0 .0 0 1
140 94" I P 2 0 *’ 1 2*’ 17.36 < 0 .0 0 1
154 1 2 1 " 13*’ T 9*’ 16.15 < 0 .0 0 1
168 < 1" 6*’ 9*’ 4ab 2.615 0.033
182 < T 5*’ - 3“*’ 1.579 < 0 .0 0 1
Day zero is date o f first Cobalt supplementation and the values in brackets were used as covariates for the 
statistical analysis.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
Vll
F ig .3 .9  Serum GOT Activity (SF/m l)
Day No.
1
Cobalt Treatment Group Number 
2 3 4
S.E.D P
0 76»b 83*’ 67" 69" 4.59 0.008
14 65 95 70 70 14.25 0.189
1 0 0 6 8 67 6 8 47 10.45 0.750
154 130" 7 7 b 6 6 *’ 63*’ 15.07 < 0 .0 0 1
182 152" 78*’ 62*" 60*’ 32.6 0.033
Day zero is date o f first Cobalt supplementation.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
Vlll
F ig ,3 .10 . Liveweight (kg)
Day No.
1
Cobalt Treatment Group Number 
2 3 4
S.E.D P
-63 17.5" 18.2“*’ 18.0"*’ 18.4*’ 0.429 0.19
-47 18.3 18.8 18.4 18.8 0.352 0.38
-27 18.0 18.5 18.0 18.1 0.384 0.51
-14 18.3"*’ 18.8*’ 18.0" 18.1"*’ 0.347 0,16
0 (18.7) (18.2) (19.0) (19.0) - -
7 18.6 18.7 18.6 18.7 0.282 0.93
14 18.2 18.3 18.8 18.4 0.425 0,53
21 18.4 18.6 18.8 18.6 0.522 0 .8 8
28 18.4 18.3 18.6 18.3 0.506 0.90
35 18.7 19.0 19.4 18.9 0.430 0.464
43 18.8" 18.6" 2 0 . P 19.3“*’ 0.418 0.013
50 18.7 18.7 19.7 19.5 0.567 0.180
56 18.4 18.4 19.4 19.2 0.544 0.146
63 18.5" 18.9“*’ 19.9*’ 19.5"*’ 0.638 0.146
70 18.5 19.0 2 0 .0 19.8 0.725 0.168
77 18.6 19.4 20.3 2 0 .2 0.855 0.181
84 18.6" 19.7“*’ 2 0 . 8*’ 20.4“*’ 0.884 0 .1 1 1
91 18.7" 2 0 .0 "*’ 21.4*’ 2 1 .2 *’ 0.896 0.025
1 0 0 18.2" 2 0 .2 “*’ 2 1 .6 *’ 21.3*’ 1.217 0.051
105 18.2" 20.7*’ 2 2 .0 *’ 2 1 .6 *’ 1.094 0 .0 1 2
1 1 2 18.0* 21.7*’ 2 2 .6 *’ 2 2 .6 *’ 1.268 0.006
119 18.4" 2 2 .2 *’ 23.5*’ 23.0*’ 1.226 0 .0 0 2
126 17.5" 22.5*’ 23.9*’ 23.5*’ 1.349 < 0 .0 0 1
135 17.3“ 24.6*’ 25.2*’ 25. P 1.390 < 0 .0 0 1
140 16.8" 24.4*’ 25.2*’ 24.7*’ 1.499 < 0 .0 0 1
144 16.6" 25. P 25.5*’ 25.2” 1.517 < 0 .0 0 1
154 16.0" 25.7*’ 26.9*’ 26.6” 1.447 < 0 .0 0 1
161 15.7“ 26.6*’ 27.0*’ 27.3” 1.620 < 0 .0 0 1
168 17.4“ 26. P 27.4*’ 27.3” 1.920 < 0 .0 0 1
175 18.2“ 27.2*’ 28.3*’ 28.2” 1.679 < 0 .0 0 1
182 18.7“ 26.8*’ 29.0*’ 28.8” 1.564 < 0 .0 0 1
Day zero is date o f first Cobalt supplementation and the values in brackets were used as covariates for the 
statistical analysis.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
IX
F ig .3 .11. Plasma Vitamin E Concentrations (jamol/1)
Day No. Vitamin E Treatment Groups 
-E +E
S.E.D P
-47 3.22 3.36 0.446 0.747
0 1.73 1 .8 6 0.238 0.569
14 1.85 1.78 0.227 0.741
35 1.62 1.65 0.269 0.905
56 1.61 1.56 0.247 0.821
64 1.32 1.29 0.229 0.909
70 1.40 1.50 0.213 0.670
84 1.18 1 .1 2 0.246 0.820
1 0 0 1.16 1 .2 2 0.180 0.771
1 1 2 1 .1 2 1.29 0.188 0.378
126 1.17 1.16 0.156 0.976
140 1.32 1.36 0.219 0.848
154 1.60 1.67 0.266 0.811
161 1.73 1.71 0.259 0.938
163 1.80 1.81 0.289 0.972
168 1.70 1.78 0.298 0.785
175 1 .6 8 " 3.77” 0.512 < 0 .0 0 1
182 1.82" 4.39” 0.405 < 0 .0 0 1
Day 169 is the date o f first vitamin E treatment.
F ig.3.12. Whole Blood GSH-Px Activity (/j/ml at 30°C)
Day No. Cobalt Treatment Group Number S.E.D. P
1 2 3 4
-63 40.1 60.8 49.7 44.3 1 2 .8 6 0.429
-47 14.7 16.2 1 1 .6 12.4 4.28 0.702
-27 42.3 57.8 44.1 48.5 10.36 0.465
-14 10.3" 24.3” 14.1"” 11.3" 6.06 0.115
0 28.5 38.0 31.2 31.2 5.48 0.374
14 37.3 44.5 45.8 37.9 7.64 0.579
35 38.5 43.5 33.0 32.7 6.30 0.293
56 17.6" 28.4” 20.3" 19.2" 3.79 0.043
70 23.8 30.4 24.4 25.3 3.46 0.236
84 23.4 29.8 23.8 24.0 3.14 0.166
1 0 0 25.0 32.4 27.2 28.2 3.71 0.281
11 2 29.8" 38.2” 34.2“” 34.8“” 3.10 0.093
126 48.7 51.2 47.1 52.0 3.63 0.528
140 42.6 40.5 38.6 40.1 2 .8 8 0.579
154 47.1 45.8 41.9 42.4 4.54 0.611
168 43.2 40.1 35.9 39.1 3.52 0.253
182 43.9” 40.2“” 34.4“ 39.8“” 4.13 0.186
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Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 )
Fig. 3 .13 . Plasma CK Activity (U/1 at 30PC)
Day No.
1
Cobalt Treatment Group Number 
2 3 4
S.E.D P
14 107 67 81 71 39.2 0.736
84 70 69 93 94 14.9 0.310
161 180“ 1 0 2 “” 76” 73” 39.4 0.043
182 387 111 82 72 154.6 0.166
Fig.3.14. Serum Copper, Magnesium and Calcium Concentrations.
Mineral 
Day No. 1
Cobalt Treatment Group Number 
2 3 4
S.E .D . P
Cu /imol/1
-47 1 2 .6 13.5 13.0 1 1 .6 1.368 0.527
-27 17.7 18.4 18.3 18.1 1.440 0.963
-14 12.4 14.0 13.2 1 2 .8 1 .0 2 2 0.460
56 12.9 14.0 13.2 12.4 1.192 0.591
Mg mmol/1
-47 1.14 1 .2 0 1.24 1.17 0.0522 0.244
-14 1 . 10“ 1.05“ 1.13” 1 . 10“ 0.0324 0 .1 2 2
56 0.95 1 .0 0 1 .0 2 0.90 0.0589 0 .2 1 0
64 0.99“” 1.09”“ 1.15“ 0.98" 0.0501 0.007
70 1 .0 1 1 .0 0 1.05 1 .0 0 0.0479 0.703
Ca mmol/1
-47 2.91 2.90 2.96 2.75 0 .1 0 1 1 0.228
-14 2.74“” 2.77” 2.63“ 2.74“” 0.0537 0.076
56 2.52 2.54 2.55 2.56 0.0272 0.455
64 2.48 2.57 2.50 2.55 0.0741 0.528
70 2.30“ 2.38“” 2.38“” 2.48” 0.0568 0.034
Day zero is date o f first Cobalt supplementation.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
XI
F ig .3 .15 . Neutrophil Function (% kill)
Day No.
1
Cobalt Treatment Group Number 
2 3 4
S.E.D. P
14 23 27 23 29 4.34 0.459
35 24 23 28 37 7.12 0.231
56 36 26 32 32 4.61 0.238
70 2 1 “” 16“ 27” 24“” 4.77 0.196
84 25 23 26 21 4.67 0.741
1 0 0 15 14 2 0 19 3.96 0.473
1 1 2 2 2 ” 19“” 15“ 2 1 ” 2.19 0.070
126 17 14 14 18 2.47 0.321
140 21 2 2 17 18 2.85 0.259
Day zero is date of first Cobalt supplementation.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
Xll
Table. 3.16. Serum Vitamin B ,2 Concentrations (ng/i)
Day No. Cobalt Treatment Group Number S.E.D P
1 2 3 4 5 6
-91 430“” 429“” 424“” 484"” 370“ 652” 118.0 0.356
-77 271 198 193 242 213 266 69.8 0.776
-63 117 156 128 129 11 0 149 39.9 0.841
-49 74“ 123” 91“” 90“” 83“” 104“” 22.1 0.330
-35 57 69 6 6 59 70 62 13.3 0.883
-22 61 51 1 1 0 63 39 56 40.5 0.597
0 (45) (44) (49) (56) (35) (61) - -
14 40“ 50“” 42“” 53“” 57“” 63” 10.25 0.231
28 34“ 56“” 57“” 62“” 62“” 80” 14.3 0 .1 1 1
42 36“ 37“ 55“” 58“” 37“ 77” 13.1 0.058
56 30“ 39*” 65” 59“” 48“” 1 0 0 " 15.7 0.009
69 34“ 85” 99*” 6 8 “” 82” 140" 21 .8 0.005
84 40“ 8 8 ” 84” 89” 1 0 0*” 135" 18.2 0.003
97 32“ 57“” 69” 71” 88” 148" 17.3 < 0 .0 0 1
111 52“ 58“ 71“ 57“ 8 6 “” 1 1 2” 18.7 0.039
125 37“ 52“” 57“” 59*” 79od 96** 1 0 .0 < 0 .0 0 1
139 36“ 50“” 52“” 64"*” 75*” 95" 15.6 0 .0 2 2
153 359 51 55 71 90 103 387 0.560
Day zero is date o f first Cobalt supplementation and the values in brackets were used as covariates for the 
statistical analysis.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
Xl l l
Table 3 .17. Serum M M A Concentrations (jitmol/1)
Day No. Cobalt Treatment Group Number S.E.D P
1 2 3 4 5 6
-91 1 .6 1 .6 1.7 1.5 2.7 2.3 0.754 0.563
-77 6.3 5.5 6 .2 4.0 5.2 6.3 1.543 0.687
-63 8 . 1“” 6.4“” 3.9“ 7.0*” 11” 8 .6 “” 2.725 0.197
-49 14 9.5 11 8 .8 16 12 3.92 0.431
-35 19 16 16 16 2 2 18 4.58 0.799
-2 2 16 16 18 18 2 2 2 0 4.67 0.711
0 (16) (23) (2 1 ) (26) (18) (14) - -
14 2 1 ” 1 1“ 13“ 10“ 8.3“ 9.6“ 2.640 0 .0 0 1
28 23” 12“ 13“ 7.3“ 7 .9“ 8.5“ 3.044 < 0 .0 0 1
42 25” 12“ 10“ 11“ 8.5“ 7.7“ 3.59 0 .0 0 1
56 33” 12“ 8.7“ 10“ 9.7“ 7.8“ 3.95 < 0 .0 0 1
69 35” 14“ 10“ 11“ IT 8.7“ 2.590 < 0 .0 0 1
84 38” 15“ 11“ 10“ 8 .T 6 .6 “ 6.83 0.003
97 40” 12“ 8.4“ 6 .9“ 5 .5“ 3.5“ 6.26 < 0 .0 0 1
111 63” 19“ 12“ 11“ 8 .2 “ 6.4“ 12.23 0 .0 0 2
125 52” 2 2 “ 13“ 11“ 7.0“ 7.5“ 1 0 .0 0 0 .0 0 2
139 58” 19“ 14“ 12“ 7.1“ 7 .9“ 15.32 0.026
153 38” 14“” 18“” IT 9.4“ 10“ 12.24 0.172
Day zero is date o f first Cobalt supplementation and the values in brackets were used as covariates for the 
statistical analysis.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 )
XIV
Table 3 .18 . Serum Succinate Concentrations t/rmo'/l)
Day No. Cobalt Treatment Group Number S.E.D P
1 2 3 4 5 6
-91 9.6 9.3 11 12 9.6 10 1.710 0.645
-77 9.3*” 6 .2 “ 8 . 1“*’ 11" 8 . 1“*’ 7 .6“” 1.097 0.045
-63 7 .T 9 .P 7.3“*’ 7 .4“*’ 7 .1“ 8.9“” 0.881 0.205
-49 9.3* IP 10“*’ 9.3“ 10“*’ 9.7“ 0.600 0.106
-35 9.8 12 11 11 11 12 1.348 0.568
-2 2 9.2 10 10 9.8 8 .8 11 0.822 0.175
0 ( 1 1 ) ( 12) (9.9) (8.7) (9.4) ( 11) - -
14 7.6 8 .6 9.5 8 .6 8 .1 8.4 0.955 0.479
28 7.4 8 .8 8 .6 8.3 8 .2 8.9 0.815 0.458
42 6.7“ 8 .2 *^ 8.7*’ 7.5“*’ 7 .9“*’ 8.4” 0.681 0.069
56 9.6“ 11“*’ 2 1 " 17*” 16*” 13“” 2.663 0 .0 1 0
69 2 0 2 2 17 13 17 16 4.09 0.492
84 7.1“ 11“*’ 8.4“ 8 .2 “ 12*’ 11“” 1.930 0.068
97 5.8“ 8 .8*’ 8 .6 *’ 8 .2 *’ 7.3“*’ 8.3” 1.039 0.042
111 6.9“ 8 .8*” 8.3*’ 8 .P 8 .6 *’ 9.9" 0.555 0 .0 0 1
125 7.4“ 10*’ 8.3“*’ 7.1“ 8.4“*’ 7.8* 1.090 0.141
139 6 .8“ 8 .8*’ 8.7“*’ 7.7“*’ 7 .9“*’ 9.0” 0.922 0.188
153 5.9“ 8.7" 8 .2 *” 6.5“*’ 6 .9“*” 7.6“*” 0.978 0.084
Table.3.19. Serum GOT Activity (SF/ml)
Day No. Cobalt Treatment Group Number S.E.D P
1 2 3 4 5 6
0 124” 8 8“” 69“ 6 8 “ 78“” 82“” 23.7 0.235
14 105 107 81 75 96 105 21.9 0.572
28 101 98 72 76 83 119 26.6 0.515
42 75“” 78“” 6 6 “” 60“ 70“” 84” 9.0 0.167
56 96“” 8 8 “” 74“ 64“ 73“ 130” 2 2 .2 0.090
69 1 1 1 ” 103“” 84“” 78“ 91“” 98“” 15.4 0.326
84 75 85 70 6 8 77 76 9.5 0.547
97 75“ 1 1 2“” 93“ 90“ 147” 109“” 2 0 .2 0.035
111 74 91 76 74 91 82 9.6 0.262
125 1 1 2 90 77 76 77 80 21.4 0.507
139 1 1 0 115 86 83 98 99 16.5 0.379
160 104 85 72 6 6 76 86 23.6 0.671
Day zero is date o f first Cobalt supplementation and the values in brackets were used as covariates for the 
statistical analysis.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
XV
Table 3 ,20 . Liveweight (kg)
Day No. Cobalt Treatment Group Number S.E.D P
1 2 3 4 5 6
-91 2 0 . 1" 19.4”" 17.8“ 18.2“” 18.8“”" 19.3“”" 0.717 0.06
-77 20.4 2 0 .2 19.0 19.2 19.6 19.5 0.698 0.305
-63 2 0 .8” 19.8“” 19.0“ 19.4“ 2 0 .2 “” 19.7“” 0.607 0.104
-49 2 1 .0 ” 19.5“ 19.2“ 19.7“ 19.5“ 20. T” 0.575 0.08
-35 2 0 .2 19.9 19.4 19.6 2 0 .0 2 0 .0 0.403 0.341
-2 2 2 1 .0 2 0 .6 19.8 19.9 2 0 .8 2 0 .2 0.631 0.408
0 (19.6) (19.8) (20.5) (2 0 .0 ) (19.1) (19.8) - -
7 20.9 2 0 ,8 2 0 .0 19.7 2 0 .1 20.3 0.528 0 .2 1
14 2 0 .8 2 0 .8 2 0 .2 19.5 20.4 20.5 0.706 0.499
21 2 1 .0 “” 2 1 .2 ” 20.5*” 19.8“ 20.5“” 20.7“” 0.639 0.341
28 2 1 .0 21.4 2 0 .6 19.7 20.4 2 0 .8 0.849 0.515
35 21.3 2 1 .8 2 1 .2 2 0 .2 2 1 .1 2 1 .2 0.766 0.474
42 21.4 21.9 21.3 2 0 .2 2 1 .2 21.4 0.856 0.517
49 2 1 .8 2 2 .2 21.9 2 0 .6 21.4 2 1 .8 0.869 0,577
56 20.7 21.7 2 1 .6 2 0 .0 2 0 .6 20.9 1.003 0.567
63 21.7 23.0 22.4 21.4 2 2 .2 22.5 1.098 0.737
69 21.9 23.0 2 2 .6 21.5 22.5 22.7 1.066 0.728
77 2 2 .1 24.0 23.3 2 2 .2 2 2 .8 23.1 1.182 0.582
84 22.7 25.1 24.2 23.0 23.8 24.1 1 .2 1 1 0.430
91 2 2 .6 “ 25.2” 24.5*” 23.8“” 24. T” 24.2“” 1.070 0.304
97 23.0 25.1 24.2 23.5 23.7 23.5 1.228 0.621
104 23.1“ 26.8” 24.4“” 23.2“ 24.4“” 24.5“” 1.485 0 .2 2 2
111 23.6“ 27.6” 25.7“” 24.3“” 25.0“” 26. T” 1.647 0.258
118 24. T 27.9” 27. T” 25.4“” 25.6“” 26.6“” 1 .6 8 8 0.318
125 22.9“ 27.4” 26.4“” 26.0“” 25.4*” 26.0“” 1.703 0.237
132 23.7“ 29.2” 27.8” 25.9“” 27.0“” 27.9” 1.876 0.114
139 24.1“ 30.0” 29.0” 27.4“” 28.0“” 28.9” 2.064 0.130
146 24.6“ 30.6” 29.0” 27.4“” 28.6“” 29.0” 1.974 0.108
153 25.2“ 31.0” 29.2“” 27.3“” 28.3“” 28.7“” 1.912 0.129
160 25.9“ 32.2” 30.1” 28.3“” 30.0“” 30.5” 1.971 0.077
Day zero is date o f  first Cobalt supplementation and the values in brackets were used as covariates for the 
statistical analysis.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
XVI
Table 3 .21 . Plasma Vitamin E Concentrations (/x.mol/1)
Day No. Vitamin E Treatment Groups 
+ E  -E
S.E.D P
-77 2.71 3.09 0.269 0.272
-63 1.99 2 .0 2 0.238 0.867
-49 1,39 1.60 0 .2 1 0 0.516
-35 1.26 1.46 0,1594 0.334
-2 2 1.27 1.27 0.1156 0.956
0 1.23 1.18 0.1411 0.654
14 1.30 1.31 0.1531 0.948
28 1.31 1 .2 1 0.1525 0.503
42 1.60 1.39 0.1722 0.263
56 1.53 1.48 0.1854 0.790
69 1.54 1.60 0 .2 0 0 0.778
84 1.60 2 .1 1 0.269 0.449
97 2.40 2.33 0.288 0.819
105 51.1” 2 .2 0 “ 3.57 < 0 .0 0 1
108 1 0 .0 - - -
111 7.00” 2.46“ 0.505 < 0 .0 0 1
125 5.70” 2 . 8 8 “ 0.424 < 0 .0 0 1
139 4.33” 2.69“ 0.371 < 0 .0 0 1
153 4.68 2.99 0.456 0 .0 0 1
Day 104 is the date o f first Vitamin E treatment.
Table.3.22. Whole blood GSH-Px activity (ju/ml at 30**C)
Day No. Cobalt Treatment Group Number S.E.D P
1 2 3 4 5 6
-77 24“” 26“” 34” 19“ 2 2 “” 30“” 6 .2
-49 27“” 24“” 36” 2 2 “ 2 1 “ 26“” 5.9 0 .2 1 0
0 33“” 27“” 39” 2 2 “ 25“ 30“” 6 .8 0.208
28 30 23 30 19 2 0 24 5.8 0.266
42 28 27 31 2 0 23 25 5 .4 0.414
56 40 39 44 33 35 36 5.7 0.440
97 44” 39“” 44” 31“ 33“” 37“” 5.8 0.180
111 31 28 33 26 25 28 5.5 0.697
139 41" 27“” 36”" 23“ 28“” 29“” 5.6 0.058
Day zero is date o f first Cobalt supplementation.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
xvii
Table 3 .23 . Plasma CK Activity (U/1 at 30 C .)
Day No. Cobalt Treatment Group Number S.E .D P
1 2 3 4 5 6
0 104 67 57 61 74 85 34.4 0.762
28 136 77 54 74 121 227 82.6 0.367
56 72“” 104” 63“ 56“ 65“ 71“ 15.4 0.080
97 51“ 70“” 52* 61“ 128” 54“ 28.5 0 .1 1 0
125 85” 64*” 52“” 40“ 38“ 52“” 17.2 0 .1 1 1
153 186” 80“” 58“ 51“ 56“ 62“” 60.2 0.249
Table.3.24. Serum Copper, Magnesium and Calcium Concentrations
Mineral 
Day No. 1
Cobalt Treatment Group Number 
2 3 4 5 6
S.E.D P
Cu jamol/1
-91 14 15 15 16 14 17 1.497 0.410
0 12“ 13“” 14“” 14“” 12“ 15” 1.167 0.191
153 16“” 16“” 15“” 13“ 15“” 17” 1.571 0.204
Mg
mmol/1
-91 0.96“ 0.97“” 1 .0 0 “” 1.07” 1 .0 0 “” 0.94“ 0.0515 0.227
0 1.03 1 .0 0 0.98 1 .0 1 0.97 0.96 0.0534 0.808
153 1.04”" 1.06" 0.96*” 0.92“ 0.95“” 0 .8 8 “ 0.0406 0.003
Ca mmol/1
-91 2 .3“”" 2.3*”" 2 ,4”" 2 .2 “” 2 .2 “ 2.5" 0.0796 0.039
0 2.4" 2 .2 “ 2 .4”" 2 .3“”" 2 .2 “”" 2 .2 “” 0.0939 0.136
153 2 .0 “ 2 .2 “” 2.3” 2 .2 ” 2 .2 ” 2 .2 ” 0.0610 0.028
Day zero is date o f first vitamin E supplementation.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
X V I 11
Table 3 .2 5 . Differential Cell Counts (%)
Day No. Cobalt Treatment Group Numbers S.E.D P
1 2 3 4 5 6
Neutrophills
28 30 25 26 33 35 26 4.9 0.247
56 37 32 34 38 33 34 6.74 0.964
69 37 30 29 35 40 30 5.27 0.254
97 33 40 32 40 36 34 6.82 0.797
111 28 36 29 35 35 26 4.90 0.245
125 34 25 34 38 28 36 7.07 0.448
153 38" 31“*’" 27“*’ Sô**" 28“*’ 26“ 4.41 0.090
Lymphocytes
28 67 71 70 64 62 72 4.70 0.283
56 62 64 62 60 65 64 6.56 0.980
69 62 66 70 63 58 66 5.56 0.403
97 64 58 64 58 62 64 7.16 0.907
111 68 63 69 62 63 71 5.21 0.431
125 62- IT 64“*’ 59" 70“*’ 61“ 7.10 0.154
153 60“ 66“*’" 70*’" 61“*’ 67“*’" 72" 4.42 0.098
Monocytes
28 0.25“ 1.5“*’ 3" 1.75*’" 2*’" ja b 0.68 0.016
56 1.25“ 3*’ 1“ T 1.25" 1“ 0.72 0.081
69 0.75 1.33 1.25 1 1.25 1.25 0.87 0.983
97 0.75 0.33 1.5 0.75 1 0.75 0.77 0.767
111 0.25 0 0.75 0 0.75 1 0.43 0.128
125 1 0.67 0.75 0.5 1 0.75 0.52 0.917
153 0.25 0.67 1.25 1.25 1 0.25 0,68 0.489
Eosinophills
28 2 1.75 0.75 0.5 0.25 0.5 1.00 0.413
56 0 0.33 1 0.5 0.5 0.5 0.53 0.607
69 0.75 1.33 0.25 1 0.75 2 0.86 0.457
97 2 1 1.25 0.5 0.5 0.75 0.76 0.381
111 2.5 0.67 0.5 1.75 1 1 1.41 0.720
125 3.5 0.33 0.75 0.75 1.25 2.25 2.20 0.710
153 1.25 1.33 1.5 1.25 2.25 1 0.94 0.824
Basophills
28 0.25 0.75 0.25 0.75 0.25 0.5 0.68 0.929
56 0.25 0 1 0.5 0.5 0.75 0.53 0.507
69 0 0.67 0.25 0.25 0.5 1 0.46 0.349
97 0.5 1 0.75 0.75 0.75 1.25 0.64 0.892
111 0.5 0 0.75 1 0.5 0.75 0.53 0.543
125 0.5“ 0.33“ 0.5“ 1.75*' 0.5“ 0.5" 0.47 0.067
153 0.5 1.67 0.25 1 1.25 0.5 0.69 0.341
Day zero is date of first vitamin E supplementation.
Values with different superscripts were significantly different from others in the same row (p <0.05).
XIX
Table.3 .26 . Serum Vitamin Concentrations (ng/1)
Day No. Cobalt Treatment Group Number S.E .D . P
1 2 3 4
-56 586 556 577 452 78.8 0.356
-42 430**= 396*= 558“ 260“ 63.9 0.003
-28 228^ 253“*= 265*= 134“ 59.4 0.181
-14 121 127 143 93 29.6 0.457
0 (84) (78) (63) ( 1 1 0 ) - -
2 1 53* 63“ 70“ 97*= 1 1 .8 0 .0 1 0
35 37“ 34“ 47“ 85*= 1 2 .1 0.008
49 52“*= 46“ 44“ 71*= 1 1 .8 0.147
63 30* 31“ 47*= 61*= 6.5 < 0 .0 0 1
78 6 6 “*= 49“ 48” 69*= 8 .8 0.053
91 79 59 89 65 26.6 0 .6 6 8
105 48 62 74 6 6 15.1 0.384
118 52“ 56“ 82*= 78*= 6.9 < 0 .0 0 1
133 65“*’ 59“ 76“*= 82*= 9.2 0.078
147 48“*= 46“ 74“ 6 8 *“= 9.9 0.017
161 67 46 69 84 2 0 .2 0.325
Table.3.27. Serum MMA Concentrations (^amol/l)
Day No.
1
Cobalt Treatment Group Number 
2 3 4
S.E .D . P
-56 2 .2 2 .0 2 .2 2.3 0.47 0.896
-42 2 .0 1.7 2.4 1.9 0.49 0.570
-28 5.1 3.7 8 ,2 3.9 2.40 0.346
-14 8.4 5.9 8 .0 6.5 2 .8 6 0.769
0 (8 . 1) (7.2) (28) (5.1) - -
21 17*= 13*= 18*= 3.7“ 3.46 0 .0 0 2
35 32"= 2 0 *= 15“*= 7 .0“ 4.94 < 0 .0 0 1
49 38*= 19“*= 30“*= 7.5" 13.01 0 .1 1 0
63 42*= 28*" 2 1 “*= 11“ 7 .52 0 .0 0 2
78 52*= 32“*= 44*= 9.6“ 16.23 0.064
91 58*= 26“*= 55*= 14" 18.19 0.066
105 44*= 16“*= 34*" 10“ 9.51 0.006
118 75*= 57“*= 51“*= 2 0 " 24.3 0.1444
133 60 42 65 14 27.3 0.267
147 104*= 57“*= '7Qab 18“ 33.0 0.074
161 136*= 54“*= 2 1 “ 16“ 45.4 0.039
used as covariates tor the
statistical analysis.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
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T able.3.28. Serum Succinate Concentrations (jumoI/1)
Day No.
1
Cobalt Treatment Group Number 
2 3 4
S.E.D . P
-56 11 9.0 9.2 9.9 1 .1 2 0.418
-42 16*= l l ‘b 12‘b 7.9* 3.22 0.127
-28 7.5*= 6 .6 ‘b 7.2“b 6 .0 * 0.61 0.131
-14 11 12 10 11 1.81 0.789
0 (6.9) (7.5) (7.4) (8.7) - -
21 8 .1 7.2 6 .8 7.6 0.72 0.289
35 7.2 6 .8 6.7 7.6 0.61 0.491
49 6.3 6 .8 5.9 6.4 0.60 0.550
63 13 10 9.6 9.9 1.77 0.242
78 8 .1 7.6 8.9 10 1.75 0.467
91 14 14 13 16 1.71 0.415
105 13 11 11.4 11 1 .2 2 0 .8 6
118 8.9*= 9.1*= 6 .8* 8 .6 *= 0.85 0.04
133 11 8 .0 10 9.5 1.67 0.317
147 11 9.3 9.9 11 1.49 0.681
161 10 7.6 6 .8 8 .8 1.97 0.395
Table.3.29. Serum GOT Activity (SF/ml)
Day No.
1
Cobalt Treatment Group Number 
2 3 4
S.E .D . P
2 1 125 98 80 87 24.9 0.319
49 141 128 99 10 2 24.4 0.264
78 73 78 6 6 75 1 0 .2 0.683
105 98 106 70 76 25.6 0.450
133 156*= 76**= 61* 69**= 44.8 0.159
161 337 56 46 48 166 0.248
Day zero is date o f first Cobalt supplementation and the values in brackets were used as covariates for the 
statistical analysis.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
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Table.3 .30 . Liveweight (kg)
Day No. Cobalt Treatment Group Number S.E.D. P
1 2 3 4
-56 20.1 20.5 19.9 20.3 0.48 0.587
-42 20.1 20.4 19.4 20.5 0.59 0.303
-28 20.8 20.5 20.0 21.1 0.55 0.254
-14 21.3*= 21.2* 20.6* 2 1 .7 b 0.29 0.011
0 (20.5) (20.4) (20.9) (19.8) - -
7 20.6 20.9 20.7 20.4 0.28 0.325
21 20.2 20.5 20.2 20.0 0.32 0.432
28 20.6 20.9 20.5 20.6 0.41 0.822
35 20.5 21.0 20.0 20.6 0.64 0.494
42 20.0 20.7 20.1 20.6 0.74 0.756
49 20.4 21.2 20.4 21.0 0.84 0.707
56 20.3 21.0 20.4 20.8 0.95 0.871
63 20.3 21.6 20.1 21.8 0.97 0.225
70 20.7 21.3 20.3 21.7 0.93 0.461
78 20.7 21.6 20.8 22.5 1.10 0.360
84 20.6‘ 21.8'b 21.1* 23.0b 1.13 0.198
91 20.4' 21.6‘b 21.0* 23.8b 1.06 0.028
98 20.4' 21.6* 21.7* 24.2b 1.10 0.019
105 20.2' 22.1*b 22.1* 2 4 .4 b 1.33 0.040
112 19.9' 22.3'b 22.1* 25.0b 1.41 0.018
118 19.5' 22.6* 22.2* 2 5 .7 b 1.44 0.004
126 20.0' 23.2*= 23.0* 26.3* 1.44 0.004
133 20.2' 23.6*" 23.4* 26.8* 1.57 0.006
140 20.4' 23.8*= 24.5*" 27.9* 1.63 0.002
147 20.2' 24.1*= 24.4*" 28.0* 1.76 0.003
154 20.3* 24.7*= 24.6b 29.1* 1.77 0.001
161 20.4* 25.1b 25.0b 28.8b 1.92 0.004
Day zero is date o f first Cobalt supplementation and the values in brackets were used as covariates for the 
statistical analysis.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
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T able.3.31. Plasma CK Activity (U/I at 30PC)
Day No.
1
Cobalt Treatment Group Number 
2 3 4
S.E.D . P
21 84 55 63 56 23.2 0.572
49 91 76 59 50 20.8 0.230
78 72 75 48 47 19.9 0.343
105 92 89 56 52 29.6 0.399
133 547*= 60“ 47“ 46“ 222 0.089
161 570 59 45 53 263 0.155
Table.3.32. Whole Blood GSH-Px Activity (/i/ml at 30“C)
Day No.
1
Cobalt Treatment Group Number 
2 3 4
S.E.D . P
-56 77 71 73 77 7.6 0.801
-28 90 78 80 85 6.4 0.216
0 85 82 80 91 6.8 0.396
35 73 76 71 83 6.1 0.223
63 53 69 62 66 8.6 0.323
91 54“ 58* 63* 72*= 8.7 0.206
118 46“ 57“ 69* 81*= 10.6 0.023
147 48“ 69*= 74*= 95* 10.0 0.002
161 67“ 93*= 87* 111*= 11.8 0.013
Day zero is date o f first Cobalt supplementation.
Values with different superscripts were significantly different from others in the same row (p < 0 .05 ).
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Table.3 .33 . Serum Copper, M agnesium and Calcium Concentrations
Mineral Cobalt Treatment Group Number S.E.D. P
Day No. 1 2 3 4
Cu jnmol/1
-56 24.5 23.2 23.7 23.8 1.26 0.777
0 12.9 13.5 12.3 13.7 1.06 0.551
161 12.4 11.1 10.7 12.9 1.68 0.529
Mg mmol/1
-56 0.9 0.9 1.0 0.9 0.059 0.474
0 1.0* 1.0*" 1.1* 1.0“ 0.034 0.025
161 1.0 1.0 1.0 1.0 0.045 0.517
Ca mmol/1
-56 2.1“ 2 .1* 2 .1“ 2.3*= 0.093 0.132
0 2.7 2.7 2.7 2.7 0.070 0.932
161 2.5 2.6 2.4 2.6 0.088 0.208
Table.3.34. Serum IgG Titre (mg/lOOml)
Day No.
1
Cobalt Treatment Group Number
2 3 4
S.E .D . P
161 4100 4800 4083 3050 1692 0.78
Day zero is date o f  first Cobalt supplementation.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
XXIV
APPENDIX II
Table 4.1. Composition o f Hay
1 2
Contents
3 4 5 Mean (S.E.)
DM g/kg 846 813 854 877 838 846 10.4
Co mg/kg 0.04 0.05 0.09 0.08 0.06 0.06 9.3*103
Vitamin E 5.4 8.3 9.6 4.7 11.1 7.8 1.22
Se mg/kg 0.03 0.04 0.66 - - 0,04 8.8*10-3
CP g/kg 66 68 88 130 88 88 11.5
OM g/kg 952 945 939 958 940 947 3.6
IVOMD% 61.2 59.4 55.5 50.5 51.8 55.7 2.08
In vitro D 58.3 56.2 52.2 48.4 48.7 52.8 1.98
M/D 9.1 8.7 8.0 7.3 7.4 8.1 0.35
Ca g/kg 2.8 3.0 3.5 3.3 3.8 3.3 0.18
P g/kg 1.4 1.5 1.6 1.4 2.0 1.6 0.11
Mg g/kg 0.8 0.8 1.0 0.8 1.0 0.9 0.05
K g/kg 15.1 15.5 15.2 13.2 17.0 15.2 0.61
Na g/kg 0.18 1.01 1.36 0.83 2.12 1.1 0.319
Cu mg/kg 3.18 3.37 4.62 3.94 3.94 3.81 0.253
Mo mg/kg 0.49 0.37 0.37 0.11 0,19 0.31 0.068
S g/kg 1.06 1.17 1.04 0.9 1.14 1.06 0.047
Zn mg/kg 18.5 20.9 24.4 27.8 22.7 22.9 1.58
Fe mg/kg 85.3 62.4 100.00 67.4 73.7 77.8 6.75
Mn mg/kg 30.3 101.0 125.00 103.00 244 121 34.7
Available Cu 
mg/kg
PUFA
0.29 0.31 0.44 0.42 0.38 0.37 0.03
16:1 3.3 3.3 1.8 2.6 2.1 2.6 0.31
18:1 5.1 5.6 7.2 8.2 10.0 7.2 0.89
18:2 20.7 19.5 19.0 21.7 18.6 19.9 0.57
18:3 38.9 38.4 30.8 31.0 24.8 32.8 2.64
20:3 2.0 2.0 1.9 1.8 3.4 2.2 0.30
20:4 - - 0.1 0.1 - 0.1 0
20:5 3.0 1.3 3.2 2.0 3.5 2.6 0.41
22:5 1.0 0.8 1.7 2.6 1.8 1.6 0.32
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Table 4 .2 . Composition o f  Concentrates.
SOYA BARLEY
1
NaOH treated BARLEY 
2 Mean (S.E.)
DM g/kg 859 838 795 797 796 1
Co mg/kg 0.25 0.04 0.01 0.02 0.02 5*10-^
Vitamin E 1.52 6.9 0.5 0.7 0.6 0.1
Se 0.18 - - - - -
CP g/kg 527 96 91 90 90.5 0.5
OM g/kg 926 979 937 933 935 2
IVOMD% 93.5 84.0 90.1 90.6 90.4 0.25
In vitro D 86.5 82.2 84.3 84.4 84.4 0.05
M/D 13.8 13.2 13.5 13.5 13.5 -
Ca g/kg 3.5 0.5 0.4 0.5 0.45 0.05
P g/kg 7.0 3.5 3.3 3.5 3.4 0.1
Mg g/kg 3.5 1.3 1.2 1.1 1.2 0.05
K g/kg 26 4.48 3.89 3.92 3.90 0.02
Na g/kg 0.07 < 0 .1 22.1 22.1 22.1 -
Cu mg/kg 17.7 4.41 5.06 4.68 4.87 0.19
Mo mg/kg 4.29 0.13 0.10 0.11 0.10 5*1C^
S g/kg 4.75 0.9 0.95 0,87 0.91 0.04
Zn mg/kg 55.9 21.6 24.6 23.6 24.1 0.5
Fe mg/kg 162.00 72.3 93 61.8 77.4 15.6
Mn mg/kg 45.5 18 18 17.0 17.5 0.5
Available Cu 
mg/kg
PUFA
0.29 0.44 0.51 0.47 0.49 0.02
16:1 0.52 0.1 - - - -
18:1 16.0 15.9 14.4 15.5 15.0 0.55
18:2 53.5 46.6 53.8 55.6 54.7 0.9
18:3 6.7 4.2 6.7 5.9 6.3 0.4
20:3 - - - 0.1 - -
20:4 - 0.1 - 0.3 - -
20:5 - 1.0 0.9 0.5 0.7 0.2
22:6 - 3.4 - 0.05 - -
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Table 4 .3 . Composition o f  Propcom Barley.
1
Contents
2 3 4 Mean (S.E.)
DM g/kg 851 810 768 778 802 18.7
Co mg/kg 0.05 0.08 0.05 0.03 0.05 0.010
Vitamin E 4.08 1.52 9.38 3.1 4.52 1.70
Se 0.05 0.01 0.01 - 0.02 0.01
CP g/kg 122 103 113 113 113 3.88
OM g/kg 972 971 971 976 972 1.19
IVOMD% 84 82.3 82.3 80.1 82.2 0.80
In vitro D 81.7 79.9 79.9 78.2 79.9 0.71
M /D 13.1 12.8 12.8 12.5 12.8 0.12
Ca g/kg 0.6 0.8 0.6 0.5 0.6 0.06
P g/kg 3.5 3.8 4.1 4.0 3.85 0.13
Mg g/kg 1.3 1.3 1.4 1.3 1.3 0.025
K g/kg 5.13 4.9 4.89 4.23 4.81 0.17
Na g/kg 0.10 0.19 0.11 < 0 .1 0.12 0.02
Cu mg/kg 4.78 5.26 4.64 5.63 5.08 0.23
Mo mg/kg 0.46 0.21 0.32 0.26 0.31 0.05
S g/kg 1.55 1.27 1.32 1.14 1.32 0.09
Zn mg/kg 25.3 24.2 33.2 36.8 29.9 3.06
Fe mg/kg 126.00 138.00 191 152 152 14.1
Mn mg/kg 16.2 21.4 24.1 23.1 21.2 1.76
Available Cu 
mg/kg
PUFA
0.48 0.53 0.46 0.56 0.51 0.02
16:1 - 1.3 0.5 - 0.9 0.4
18:1 12.8 20.9 15.5 14.8 16 1.73
18:2 56.1 38.3 51.0 56.5 50.5 4.25
18:3 7.1 4.8 6.5 6.4 6.2 0.49
20:4 - 0.7 0.3 - 0.5 0.2
20:5 - 1.0 0.9 - 0.95 0.05
22:6 - 0.4 - - - -
N .B. Urea contains < 0 .01  mg/kgDM Cobalt.
XXVll
Table 4.4. Plasma Vitamin E Concentrations (jumol/1)
DAY No. VITAMIN E TREATMENT GROUPS 
CONTROL ORAL INJECTION
S.E.D P
-70 1.87 1.87 2.18 0.90 0.92
-63 0.78 0.72 1.18 0.37 0.44
-56 0.92 0.80 0.95 0.24 0.82
-49 1.06 0.83 0.96 0.17 0.48
-42 1.14 1.04 1.16 0.14 0.73
-35 1.27 1.24 0.94 0.37 0.62
-28 1 .4 9 b 1.24“b 0.95“ 0.20 0.10
-21 1.50 1.27 1.44 0.16 0.41
-14 1.60 1.44 1.61 0.18 0.60
-7 1.60b 1.30“b 1.20“ 0.13 0.06
0 (1.70) (1.48) (1.65) - -
1 1.67“ 4.28“ 3 5 . 0 7 b 2.03 <0.001
7 1.75“ 6 .9 9 b 6 .5 3 b 0.49 <0.001
14 1.89“ 8.71° 4.68b 0.79 0.001
21 1.85“ 8.86° 4.06b 0.71 <0.001
22 - - 20.3 - -
28 1.70“ 9.02° 6.88b 0.36 <0.001
35 1.78“ 9.04° 5 .0 7 b 0.48 <0.001
42 1.57“ 9.57° 3.66b 0.58 <0.001
49 1.62“ 9.96° 3.56b 0.52 <0.001
56 1.59“ 10.1b 2.62b 0.51 <0.001
63 1.41“ 7.44° 2.71b 0.40 <0.001
70 1.82“ 6.95° 3 ,0 5 b 0.34 <0.001
71 - 22.7 - -
77 1.70“ 7 .9 9 b 7 . 9 5 b 0.36 <0.001
85 2.09“ 6.55° 4 . 8 9 b 0.25 <0.001
91 1.78“ 8.18° 5.16b 0.62 <0.001
Day zero is date of first vitamin E treatment, and the values in brackets were used as covariates 
for the statistical analysis.
Values with different superscripts were significantly different from others in the same row 
(p<0.05).
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Table 4.5. Plasma Vitamin E Concentrations (/xmol/1)
DAY No. 
Vit Bi2  Treat
VITAMIN E TREATMENT GROUPS 
CONTROL ORAL INJECTION
S.E.D P
1 - 1.51“ 3.70“ 3 6 .7 3 b 2.92 0.510
1.84“ 4.85“ 3 3 . 1 7 b
7 - 1.69“ 5.84b 7.21b° 0.70 0.030
+ 1.81“ 8.13° 5.60b
14 - 1.75“ 7.87° 5.04b° 1.14 0.304
+ 2.04“ 9.56° 3.93“b
21 - 1.86“ 7.50b 4.37“ 1.02 0.122
+ 1.84“ 10.2° 3.52“
28 - 1.53“ 7.82° 7.89° 0.52 0.005
+ 1.88“ 10.2^ * 5 . 8 7 b
35 - 1.56“ 7.60° 5.60b 0.70 0.028
1.99“ 10.5“ 4 .5 4 b
42 - 1.30“ 8.17* 4.01b 0,83 0.077
+ 1.84“ 11.0“ 3.32“b
49 - 1.56“ 9.70° 3.60b 0.75 0.852
+ 1.69“b 10.2° 3.52b
5 6 - 1.55“ 9 .2 3 b 3.00“ 0.74 0.140
4- 1.64“ 11.0b 2.24“
63 - 1.29“ 6.42b 2.83“ 0.57 0.079
+ 1.52“ 8 .4 7 b 2.59“
7 0 - 1.74“ 6.07° 3.21b 0.50 0.069
+ 1.91“ 7.83° 2.88“b
77 - 1.20“ 6 .6 3 b 9.04° 0.52 0.003
+ 2.19“ 9.35° 6 . 8 5 b
85 - 1.95“ 5.82b 5.28b 0.36 0.019
+ 2.23“ 7.29° 4.50b
91 - 1.83“ 6 .6 3 b 5.68b 0.89 0.050
“h 1.72“ 9.72° 4 .6 3 b
Day zero is date of first vitamin E treatment, and the values in brackets were used as covariates 
for the statistical analysis.
Values with different superscripts were significantly different from others in the same row 
(p<0.05).
no B12 injection, + =  received B12 injection
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Table 4.6. EST, 1% Tween (% haemolysis)
DAY No. VITAMIN E TREATMENT GROUPS 
CONTROL ORAL INJECTION
S.E.D P
-28 32 18 22 14.5 0.64
-7 45 28 36 15.2 0.55
0 27 14 21 13.4 0.66
1 46 30 44 19.1 0.67
7 38 20 25 13.3 0.42
14 46 36 50 19.0 0.77
21 28 15 25 13.6 0.64
28 46 29 38 21.6 0.73
35 38 20 29 20.0 0.68
42 46 20 38 24.0 0.57
49 44 20 37 24.4 0.65
56 53 37 45 26.9 0.84
63 46 21 38 22.3 0.55
Table 4.7. EST, 3% Tween (% haemolysis)
DAY No. VITAMIN E TREATMENT GROUPS 
CONTROL ORAL INJECTION
S.E.D P
-28 62 52 51 15.1 0.74
-7 68 69 68 12.3 1.0
0 62 68 54 15.2 0.69
1 64 44 47 15.7 0.42
7 56 24 34 15.1 0.18
14 62 49 60 20.2 0.80
21 59 52 55 26.6 0.97
28 61 27 44 20.4 0.32
35 70 44 57 18.7 0.44
42 68 36 58 22.7 0.40
49 76 54 76 17.8 0.43
56 75 55 70 22.2 0.67
63 76 36 68 18.2 0.14
Day zero is date of first vitamin E supplementation.
Values with different superscripts were significantly different from others in the same row 
(p<0.05).
XXX
Table 4.8 . EST, 5% Tween (% haemolysis)
DAY No. VITAMIN E TREATMENT GROUPS S.E.D P
CONTROL ORAL INJECTION
-28 77 80 76 11.0 0.90
-7 76 79 76 8.7 0.92
0 78 78 76 12.2 0.99
1 75 41 47 16.6 0.15
7 74 54 57 13.1 0.32
14 89 84 86 5.9 0.68
21 85 78 79 14.7 0.88
28 72 45 59 17.8 0.38
35 79 61 69 15.3 0.53
42 80 56 77 18.0 0.40
49 74 62 83 15.0 0.31
56 85 76 83 15.3 0.83
63 84 52 78 15.7 0.18
Table 4.9 Plasma CK Activity (U/1 at 30°C)
DAY No. VITAMIN E TREATMENT GROUPS S.E.D P
CONTROL ORAL INJECTION
-70 45 45 60 10.6 0.34
-56 28 33 32 6.7 0.75
-42 32 32 48 15.1 0.48
-28 34 33 36 7.6 0.89
-14 77 66 88 36.9 0.84
0 48 55 64 26.4 0.84
1 45“ 51“ 1 2 4 b 24.9 0.03
7 37 50 31 8.1 0.12
14 36 34 30 3.7 0.38
28 38 35 34 2.0 0.13
42 44 44 45 7.7 1.00
56 34 32 29 4.6 0.58
70 35 35 33 4.5 0.87
85 59 48 55 15.1 0.79
Day zero is date of first vitamin E treatment.
Values with different superscripts were significantly different from others in the same row 
(p<0.05).
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Table 4.10. Serum GOT Activity (SF/ml)
DAY No. VITAMIN E TREATMENT GROUPS 
CONTROL ORAL INJECTION
S.E.D P
-70 75 56 64 15.2 0.50
-63 50 59 55 7.7 0.52
-56 62 79 69 12.6 0.45
-49 52 52 60 7.5 0.52
-42 61 65 70 5.4 0.36
-35 67 62 62 4.9 0.50
-28 63 60 64 2.9 0.35
-14 62 59 63 5.5 0.81
-7 50 54 58 3.6 0.13
0 59 59 59 2.9 1.0
7 55 58 53 4.0 0.39
14 69 65 69 4.4 0.52
21 62 64 67 3.9 0.57
28 66 67 65 3.8 0.87
35 66 66 64 4.4 0.86
42 60 59 66 3.4 0.13
49 57 60 56 3.5 0.54
56 58 60 58 4.8 0.88
63 59 58 60 4.4 0.88
70 70 62 68 2.6 0.07
77 66 53 64 6.5 0.17
85 62 52 70 8.1 0.16
91 88 61 70 12.1 0.16
Day zero is date of first vitamin E supplementation.
Values with different superscripts were significantly different from others in the same row 
(p<0.05).
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Table 4.11. Serum Vitamin B,2 Concentrations (ng/1)
DAY No. VITAMIN Bi2 
TREATMENT GROUPS
+
S.E.D P
-70 215 151 54.6 0.284
-28 71 46 10.6 0.057
7 63b 37“ 6.0 0.004
14 75 47 12.0 0.056
14 p.m. - 1250 - -
15 - 1250 - -
16 67* 6 7 3 b 47.6 <0.001
21 108* 2 2 5 b 18.4 <0.001
28 87* 1 5 5 b 20.0 0.014
42 56* 78b 8.5 0.039
49 57* 1 9 3 b 24,3 <0.001
56 48* 111b 16.4 0.009
63 36* 72b 11.5 0.020
70 30“ 6 5 b 6.4 0.002
77 25“ 2 0 3 b 25.5 <0.001
85 32“ 131b 16.5 <0.001
91 18“ 142b 7.3 <0.001
Day zero is date of first vitamin E supplementation.
Values with different superscripts were significantly different from others in the same row 
(p<0.05).
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Table 4.12. Serum MMA Concentrations (/xmol/1)
DAY No. VITAMIN Bi2 
TREATMENT GROUPS
S.E.D P
- +
-70 0.4 0.4 0.04 0.49
-63 0.6 0.6 0.24 0.95
-56 0.7 0.7 0.22 0.72
-49 0.9 1.0 0.28 0.57
-35 0.9 1.2 0.38 0.49
-21 0.9 1.3 0.48 0.47
-14 1.3 1.7 0.75 0.66
0 1.1 1.2 0.23 0.68
7 1.7 1.7 0.60 0.98
14 1.3 1.6 0.35 0.48
14 p.m. - 1.9 - -
15 - 0.8 - -
16 1.6b 0.7“ 0.17 0.002
21 1 .4 b 0.5“ 0.13 <0.001
28 1 .7 b 0.6“ 0.18 <0.001
42 2.0b 0.7“ 0.19 <0.001
49 2 .5 b 0.4“ 0.54 0.008
56 3.0b 0.5“ 0.71 0.012
63 3.2b 0.6“ 0.84 0.020
70 3.8b 0.5“ 1.19 0.032
77 4.1b 0.4“ 0.78 0.003
85 4.2b 0.4“ 1.21 0.014
91 5.0b 1.0“ 1.25 0.018
Day zero is date of first vitamin E treatment.
Values with different superscripts were significantly different from others in the same row 
(p<0.05).
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Table 4.13. Serum Succinate Concentrations (/xmol/1)
DAY No. VITAMIN Bi2 
TREATMENT GROUPS
-f
S.E.D P
-70 13.5 15.0 1.25 0.30
-63 8.3 9.1 1.33 0.58
-56 9.2 9.7 0.61 0.44
-49 8.4 9.1 0.82 0.42
-35 6.2 6.6 0.75 0.57
-21 4.8 4.7 0.23 0.73
-14 4.0 3.5 0.56 0.45
0 10.7 9.4 0.89 0.21
7 12.7 12.4 1.92 0.87
14 8.4 9.0 0.45 0.24
14 p.m. - 9.3 - -
15 - 9.1 - -
16 8.4 7.4 0.76 0.20
21 5.9 6.8 0.78 0.30
28 10.2 10.2 1.092 0.94
42 7.3 8.2 0.72 0.25
49 5.9 6.2 0.78 0.74
56 5.9 6.9 0.81 0.25
63 6.8 8.1 1.07 0.25
70 5.7“ 7 .3 b 0.57 0.03
77 8.1 8.2 0.94 0.95
85 5.2“ 7.6b 0.83 0.03
91 6.4 7.7 0.79 0.15
Day zero is date of first vitamin E supplementation.
Values with different superscripts were significantly different from others in the same row 
(p<0.05).
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Table 4.14. Liveweight (kg)
DAY No. VITAMIN E TREATMENT GROUP 
MEANS
CONTROL ORAL INJECTION
S.E.D P
-70 141 144 150 4.28 0.18
-63 144 143 148 3.77 0.41
-56 150 146 154 3.17 0.12
-49 158 155 162 3.11 0.19
-42 163 161 169 3.27 0.12
-35 169“b 166" 1 7 3 b 2.35 0.08
-28 179 177 182 1.87 0.12
-21 183 185 186 1.50 0.18
-14 189 188 190 1.83 0.59
-7 195 193 196 1.30 0.23
0 (195) (202) (198) - -
7 203 205 204 1.50 0.39
14 213 215 215 1.88 0.57
21 219 223 221 2.53 0.32
28 227 227 226 2.44 0.94
35 228 230 228 2.60 0.60
42 231 234 234 2.82 0.45
49 238" 2 4 5 b 241"b 1.69 0.03
56 251 258 248 4.31 0.17
63 250 261 250 4.31 0.09
70 256 268 258 5.36 0.14
77 263" 2 7 4 b 262" 4.16 0.06
85 268 278 266 7.65 0.33
91 271 284 271 10.3 0.44
Day zero is date of first vitamin E treatment, and the values in brackets were used as covariates 
for the statistical analysis.
Values with different superscripts were significantly different from others in the same row 
(p<0.05).
XXXVl
Table 4.15. Neutrophil Function Test (% kill)
DAY No. VITAMIN
CONTROL
E TREATMENT GROUPS 
ORAL INJECTION
S.E.D P
E.coli
70 64b 68b 54“ 2.8 0.009
85 49 49 48 5.7 0.96
S.aureus
70 61 62 62 12.8 1.0
85 61 64 56 4.7 0.26
C. albicans
77 16 16 16 1.6 1.00
91 17 14 16 1.9 0.46
Day No. VITAMIN Bi2 TREATMENT 
GROUPS
+
S.E.D. P
E.coli
70 59“ 66b 2.3 0.03
85 47 49 4.6 0.73
S. aureus
70 59 64 10.5 0.68
85 62 59 3.8 0.46
C. albicans
77 14“ 18b 1.3 0.05
91 16 16 1,5 0.92
Day zero is date of first vitamin E supplementation.
Values with different superscripts were significantly different from others in the same row 
(p<0.05).
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Table 4.16. Whole Blood GSH-Px Activity (jx/ml at 30T )
DAY No. VITAMIN E TREATMENT GROUPS 
CONTROL ORAL INJECTION
S.E.D P
-70 54 70 70 11.0 0.31
-63 39 55 49 9.0 0.26
-56 43 59 52 9.0 0.28
-49 40 55 47 7.8 0.26
-42 42 54 51 7.9 0.34
-35 38 49 44 6.6 0.32
-28 41 52 48 8.8 0.50
-21 41 53 48 6.8 0.29
-14 38 54 47 7.5 0.19
-7 29 43 35 7.9 0.30
0 29 43 35 6.0 0.13
7 29 41 32 5.3 0.12
14 25 37 30 5.4 0.18
21 26 34 27 5.3 0.33
28 25 34 28 3.8 0.15
35 24 31 24 4.5 0.28
42 23 29 23 2.8 0.12
49 18 24 19 2.5 0.13
56 18 24 19 3.4 0.27
63 18 22 18 2.4 0.27
70 17 22 19 2.2 0.18
77 15 19 16 1.8 0.16
85 16 17 16 2.2 0.86
Day zero is date of first vitamin E supplementation.
Values with different superscripts were significantly different from others in the same row 
(p<0.05).
XXXVllI
Table 4.17. Serum Copper, Magnesium and Calcium Concentrations.
DAY No. VITAMIN E TREATMENT GROUPS 
CONTROL ORAL INJECTION
S.E.D P
Cu umol/1
-70 12.5 9.8 10.8 1.94 0.41
21 12.5 11.5 11 1.41 0.59
91 1 3 b 9" 11.5"b 1.19 0.04
Mg mmol/1
-70 0.93 0.92 0.90 0.07 0.91
21 0.91 0.96 0.94 0.04 0.46
91 0.90 0.90 0.93 0.04 0.72
Ca mmol/1
-70 2.8 2.9 3.0 0.08 0.27
21 2.6 2.6 2.5 0.05 0.11
91 2.2" 2.4"b 2 .5 b 0.09 0.11
Day zero is date of first vitamin E supplementation.
Values with different superscripts were significantly different from others in the same row 
(p<0.05).
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APPENDIX III 
Table.5.1 Diet Compositions
Straw Pellet Complete Pellet
DM g/kg 841 885
Co mg/kg 0.06 0.13
Se mg/kg 0.05 0.10
CP g/kg 35 93
OM g/kg 888 926
IVOMD % 59.5 74.3
In vitro D 52.8 68.8
M/D 8.2 11.0
Ca g/kg 5.0 5.7
P g/kg 0.6 3.1
Mg g/kg 0.8 2.0
Kg/kg 10.1 7.32
Na g/kg 27.9 14.9
Cu mg/kg 2.65 4.26
Mo mg/kg 0.64 0.55
S g/kg 1.65 -
Zn mg/kg 6.96 18.4
Fe mg/kg 195 289
Mn mg/kg 40.1 33.9
Available Cu mg/kg 0.21 -
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Table.5 .2 . Concentrate Refusals (%)
Month (Pre)
C
Treatment Group 
B M
S.E.D. P
Dec 2.1 1.9 5.1 2.10 0.290
Jan 2.3 2.4 2.8 1.34 0.935
Feb 1.2 1.4 1.4 0.70 0.971
April 32 8.0 29 22.8 0.545
May 59 31 52 22.1 0.444
June 39 70 64 18.6 0.302
Week No.
(Post)
1 56* 33“ 85*= 21.0 0.096
2 12* 6.8“ 87*= 10.3 < 0 .001
3 14* 5.6“ 78*= 12.1 < 0 .001
4 12* 1.9“ 79*= 9.5 < 0 .001
Table.5.3. Forage Refusals (%)
Month (Pre)
C
Treatment Group 
B M
S.E.D. P
Dec 63 61 48 16.0 0.623
Jan 50 55 48 13.5 0.77
Feb 60*= 38“ 60*= 5.4 0.038
April 72 61 62 16.5 0.777
May 65 65 53 18,4 0.767
June 77 59 44 17.6 0.277
Week No.
(Post)
1 72 60 50 19.7 0.557
2 79 70 44 19.2 0.224
3 70 63 55 17.9 0.693
4 69 59 45 18.4 0.444
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
For pre treatment means groups C and M n = 4 , group B n = 5 , except in June n = 2  for all groups 
For post treatment means n = 4 .
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Table.5.4, Serum Vitamin B,; Concentrations Post Treatment (ng/1)
Day No.
C
Treatment Group 
B M
S.E.D. P
0 106 64 61 50 0.616
1 339*= 2500* 56“ 90 < 0 .001
2 678*= 2255* 70“ 266 < 0 .001
3 1010* 1805*= 76“ 492 0.020
6 1038*= 655* 70“ 410 0.112
7 918*= 495* 70“ 310 0.065
8 953*= 2500* 73“ 222 < 0 .001
9 1195*= 2500* 65“ 365 < 0 .001
10 1 1 7 3b 2095*= 65“ 417 0.003
13 1303*= 959* 74“ 431 0.048
14 1268*= 818* 69“ 406 0.045
21 1353*= 880* 78 (140)“ 384 0.029
28 1438*= 1128*= 70 (170)“ 427 0.032
Table.5.5. Serum MMA Concentrations Post Treatment (/xmol/1)
Day No.
C
Treatment Group 
B M
S.E.D. P
0 92 74 140 56.9 0.519
1 82 51 130 44.6 0.259
2 94 99 82 49.4 0.943
3 129 33 100 47.7 0.175
6 16 96 147 69.7 0.218
7 39 26 50 24.5 0.637
8 22 96 149 75.8 0.292
9 12“ 20" 159*= 48.7 0.025
10 31“ 15“ 171*= 42.8 0.010
13 30“ 39“ 211*= 57.7 0.020
14 29“ 31“ 206*= 59.9 0.025
21 7“ 5“ 215 (151)*= 45.8 0.005
28 8“ 4“ 235 (87)*= 52.1 0.023
Day zero is date o f first treatment.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ). 
Figures in brackets refer to sheep recieving 5,6-dimetylbenzimidazole treatment.
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T able.5.6. Serum Succinate Concentrations Post Treatment (jamol/1)
Day No.
C
Treatment Group 
B M
S.E.D. P
0 11.2 8.1 10.2 1.82 0.262
1 11.7 8.4 11.0 2.37 0.395
2 11.1 9.0 8.6 1.14 0.112
3 10.2 8.8 9.2 1.39 0.557
6 11.2 9.3 9.4 2.07 0.616
7 12.0 8.9 8.0 2.04 0.189
8 10.3 8.7 8.6 1.39 0.454
9 9.6 8.8 8.7 1.82 0.865
10 13.4 9.1 9.1 2.58 0.212
13 15.1 12.4 11.0 3.31 0.488
14 15.2*= 10.7* 9.4" 2.40 0.088
21 10.8 7.0 8.7 1.82 0.169
28 14.8 8.3 11.4 3.57 0.239
Table.5.7. Rumen Succinate Concentrations (/tmol/1)
Day No.
C
Treatment Group 
B M
S.E.D. P
0 57 126 42 66 0.429
1 32 392 35 316 0.489
2 37 191 36 112 0.327
3 31 306 300 296 0.589
6 42 1338 37 644 0.119
7 50 1099 37 626 0.206
8 131 600 24 293 0.208
9 2631 315 57 1434 0.193
10 3222 585 69 2101 0.332
13 32 689 39 510 0.375
14 37 752 143 576 0.441
21 39 1100 48 559 0.148
28 47 1127 83 782 0.337
Day zero is date o f  first treatment.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ) .
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T able.5.8. Serum GOT Activity (SF/ml)
Date
C
Treatment Group 
B M
S.E.D. P
7/1/92 66 67 61 8.5 0.722
24/3/92 64 51 62 9.0 0.307
31/3/92 62 66 74 9.8 0.497
28/4/92 59 56 78 12.3 0.209
26/5/92 45 87 88 54.6 0.664
23/6/92 83 59 107 34 0.373
Table.5.9. Liveweights (kg)
Date
C
Treatment Group 
B M
S.E.D. P
18/7/91 84 82 82 12.0 0.984
23/8/91 75 75 75 10.7 0.998
11/9/91 76 73 72 12.8 0.959
2/10/91 75 72 70 12.6 0.925
12/11/91 71 72 70 9.5 0.969
17/12/91 74 74 72 9.7 0.960
7/1/92 73 73 73 9.5 0.999
18/2/92 74 73 73 9.3 0.986
8/4/92 75 75 76 7.1 0.993
12/5/92 73 73 74 6.9 0.972
26/5/92 72 70 74 7.5 0.866
9/6/92 72 72 73 6.8 0.990
23/6/92 71 73 72 7.6 0.962
30/6/92 68 69 67 7.6 0.975
14/7/92 70 70 62 7.1 0.525
28/7/92 72 73 64 7.0 0.500
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
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Table.5.10, W hole Blood GSH-Px Activity at 30°C)
Date
C
Treatment Group 
B M
S.E.D. P
22/10/91 49 49 54 13.5 0.886
3/12/91 40 40 48 11.2 0.703
7/1/92 53 50 55 10.7 0.892
4/2/92 55 58 61 7.3 0.716
4/3/92 54 60 60 8.5 0.708
31/3/92 52 56 53 8.8 0.840
28/4/92 56 58 58 12.9 0.974
26/5/92 77 73 75 11.1 0.950
23/6/92 82 88 89 10,9 0.818
28/7/92 84 76 80 8.0 0.656
Table.5.11. Serum Copper, Magnesium and Calcium Concentrations.
Date
C
Treatment Group 
B M
S.E.D. P
Cu /imol/i
18/7/91 15.8’’ 13.2“ 14.1“’’ 1.2 0.108
26/5/92 11.6 10.4 11.2 2.0 0.815
23/6/92 10.5“’’ 8.6“ 11.9’’ 1.3 0.077
Mg mmol/1
18/7/91 0.9 1.0 1.0 0.1 0.645
26/5/92 1.1 1.0 1.1 0.1 0.637
23/6/92 1.1 1.1 1.1 0.05 0.624
Ca mmol/1
18/7/91 2.2 2,2 2.3 0.2 0.859
26/5/92 2.4 2,7 2.6 0.2 0.481
23/6/92 2.6 2.6 2.7 0.2 0.978
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
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T able.5.12. Rumen Acetate Percentage
Day No.
C
Treatment Group 
B M
S.E.D. P
0 66.2 66.7 68.0 2.39 0.750
1 64.7 66.2 64.6 2.04 0.637
2 65.7 64.8 66.4 2.10 0.772
3 67.3 65.3 66.8 2.56 0.730
6 66.4 63.4 65.8 4.30 0.761
7 66.0 64.0 65.5 3.59 0.845
8 63.4 65.2 66.6 2.99 0.576
9 62.0 64.3 63.3 2.09 0.575
10 61.3 64.6 63.3 2.12 0.341
13 59.6’’ 61.8“’’ 65.5’’ 1.90 0.036
14 60.8“ 64.0“’’ 65.5” 1.96 0.098
21 60.8“ 63.6’’ 65.8” 0.99 0.002
28 60.8“ 63.3“ 67.8” 1.74 0.009
Table.5.13. Rumen Propionate Percentage
Day No.
C
Treatment Group 
B M
S.E.D. P
0 20.6 20.2 18.7 2.32 0.703
1 21.0 21.5 22.3 2.08 0.829
2 20.9 22.8 20.1 2.16 0.484
3 19.6 21.8 19.9 2.18 0.591
6 21.9 24.0 19.2 3.19 0.369
7 22.8 23.2 19.3 3.15 0.425
8 24.0” 23.0“” 18.4“ 2.23 0.073
9 24.5 21.7 20.2 2.55 0.277
10 25.3 21.4 23.6 3.02 0.468
13 28.8” 25.5” 20.8“ 1.81 0.006
14 26.9” 22.2“” 21.3“ 2.22 0.069
21 26.3“ 22.8” 19.5“ 1.00 < 0.001
28 25,3” 22.4“” 19.5“ 1.98 0.048
Day zero is date o f  first treatment.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ) .
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T able.5.14. Rumen Butyrate Precentage
Day No.
C
Treatment Group 
B M
S.E.D. P
0 8.51 8.77 8.87 1.14 0.950
1 9.77 8.07 9.02 1.11 0.332
2 8.80 7.95 9.07 0.95 0.494
3 8.68 8.34 8.80 1.42 0.947
6 7.76 8.24 10.1 1.68 0.373
7 7.23“ 8.31“” 10.8” 1.25 0.047
8 8.57 7.68 10.3 1.43 0.226
9 9.07“ 9.46“” 11.6” 1.06 0.087
10 9.10 9.47 8.62 0.94 0.672
13 7.65 8.18 9.01 0.64 0.155
14 8.28 9.13 8,65 0.50 0.293
21 8.34 8.89 9.45 0.699 0.381
28 9.41 9.43 8.18 0.94 0.359
Table.5.15. Rumen Acetate : Propionate Ratio
Day No. Treatment Group S.E.D. P
C B M
0 3.28 3.40 3.76 0.55 0.676
1 3.12 3.11 2.89 0.395 0.810
2 3.23 2.85 3.43 0.48 0.499
3 3.48 3.03 3.54 0.55 0.626
6 3.54 2.67 3.45 0.90 0.590
7 3.19 2.80 3,48 0.70 0.637
8 2.69“ 2.90“” 3.68” 0.41 0.086
9 2.56 3.13 3.16 0.42 0.322
10 2.46 3.21 2.76 0,51 0.379
13 2.08“ 2.08“ 3.19” 0.30 0.013
14 2.28 2.99 3.10 0.38 0.118
21 2.31“ 2.82” 3.38“ 0.17 < 0 .001
28 2.43“ 2.87“” 3.52” 0.31 0.020
Day zero is date o f  first treatment.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ) .
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Table.5.16. Rumen Acetate +  Butyrate : Propionate R.Uio.
Day No.
C
Treatment Group 
B M
S.E.D. P
0 3.70 3.85 4.25 0.61 0.661
1 3.59 3.49 3.30 0.45 0.815
2 3.66 3.20 3.90 0.54 0.455
3 3.92 3.42 4.00 0.61 0.601
6 3.89 3.02 3.98 0.91 0.526
7 3.51 3.17 4.06 0.73 0.504
8 3.05“ 3.24“ 4.25” 0.44 0.050
9 2.94 3.59 3.74 0.49 0.273
10 2.83 3.68 3.14 0.61 0.405
13 2.35“ 2.80“ 3.63” 0.32 0.009
14 2.59 3.42 3.51 0.43 0.117
21 2.63“ 3.21” 3.86“ 0.20 < 0 .001
28 2.81“ 3.29“” 3.94” 0.35 0.032
Day zero is date o f first treatment.
Values with different superscripts were significantly different from others in the same row (p < 0 .0 5 ).
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